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ABSTRACT
Herpesviruses are involved in a range of prominent medical or veterinary diseases 
making this one of the most significant virus families. Their ubiquitous occurrence, 
genetic complexity and differing biological properties have stimulated considerable 
research efforts worldwide particularly in the area of molecular genetics. 
Herpesviruses differ widely in their pathogenic potential but share the ability, after 
primary infection, to establish latent infections throughout the lifetime of the host.
To date, eight different herpesviruses whose natural host is man have been identified: 
herpes simplex virus (HSV) types 1 and 2, varicella-zoster virus, Epstein-Barr virus, 
human cytomegalovirus and human herpesviruses (HHV) types 6-8. A large 
proportion of people worldwide have been exposed to, and may be latently infected 
with, one or more herpesvirus. Generally, these viruses are controlled by an intact 
immune system but they cause life-threatening disease in immunocompromised 
individuals and some are implicated in different types of cancer. With increased use 
of immunosuppressive drugs and the advent of AIDS, herpesvirus infections pose a 
growing problem . Although a number of anti-herpesvirus drugs have been marketed, 
drug resistance can develop and researchers continue to search for novel targets for 
drug development at key points in the virus lytic cycle.
HSV-1 proteins are divided into three regulatory classes, immediate-early (IE), early 
and late depending upon their kinetics of expression and requirement for ongoing 
DNA synthesis. The HSV-1 protein IE63 (ICP27) is essential for viral replication, and 
is the only HSV-1 IE protein which has homologues in every herpesvirus sequenced 
so far which infect mammals and birds, indicative of its key regulatory role and 
making it an excellent antiviral target.
IE63 is a 512 amino acid phosphoprotein which has previously been demonstrated to 
be required for virus late gene expression and DNA replication, and appears to exert 
its effects at both transcriptional and post-transcriptional levels. The mechanism of 
IE63 action at the transcriptional level is not known but IE63 appears to interact with
the essential HSV-1 transcriptional regulator IE 175 and may alter the promoter 
binding of this protein.
At the post-transcriptional level, IE63 increases RNA 3’ processing at late vital 
poly(A) sites, a process which may allow IE63 to regulate the switch between early 
and late viral gene expression. IE63 has also been shown to inhibit pre-mRNA 
splicing in HSV-1 infected cells. During HSV-1 infection, splicing factors redistribute 
within the nucleus and IE63 is necessary and sufficient for this effect, leading 
researchers to postulate that IE63 may inhibit splicing by facilitating the removal of 
splicing factors to dysfunctional aggregates. The inhibition of splicing is highly 
advantageous because the majority of HSV-1 transcripts do not contain introns and 
therefore do not require splicing, in contrast to the majority of cellular transcripts. 
Although the redistribution of splicing factors has a role in the inhibition of splicing, 
studies have shown that another, as yet unidentified mechanism, acts in concert with 
the redistribution of splicing factors to disrupt the splicing process in HSV-1 infected 
cells.
Finally, IE63 facilitates the nuclear retention of intron-containing transcripts which 
also favours the translation of viral and not cellular RNAs. IE63 binds RNA, shuttles 
between the nucleus and the cytoplasm, and it is thought that IE63 acts to selectively 
export viral RNAs from the nucleus. Other viral proteins notably the human 
immunodeficiency virus-1 (HIV-1) Rev protein shuttle between the nucleus and the 
cytoplasm transporting spliced or partially spliced HIV-1 RNAs. Interestingly, a 
number of cellular and viral proteins have an altered phosphorylation state in the 
presence of IE63 although IE63 itself does not exhibit kinase activity. This indicates 
that IE63 may exert effects by recruiting a kinase to phosphorylate proteins required 
for its various functions.
IE63 clearly exhibits several activities and it seemed likely that it exerted its effects 
by interacting with various cellular proteins involved in these processes and 
modifying their activities. The aim of this study was therefore to screen a library of 
cellular proteins to identify those which interacted with HSV-1 IE63. This 
information was likely to shed light on the mode of action of this protein.
The yeast two-hybrid system was used to identify interacting proteins. This system 
exploits the ability of a ‘bait’ protein fused to the binding domain of a yeast 
transcription factor to interact with a target protein fused to the activation domain of 
the same yeast transcription factor, bringing the two domains into close enough 
proximity to reconstitute activity of the transcription factor and subsequent 
transcription of reporter genes in yeast cells. Proteins that do not interact do not 
permit activation of reporter gene expression.
In this study, a truncated IE63 protein was used to screen proteins expressed from an 
uninfected HeLa cell cDNA library. The protein was truncated because it was found 
that that the N-terminal ten amino acids of IE63 caused transcription of reporter genes 
in the absence of an interacting protein. The screen identified eight cellular proteins 
which interacted with IE63, four of which were of initial interest. These were 
heterogeneous nuclear ribonucleoprotein K (hnRNP K), casein kinase II (CKII) p 
subunit, and the splicing factors Spliceosome Associated Protein 145 (SAP 145) and 
p32:- these interactions were all subsequently confirmed in virus infected cells by 
others in our laboratory. Truncation mutants of IE63 were constructed and using 
these in the two-hybrid assay, the regions of IE63 required for these various 
interactions were mapped as well as the IE63 region required for dimersation. 
Similarly, using hnRNP K truncations, regions required for interaction with IE63 
were identified
A region containing the zinc finger domain of IE63, located towards the C-terminus, 
was required for interaction with the CKIIp subunit, with SAP 145 and for IE63 
dimerisation. Dimerisation would permit IE63 to form interactions with multiple 
partners in a complex of proteins with RNA, allowing cross-talk between these 
molecules. An IE63 region involved in the interaction with hnRNP K contained a five 
amino acid sequence (SADET) which is well conserved throughout the 
alphaherpesviruses, and which is present in a region of hnRNP K required for 
interaction with IE63 and is necessary for the nuclear export of hnRNP K. This region 
of IE63 could have a role in nuclear export, perhaps recognising a nucleoporin also 
recognised by hnRNP K. A further IE63 region with runs of prolines was identified as
involved in interactions with hnRNP K and CKIIp, and was the only region necessary 
for the interaction with p32.
It is highly probable that IE63 inhibits splicing by interacting with SAP 145 and/or 
p32, and it appears that CKII is recruited by IE63 to phosphorylate itself, hnRNP K 
and probably other proteins. The function of hnRNP K in uninfected cells is not 
completely understood but it is thought that the protein has a role in transcription, pre- 
mRNA processing, RNA transport and translation. It is proposed that IE63 may alter 
transcription, mRNA processing and transport in the HSV-1 infected cell via its 
interaction with hnRNP K.
The study also demonstrated that IE63 can form interactions with a transcriptional 
activator ALY, a glutamine-rich protein, the protein human JTV-1 of unknown 
function and the nucleoporin RIP1. Furthermore, the nucleoporin CRM1 which 
interacts with HIV-1 Rev and facilitates its export to the cytoplasm did not interact 
with IE63 in the two-hybrid assay, suggesting that IE63 and Rev may use different 
pathways to cross the nuclear pore. Finally, the HHV-8 (Kaposi’s sarcoma 
herpesvirus) ORF57 homologue of IE63, which also acts post-transcriptionally, did 
not interact with the hnRNP K, CKIIp, SAP 145 and p32 clones identified in the 
library screen suggesting that these distantly related homologues, which belong to 
different herpesvirus subgroups, are likely to possess certain different activities.
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INTRODUCTION
1.1 THE UBIQUITOUS HERPES SIMPLEX VIRUS TYPE-1
Herpes simplex virus (HSV) causes an acute, infectious disease which is 
characterised by the development of small fluid-filled vesicles in the skin and 
mucous membranes. The virus exists in two forms, herpes simplex type 1 
(HSV-1) and herpes simplex type 2 (HSV-2), both of which are members of 
the family Herpesviridae. More than 80 herpesviruses have been isolated 
from a diverse range of species including mammals, fish, reptiles, birds, 
amphibians and marsupials. Eight of the herpesviruses have been shown to 
infect humans. Table 1.1 lists the eight human herpesviruses identified 
together with the illnesses that they cause and the subgroups of mammalian 
herpesviruses to which they belong.
All herpesviruses (reviewed in Roizman & Sears, 1996) have three distinct 
characteristics. First, all have a large genome consisting of a single molecule 
of double stranded DNA ranging in size between 120 and 250 kilobase pairs 
(kb). Second, all have the ability to enter a latent phase in the host cell which 
ensures survival of the viral genome throughout the lifetime of an infected 
individual. Third, all show the same basic morphology and this morphology 
is the primary basis of identification.
1.1.1 Virion morphology
The HSV-1 virion is approximately 150-200 nm in diameter and consists of 
four primary structural features which are illustrated diagramatically in
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Figure 1.1. The capsid has an icosahedral structure (100-110 nm in diameter) 
which consists of 162 capsomers. Enclosed inside the capsid is an electron 
opaque structure, the core, which contains the viral DNA. Both capsid and 
core are enveloped by a lipid containing membrane, the envelope, which 
contains a number of virus encoded glycoprotein spikes (HSV-1 encodes at 
least 11) and is acquired by the budding of capsids through the lipid bilayer 
membrane of the host cell. The tegument is an electron dense material which 
is located between the capsid and the envelope and is comprised of viral and 
possibly some cellular proteins, the properties and functions of which are 
largely unknown, but they include the proteins VP 16 and UL41 which 
contribute to efficient infection.
1.1.2 Clinical features and epidemiology of HSV-1 infection
The severity of the illness caused by the HSV-1 virus can vary greatly, 
ranging from the asymptomatic to a severe systemic illness which is 
occasionally fatal. The majority of childhood HSV-1 infections are 
asymptomatic but they may be followed by subsequent periods of 
symptomatic disease. In children 1-3 years of age, the major symptom of 
HSV-1 infection is gingivostomatitis, an infection of the gums, tongue, 
mouth, lip, facial area and pharynx. Reactivated HSV-1 is associated with 
mucosal ulcerations or lesions around the lips that last 4-7 days and are often 
referred to as cold sores or fever blisters. Such lesions can be both irritating 
and distressing to the sufferer. Acute HSV-1 rhinitis is a primary infection of 
the nose and is recognised by the appearance of tiny vesicles in the nostrils
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Representation o f  virion morphology o f Herpesvidae, show ing 
the outer envelope layer containing glycoprotein m olecules, the 
tegum ent and icosahedral capsid surrounding the central core o f 
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usually associated with fever and enlarged lymph nodes in the neck. Other 
HSV-1 induced diseases include primary herpes dermatitis, eczema 
herpeticum and traumatic herpes. Herpetic whitlow results from infection of 
broken skin, often on fingers after coming into contact with virus from 
another individual. HSV-1 infections of the eye can lead to 
keratoconjunctivitis which can, in rare instances, cause blindness.
HSV-1 infections occur throughout the world with approximately one third 
of the population in developing countries and the lower socio-economic 
classes of developed countries seroconverting to HSV-1 by 5 years of age, 
and the frequency increases to 70-90% during adolescence. For HSV-1 
infection to occur, the virus must come into contact with mucosal surfaces or 
grazed skin. Following replication at the site of infection, the virus is 
transported via the neurons to the dorsal root ganglia where latency is 
established. Replication in the ganglia occasionally results in a life 
threatening central nervous system infection, however, latency generally 
predominates.
1.1.3 The HSV-1 genome and life cycle
(a) Genome arrangement
The HSV-1 genome is comprised of linear, double-stranded DNA and has an 
unusually high G+C content (67%). The HSV-1 genome arrangement 
together with the position of latency associated transcripts (LATs) is
3
illustrated in Figure 1.2. The genome consists of two unique components 
designated unique long ( U l )  and unique short (Us) which comprise 82 and 
18% of the DNA respectively. Each is bounded and linked by a set of 
internal (IR) and terminal (TR) repeats; TRL/IRL and IRS/TRS which are 
also designated ab/b’a’ and a’c’/ca. A sequence which varies in length 
between 250-500 bp (the a sequence) is present as a direct repeat at both 
termini and in an inverted orientation at the L-S junction (Sheldrick & 
Berthelot, 1974, Davison & Wilkie, 1983, Delius & Clements, 1976, 
Hayward et al., 1975). During infection the L and S components invert 
relative to each other so that the progeny viral DNA consists of equimolar 
amounts of four isomers differing from each other solely in the relative 
orientation of the two components. These isomers are termed: P (prototype), 
IL (inversion of L), IS (inversion of S) and ISL (inversion of both L and S) 
(Delius & Clements, 1976, Hayward et al.> 1975, Roizman, 1979).
(b) The life cycle of the virion, L particles and PREPS
Figure 1.3 illustrates the HSV-1 life cycle which takes approximately 18 h to 
20 h in fully permissive tissue culture cells (reviewed in Roizman & Sears, 
1996). The first stage of the life cycle is entry of the virus into the host cell 
and this occurs in two phases, viral attachment with rapid transition to 
penetration of virus into the cell. Entry of the virus is thought to require the 
sequential or simultaneous interaction of the virion envelope glycoproteins 
with cell surface receptors (Fuller & Lee, 1992). The de-enveloped capsid is 
transported to the nuclear pores via the cellular cytoskeleton where its DNA
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is released into the nucleus. Host macromolecular synthesis is subsequently 
shut off. Transcription of the viral DNA by host cell RNA polymerase II 
takes place in the nucleus of the cell and the mature transcripts are 
transported to the cytoplasm where protein synthesis is carried out (Honess & 
Roizman, 1974). Viral DNA synthesis occurs in the host cell nucleus and 
can be detected from 3h post infection (pi) and continues for at least another 
9 h to 12 h pi (see Section 1.1.4). In most instances, infected cells release 
two types of HSV-1 particles, but only one, the virion, contains HSV DNA 
and is thus capable of infecting another cell. L particles (Szilagyi & 
Cunningham, 1991) lack the nucleocapsid which contains the viral DNA and 
are thus non-infectious. They can be separated from the heavier HSV virions 
by banding in a Ficoll gradient, hence their name L (light) particles.
Although the function of L particles in productive infection is not known at 
present, it is possible that they act as a decoy, enhancing the virion’s chances 
of successful infection by adsorbing to a proportion of the circulating 
antibodies.
‘Pre-DNA replication’ or PREP particles (Dargan et al., 1995) are 
synthesised by HSV-1 infected cells only when viral DNA synthesis is 
blocked either genetically in viruses with a mutation in a DNA replication 
gene or biochemically by growth of virus in the presence of inhibitors such as 
acyclovir or phosphonoacetic acid. PREP particles are not, therefore, 
normally produced during infection. PREP particles are similar to L particles 
but they either lack true late proteins or possess them in minute quantities.
5
The relative proportions of many other tegument and envelope proteins are 
also altered.
It is thought that the virion is enveloped by patches on the inner nuclear 
membrane. The virions then accumulate in the endoplasmic reticulum and 
transverse the Golgi apparatus and the trans Golgi network to the 
extracellular space.
(c) Latency
HSV-1 is able to exist in a non-replicative state which is often followed by , 
virus reactivation and symptomic disease (reviewed in Rock, 1993). 
Following replication in the epithelia, virions or capsids are transported along 
neurons to the nerve cell bodies in the tri-geminal ganglia (Kristensson et al., 
1986). Here HSV DNA is thought to exist in an extrachromosomal state, 
probably as a circular episome (Mellerick & Fraser, 1987). During latent 
infection the only detectable viral gene expression is that of a major class of 
transcripts called the latency associated transcripts (LATs) (reviewed in 
Block & Hill, 1997). Although LATs are not essential for the establishment 
and maintenance of latency it appears that both the LAT region of the 
genome (Block et al., 1993, Deshmane et al., 1993, Dobson et al., 1989, Hill 
et al., 1990, Javier et al., 1988, Leib et al., 1989) and a functional IE110 
protein (Chen et al., 1991, Harris et al., 1989, Lieb et al., 1989, Zhu et al., 
1990) affect the efficiency of reactivation of latent virus. Stimuli that cause
6
virus reactivation are thought to include fever, exposure to sunlight, stress 
and possibly hormonal irregularities.
1.1.4 DNA replication
During lytic infection with HSV-1 in cell culture, as much as 50% by mass of 
the host cell DNA content is viral following the peak rates of viral DNA 
replication; this typically occurs between lOh and 20h post infection. Viral 
DNA replication is initiated at one of the 3 origins of replication by 
interaction with the ORI binding protein UL9. The viral helicase/primase 
complex consisting of UL5, 8 and 52 subsequently associates with the origin 
and the hydrolysis of ATP creates an initiation ‘bubble’ which permits 
association with the polymerase UL30/UL42 DNA-binding protein complex. 
DNA synthesis is continuous along one strand and discontinuous on the 
lagging strand with the major DNA-binding protein UL29 maintaining the 
growing forks. Figure 1.4 shows a schematic summary of the biochemical 
activities of the HSV encoded proteins involved in DNA replication as 
proposed by Challberg (Challberg, 1991).
1.1.5 Transcription of the genome
(a) Kinetic classes of HSV-1 transcripts
Herpesvirus genes are transcribed by the host cell RNA polymerase II 
(Constanzo et al., 1977). The genes can be divided into at least 3 regulatory
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classes, immediate early (also known as a  or IE), early (also known as p, 
delayed-early or E) and late (also known as y or L) (Clements et al., 1977, 
Honess & Roizman, 1974). This classification system is based on the 
kinetics of their expression and requirements for ongoing DNA synthesis. 
Five IE proteins (reviewed by Roizman & Sears, 1996) are produced from 
transcripts that can be expressed in the absence of viral protein synthesis and 
four of these regulate expression of early and late viral genes. Early proteins 
are involved in DNA metabolism and DNA replication, their expression 
signalling the onset of viral DNA synthesis. Expression of late viral genes 
can be divided into two phases based on the stringency of their requirement 
for DNA synthesis; the leaky late class of genes (yi) expressed prior to DNA 
replication, and the strict late genes (y2) expressed once viral DNA replication 
has commenced. These proteins comprise the majority of virus structural 
components. HSV-1 transcribes some 80 genes but only four of the virus 
pre-mRNAs contain introns.
The HSV-1 genome is estimated to encode at least 80 unique proteins. Table
1.2 lists the functions or properties of the proteins encoded by the HSV-1 
genes that have been identified to date.
(b) Systems of HSV-1 protein nomenclature
There are a number of systems that have been designed to describe the 
proteins of HSV-1. These include:-
8
(i) the order of the open reading frames (ORFs) occurring in the various 
regions of the genome e.g. UL19.
(ii) a system based on protein function e.g. ribonucleotide reductase.
(iii) a system based on the apparent molecular weight of the protein as 
determined by migration of viral proteins in denaturing polyacrylamide 
gels e.g. viral protein of molecular weight 63 kDa (Vmw63) or 
immediate-early 63 (IE63). This system is known as the Glasgow 
system.
(iv) The Chicago or Infected Cell Protein (ICP) system. This is distinct 
from the Glasgow system and represents a number corresponding to the 
location on a polyacrylamide gel rather than the actual molecular 
weight of the protein e.g. ICP27 corresponds to IE63.
In this thesis, the IE proteins have been referred to using the Glasgow system. 
Table 1.3 shows the corresponding Chicago system nomenclature for the 
immediate-early genes. The majority of other proteins have been referred to 
on the basis of their ORF location or function.
9
Table 1.2. FUNCTIONS AND PROPERTIES OF HSV-1 PROTEINS
Gene Function of Protein
RL1 Neurovirulence factor (ICP34.5)
RL2 IE protein; modulator of cell state and gene expression (ICPO, 
VmwllO)
LAT Latency associated transcripts
UL1 Glycoprotein L; complexes with glycoprotein H (UL22)
UL2 Uracil-DNA glycosylase
UL3 Function unknown
UL4 Function unknown
UL5 Component of DNA helicase-primase complex; possesses 
helicase motifs
UL6 Minor capsid protein
UL7 Function unknown
UL8 Component of DNA helicase-primase complex
UL8.5 Encodes a 486 amino acid protein; potential role in DNA 
replication
UL9 Ori-binding protein essential for DNA replication
UL9.5 Function unknown
UL10 Virion surface glycoprotein M
UL11 Myristylated tegument protein; role in virion envelopment
UL12 Deoxyribonuclease; role in maturation/packaging of DNA
UL13 Tegument protein, protein kinase
UL14 Function unknown
UL15 Role in DNA packaging, putative terminase component
UL16 Function unknown
UL17 Function unknown
UL18 Capsid protein (VP23); component of intercapsomeric triplex
UL19 Major capsid protein (VP5); forms hexons and pentons
UL20 Integral membrane protein; role in egress of nascent virions; 
host range phenotype; syn locus
UL21 Tegument protein
UL22 Virion surface glycoprotein H; complex with glycoprotein L 
(UL1)1; role in cell entry
UL23 Thymidine kinase
UL24 Function unknown, syn locus
UL25 Capsid-associated tegument protein
UL26 Protease, acts in virion maturation; N-terminal portion is 
capsid protein (VP24)
UL26.5 Internal protein of immature capsids (VP22a); processed by 
UL26 protease
UL27 Virion surface glycoprotein; role in cell entry; syn locus
UL27.5 ORF is antisense to UL27; function unknown
UL28 Role in DNA packaging
UL28.5 Function unknown
UL29 Single-stranded DNA-binding protein (ICP8)
UL30 Catalytic subunit of replicative DNA polymerase; complexes 
with UL42 protein
Gene Function of Protein
UL31 Function unkown
UL32 Function unknown
UL33 Role in DNA packaging
UL34 Membrane-associated phosphoprotein; substrate for US3
protein kinase
UL35 Capsid protein (VP26); located on tips of hexons
UL36 Very large tegument protein
UL37 Tegument protein
UL3 8 Capsid protein (VP 19C); component of intercapsomeric triplex
UL39 Ribonucleotide reductase large subunit (ICP6, Vmwl36, R l)
UL40 Ribonucleotide reductase small subunit (Vmw38, R2)
UL41 Tegument protein, host-off factor
UL42 Subunit of replicative DNA polymerase; increases
processivity; complexes with UL30 protein 
UL43 Function unknown, probable integral membrane protein
UL43.5 ORF is antisense to UL43. Localizes with capsid proteins in
the nucleus; may play a role in capsid assembly 
UL44 Virion surface glycoprotein C; role in cell entry
UL45 Tegument/envelope protein
UL46 Tegument protein; modulates IE gene transactivation by UL48
protein
UL47 Tegument protein; modulates IE gene transactivation by UL48
protein
UL48 Tegument protein; transactivates IE genes (VP 16, Vmw65, a-
TIF)
UL49 Tegument protein
UL49A Envelope protein disulphide-linked to tegument
UL50 Deoxyuridine triphsophatase
UL51 Function unknown
UL52 Component of DNA helicase-primase complex
UL53 Glycoprotein K
UL54 IE protein; post-translational regulator of gene expression
(ICP27, Vmw63)
UL55 Function unknown
UL56 Function unknown
RSI Nucleotidylated, polyADP-ribosylated immediate early
phosphoprotein (Vmwl75, ICP4) regulates positively most 
early and late genes and negatively itself and RL2. It binds to 
DNA in sequence specific manner 
US 1 Nucleotidylated immediate early protein (Vmw68, ICP22);
function unknown; host range phenotype 
US 1.5 Gene 3’ co-terminal with US 1
US2 Function unknown
US3 Protein kinase; phosphorylates UL34
US4 Virion surface glycoprotein G; function unknown
US5 Virion surface glycoprotein J; function unknown
US6 Virion surface glycoprotein D; role in cell entry and cell-cell
spread
Gene
US7
US8
US9
US10
US11
US12
LAT 
ORF P
ORF O
Function of Protein
Virion surface glycoprotein I; complexed with glycoprotein E
(US8) to form Fc receptor; role in cell-cell spread
Virion surface glycoprotein E; complexed with glycoprotein I
(US7) to form Fc receptor; role in cell-cell spread
Virion protein; function unknown
Virion protein; function unknown
Abundant tegument protein; localizes to the nucleolus and
ribosomes in infected cells; RNA binding protein
Immediate early protein (Vmwl2, ICP47); role in preventing
antigen presentation
Latency-associated transcript; probably not protein-coding 
Encodes a 248 amino acid protein of unknown function. ORF 
is antisense to RL1. The gene is expressed under conditions in 
which Vmwl75 is not functional
ORF is partially antisense to RL1. The protein is expressed 
under conditions in which Vmwl75 is not functional.
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(c) Promoter sequences
Transcription of the immediate-early genes proceeds from enhanced 
promoters by interaction of the virion protein a-TIF (also known as Vmw65 
or VP 16) (Campbell et al., 1984) with cellular transcription factors (Preston 
et al., 1988) and does not require de novo protein synthesis in the infected 
cell (reviewed by O'Hare, 1993). The complex containing a-TIF activates 
gene transcription by recognition of ‘TAATGARAT’ sequences upstream of 
immediate early gene promoters (Gaffney et al., 1985). The basic promoter 
for all early viral transcripts is a RNA polymerase II promoter similar to 
those that exist in a number of eukaryotic genes and other DNA-containing 
viruses. The promoters controlling the leaky late transcripts also include an 
80-120 bp pol II promoter element, but some have transcriptional regulatory 
elements near and downstream of the cap site (Wagner et al., 1995). The 
functional portion of ‘strict’ late promoters extends 5’ of the cap site 25-30 
bases to a ‘TATA’ box, but elements at and 3’ of the cap site are also present.
(d) Proteins that function in the regulation of viral transcription
The a-TIF protein (VP 16, or Vmw65) has a relative molecular weight of
65,000 Daltons and is comprised of two separable functional domains 
(reviewed by Flint & Shenk, 1997). The N-terminal 80% interacts with the 
cellular transcription factor Oct-1 and at least one additional cellular protein 
to form a DNA-protein complex which binds to the consensus
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‘TAATGARAT’ upstream of immediate-early gene promoters (Gaffney et 
al., 1985). The C-terminal 20% of the protein is extremely acidic and acts as 
a generalised ‘acidic blob’ type of transcriptional activator. Although the 
transactivation function of the a-TIF protein is dispensable at least in tissue 
culture, the protein probably has a role in the extremely rapid lytic replication 
cycle of HSV.
Five HSV genes IE 175, IE110, IE68, IE 12 and IE63 are expressed at 
immediate-early times post infection and function in the earliest stages of the 
lytic cycle. With the exception of IE 12, these proteins appear to have a role 
in the regulation of viral gene expression.
The protein encoded by the IE 175 transcript is a large multifunctional protein 
that has a predicted unmodified molecular weight of 140,000 and possesses 
an autoregulatory function (Muller, 1987). IE 175 is strictly required for virus 
replication and is continuously required for transcription of all but the 
immediate-early class of viral mRNA (Dixon & Schaffer, 1980, Watson & 
Clements, 1980). IE 175 acts as a transcription factor that either represses or 
activates transcription through contacts with the general transcriptional 
machinery. It can be located in the nucleus of infected cells by 
immunofluorescence and multiple phosphorylated forms of the protein have 
been identified (Pereira et al., 1977, Wilcox et al., 1980). The protein has a 
sequence-specific DNA-binding ability, with preference for the consensus 
ATCGTCN4YGCRC.
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The nonessential nuclear IE110 protein (primary predicted molecular weight
79,000 Da) enhances the transcriptional activation of IE 175 in transient 
assays and can act as a powerful transcriptional activator on some viral 
promoters by itself (Everett, 1984, O'Hare & Hayward, 1985, Quinlan & 
Knipe, 1985). It also facilitates the reaction of virus from latency in mice 
(Cai et al., 1993, Lieb et al., 1989). HSV-1 mutants deleted for the IE110 
gene grow poorly in cell culture, particularly at low multiplicities of infection 
(MOIs) but remain viable (Sacks & Schaffer, 1987, Stow & Stow, 1986).
Much less is known about the IE68 protein. It is dispensable for virus 
replication in cell culture, but is required for HSV replication in certain types 
of cultured cells (Post & Roizman, 1981, Purves et al., 1993) and may have a 
role in maintaining the virus’s ability to replicate in a wide range of cells in 
the host. This protein also appears to be required for modification of RNA 
polymerase II and establishment of viral transcription (Rice et al., 1995).
The IE 12 protein has a role in inhibiting the presentation of peptide 
fragments of viral proteins at the cell surface by the MHC system, and thus 
acts to repress recognition of virus-infected cells (York et al., 1994). Finally, 
the structure and function of the IE63 protein which is the subject of this 
thesis is described in detail in Section 1.2.
HSV regulatory proteins from other kinetic classes also exist. These include 
three leaky late proteins: the UL46 and 47 proteins which modulate the 
activity of a-TIF by unknown mechanisms, and the virion-associated host 
shut-off protein (vhs, UL41) which functions by generally destabilising all
12
mRNA molecules in the infected cell. The major DNA-binding protein 
(UL29) which has an essential role in viral DNA replication, also appears to 
function in gene regulation by mediating the shut-off of transcription of at 
least some early genes and activating expression of late genes (Roizman & 
Sears, 1996).
1.1.6 Virion host shutoff function
Infection of cells with HSV-1 results in the shutoff of host protein synthesis. 
The inhibition of host protein synthesis is a multiphase process. In brief, a 
primary phase of the shutoff of host protein synthesis is mediated by the 
virion component known as the virion-associated host shutoff protein (vhs) 
(UL41) and at least one other virion protein (reviewed in Roizman & Sears,
1996). This results in dissociation of mRNA from the polysomes and mRNA 
degradation. A late (secondary) shutoff function reduces the remaining 
levels of host protein synthesis and requires the presence of viral IE proteins 
such as IE68 and IE63. The mode of action of the secondary shutoff function 
is not, as yet, understood.
1.1.7 Posttranslational modification of HSV-1 proteins
The majority of HSV proteins examined to date appear to have extensive 
post-translational modifications. Such modifications include cleavage (e.g. 
UL26), phosphorylation (a number of HSV-1 proteins are phosphorylated 
including the IE proteins IE175, IE110, IE68 and IE63), sulphation
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(glycoproteins), glycosylation (glycoproteins), myristylation (UL11) and 
poly(ADP-ribosyl)ation (IE 175, UL18) (Roizman & Sears, 1996).
Unusually, only a relatively small proportion of HSV mRNAs (IE110, IE68, 
IE 12, UL15) have been shown to be derived by splicing.
1.2 THE ESSENTIAL HSV-1 PROTEIN 1E63
IE63 is required for early and late viral gene expression (McCarthy et al., 
1989, Rice & Knipe, 1990, Sacks et al., 1985). How IE63 activates the 
expression of early genes is not known but it appears that IE63 carries out 
two distinct functions which contribute to late gene activation. First, IE63 
increases the level of viral DNA replication up to 10-fold (Rice & Knipe, 
1990), possibly by transactivating a subset of E genes involved in DNA 
replication (McGregor et al., 1996, Uprichard & Knipe, 1996) or by altering 
the redox state and subsequent folding and/or localisation of the essential 
DNA replication protein ICP8 (Curtin & Knipe, 1993). Second, IE63 
enhances L gene expression by a mechanism that does not involve the 
stimulation of viral DNA replication (Hibbard & Sandri-Goldin, 1995, Rice 
& Knipe, 1990, Rice & Lam, 1994).
Although the exact mechanism(s) by which IE63 regulates viral and also 
cellular genes during HSV-1 infection is unknown, evidence suggests that the 
protein exerts its effects both at the level of transcription and via a number of 
posttranscriptional control mechanisms.
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1.2.1 IE63 can affect the transcription of viral and cellular genes during
infection
Studies investigating the effect of IE63 mutants on the expression of a 
number of HSV-1 immediate-early, early and late genes have shown that the 
expression of the early glycoprotein B (gB) gene is increased significantly by 
IE63(Rice & Knipe, 1988). Several other early and late genes such as ICP5 
show lesser dependence on IE63 expression. This effect appears to act at the 
level of transcription since when the gB gene is fused to the reporter gene 
encoding chloramphenicol acetyltransferase (CAT), induction of CAT 
activity correlates with an increase in the amount of CAT transcripts initiated 
from the transcriptional start site of the gB gene. However, increased 
stability of mRNA in the presence of IE63 may occur.
Examination of transcription patterns of genes in cells infected with mutant 
and wt HSV-1 suggests that IE63 effectively down-regulates transcription of 
the cellular GAPDH and histone H2b genes (Pangiotidis et al., 1997). 
However, c-myc, c-fos, and y-actin genes are repressed transcriptionally by 
both wild-type virus and viruses with mutations in IE63. The repression of 
histone H2b gene transcription requires IE63 yet this gene does not contain 
introns and its mRNA is not polyadenylated. This suggests that IE63 is not 
exerting control in this instance via its previously characterised 
posttranscriptional mechanisms (see Section 1.2.2) but that it may indeed 
have a role in control of gene expression at the transcriptional level.
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IE63 may also exert an effect on the transcription of gene expression by 
interacting with and modulating the principal viral gene regulator IE 175. 
Transient expression systems have shown that IE63 can increase or decrease 
the ability of IE175 to activate HSV-1 genes (Su & Knipe, 1989) and GST 
fusion assays have suggested that IE 175 and IE63 interact directly 
(Pangiotidis et al., 1997). Although the level of expression of IE 175 does not 
appear be altered by IE63, an alteration in the electrophoretic mobility of 
IE 175 is observed in the presence of IE63. Since differently phosphorylated 
forms of IE 175 have been shown to have different DNA binding activities it 
is plausible that IE63 either directly or indirectly alters the phosphorylation of 
IE 175 leading to the different promoter-binding properties of the IE 175 
protein (Michael et al., 1988).
Finally, IE63 appears to have a direct effect on RNA polymerase III 
transcription in vitro and this effect is mediated by the transcription factor 
TFIIIC (Jang & Latchman, 1992). However, the significance of this 
observation is as yet unclear since no HSV-1 genes are known to be 
transcribed by RNA polymerase III.
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1.2.2 1E63 acts at the posttranscriptional level to regulate gene expression
(a) IE63 modulates virus poly(A) site usage
(i) Polyadenylation is an essential step in the generation o f  mature eukaryotic
mRNA
An essential step in the generation of mature eukaryotic mRNAs is the 
formation of a specific 3’ terminus. In the majority of mRNAs this requires a 
sequence-specific endonucleolytic cleavage followed by the addition of <250 
adenylate residues to the newly generated 3’ end. The purposes of this 
polyadenylation appears to be: (1) to aid the export of mature mRNA from 
the nucleus ; (2) to increase the stability of at least some mRNAs in the 
cytoplasm; and (3) for efficient translation of the mRNA (Atwater et al.,
1990, Bachvarova, 1992, Jackson & Standart, 1990, Wickens, 1990). Many 
genes encode multiple polyadenylation sites and in some mammalian and 
viral systems, alternative or regulated usage of poly(A) sites is used as a 
means of controlling gene expression .
Two sequence elements that specify pre-mRNA cleavage and poly(A) 
addition have been identified. The sequence AAUAAA is located 10-30 
bases upstream of the cleavage/polyadenylation site and the downstream 
sequence a G+U/U-rich motif is located 20-40 bases downstream of the 
cleavage site (McLauchlan et al., 1989). These two sequences and their 
relative spacing with one another determine the site and strength of poly(A)
17
signal (Chen et al., 1995, MacDonald et al., 1994), with pre-mRNA cleavage 
occurring after an ‘A’ located between them.
Figure 1.5 shows the proteins required for cleavage and polyadenylation of 
mRNA 3’ ends. The proteins required for recognition of a poly(A) signal and 
cleavage of the RNA include the Cleavage Poly(A) Specificity Factor (CPSF) 
and Cleavage Stimulatory Factor (CstF) together with two Cleavage Factor 
proteins (CFI and CFII). Poly(A)Polymerase (PAP) adds poly(A) to the 
newly formed 3’ end and this activity requires RNA-bound CPSF and 
another polypeptide, Poly(A) Binding Protein II (PABII), to assist in making 
the full poly(A) tail. The 160 kDa protein of CPSF binds to the AAUAAA 
sequence and the 64 kDa protein of CstF binds to the G+U/U-rich sequence.
(ii) IE63 increases RNA 3 ’processing at inherently weak poly (A) sites
HSV-1 transcripts which have common 5’ termini but different poly(A) sites 
have been identified (McGeoch et al., 1988). This observation raises the 
possibility that HSV-1 gene expression could be influenced by the efficiency 
of poly(A) site usage. Studies using precursor RNAs containing 3’ 
processing sequences from different HSV genes have shown that an activity 
which was named late processing factor (LPF) and which is present in HSV- 
1 infected nuclear extracts can stimulate RNA 3’ processing specifically at a 
late HSV poly(A) site of the UL38 gene (McLauchlan et al., 1989).
Increased usage of the late UL38 poly(A) site was shown to be dependent 
upon IE63 expression alone.
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This work has been extended by McGregor et al (McGregor et al., 1996) who 
showed that the 3’ processing of the two late genes UL38 and UL44 was 
increased by an IE63-induced activity whereas there was no detectable 
change in the processing of a number of immediate-early and early transcripts 
in the presence of IE63 expression. In vitro polyadenylation assays 
determined that the 3’ processing sites of the late genes that were tested were 
predominantly weak and that the 3’ processing sites of the immediate-early 
and early genes were relatively strong.
Previous UV cross-linking studies have shown CPSF and CstF bind directly 
to pre-mRNA templates and the binding of CstF is though to determine the 
efficiency of polyadenylation (Takagaki et al., 1989). Using HSV-1 infected 
cell extracts, UV cross-linking of the 64 kDa CstF component to poly(A) 
sites of all temporal classes is increased and this binding appears to be 
dependent upon the expression of IE63 (McGregor et al., 1996).
These findings suggest that IE63 increases 3’ processing at inherently weak 
poly(A) sites, perhaps by increasing the binding of factors required for 
processing. Immediate-early and early poly(A) sites which are efficiently 
used are unaffected by this increased binding of processing factors. 
Conceivably, IE63 could regulate the switch between early and late gene 
expression by increasing CstF binding at late times during infection when the 
activity of such proteins is likely to be significantly reduced.
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(b) IE63 inhibits pre-mRNA splicing
(i) Mechanisms o f  mammalian pre-mRNA splicing
Splicing is the process by which non-coding sequences, or introns, are 
removed from pre-mRNA molecules and exon sequences are ‘spliced’ 
together. The splicing reaction is catalysed by the spliceosome, a complex 
made up of five small nuclear ribonucleoprotein particles (snRNPs) and more 
than 50 non-snRNP proteins (Will & Luhrmann, 1997). Spliceosomes 
assemble in a highly ordered and stepwise manner (see Figure 1.6).
Assembly begins with the association of the U1 snRNP with pre-mRNA. 
Next the U2 snRNP and then the U4/U6.U5 triple snRNP bind, U1 and U4 
become destabilised and the spliceosome is activated for catalysis. The 
splicing reaction takes place within the spliceosome in two distinguishable 
steps via a branched lariat intermediate. In the initial step, the 2’ hydroxyl of 
a conserved, intronic adenosine attacks the phosphate at the 5’ splice site, 
producing a free 5’ exon and branched species, termed the lariat intermediate. 
In the second reaction, the 3’ hydroxyl of the 5’ exon attacks the phosphate at 
the 3’ splice site, yielding ligated mRNA and a lariat intron.
In the nucleus of mammalian cells, splicing factors are preferentially 
accumulated in 20-40 nuclear domains or speckles when visualised by 
fluorescence microscopy (Figure 1.7A). In some cell types, the snRNP 
proteins localize at small nuclear structures termed coiled bodies. The 
majority of speckles correspond to interchromatin granule clusters (IGCs).
20
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Fibrillar structures, called perichromatin fibrils (PFs) extend from the 
periphery of IGCs. It is thought that IGCs may function as storage/assembly 
sites for splicing factors and that factors are recruited from IGCs to PFs when 
necessary.
Splicing is thought to be regulated by the SR proteins (Fu, 1995). These 
proteins appear to be required for splice site selection and spliceosome 
assembly and are so named because they contain a carboxy-terminal 
serine/arginine rich domain which mediates interactions with other SR 
proteins and facilitates the recruitment and stabilisation of snRNPs with pre- 
mRNA during splicing. SR proteins interact with RNA enabling them to 
bind to specific splicing enhancer or repressor sequences (reviewed in 
Manley & Tacke, 1996).
ASF/SF2 is a typical SR protein which has constitutive splicing activity in 
vitro (Krainer et al., 1990) and influences splice site selection. ASF/SF2 
interacts with at least two other SR proteins, the U1 specific protein SC35 
and the essential splicing factor U2AF. ASF/SF2 interacts with RNA via an 
RNP domain and is thought to be typical of SR protein control of splicing.
(ii) IE63 expression causes the redistribution o f  splicing factors and inhibits host 
cell splicing
Upon HSV-1 infection the snRNPs and the non-snRNP protein SC35 
redistribute within the nucleus to form clusters which colocalize with the 
IGCs (Martin et al., 1987, Sandri-Goldin et al., 1995). These clusters
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condense and migrate to the nuclear periphery as infection proceeds (depicted 
in Figure 1.7B). Subsequent studies have shown that the IE63 protein is both 
necessary and sufficient for this effect (Phelan et al., 1993, Sandri-Goldin et 
al., 1995) and that IE63 colocalises with the redistributed snRNPs at later 
times post-infection (Phelan et al., 1993, Sandri-Goldin et al., 1995).
Sandri-Goldin et al have further shown that IE63 coimmunoprecipitates with 
anti-Sm antisera during wild-type HSV-1 infection (Sandri-Goldin & 
Hibbard, 1996). Since Sm is an epitope which is common to a number of 
snRNPs it was not possible to identify any specific RNP which was 
coimmunoprecipitating with IE63. The snRNPs and SC35 redistribution may 
reflect a movement from the active splicing sites to inactive storage centres.
IE63 viral mutants are defective in host shutoff (Hardwicke & Sandri- 
Golding, 1994). While the majority of mammalian genes contain introns, 
HSV-1 encodes relatively few spliced products and these gene products,
(IE110, IE68, IE 12 and UL15), are predominantly expressed at immediate- 
early times post-infection. Therefore, it is plausible that the IE63-induced 
redistribution of splicing factors which occurs quite early in infection could 
contribute to host shutoff whilst having little or no detrimental effect on viral 
gene expression. Hardwicke and Sandri-Goldin (Hardwicke & Sandri- 
Goldin, 1994) have analysed the levels of spliced cellular mRNAs during 
HSV-1 infection and found that during infection with IE63 viral mutants, the 
levels of at least 3 spliced host mRNAs were higher than those seen with 
wild type infected cells. These effects could not be attributed to effects on 
transcription or RNA stability. Further studies have investigated the
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consequences of the proposed impaired splicing efficiency on the nuclear and 
cytoplasmic accumulation of two viral transcripts which contain introns; an 
immediate early gene product (IE110) and a late gene product (UL15) (Hardy 
& Sandri-Goldin, 1994). These studies showed that pre-mRNA accumulated 
in the nucleus of the cell suggesting that splicing and not transport of the 
gene products was being affected. Further, these studies showed that splicing 
was inhibited in extracts from wt infected cells but not in extracts from cells 
infected with an IE63 null mutant.
An IE63 repressor mutant with a base substitution at aa 480 has been 
characterised and this mutant showed a redistributed snRNP staining pattern 
but splicing was not inhibited (Sandri-Goldin et al., 1995). This suggests 
that although the redistribution of snRNPs and SC35 correlates with the 
impairment of splicing, these alterations do not fully inhibit splicing and 
sufficient snRNPs may be left distributed throughout the nucleoplasm to 
perform the splicing of UL15 and other cellular intron-containing transcripts.
Studies have been carried out to determine the effect IE63 could have on the 
splicing proteins which might cause their redistribution (Sandri-Goldin & 
Hibbard, 1996). These studies showed that there was an increase in the 
phosphorylation state of two cellular proteins during wt HSV infection, one 
of which is likely the U 1 snRNP 70 kDa protein. This effect was lost when 
an IE63 null mutant was used. The movement of splicing factors between 
active and storage sites has been shown to be dependent upon their 
phosphorylation state (Mermoud et al., 1994). Therefore it is plausible that 
IE63 causes snRNP redistribution by directly or indirectly causing a change
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in the phosphorylation state of the snRNP molecules. It appears that this 
redistribution is not sufficient to cause a total inhibition of splicing but it may 
complement a more direct mechanism such as disruption of spliceosome 
complex formation.
It is of interest to note that infections with adenovirus and influenza virus 
also cause a redistribution of snRNPs (Bridge et al., 1993, Fortes et al.,
1995). Adenovirus RNAs are extensively spliced and the splicing factors are 
recruited into virus transcription and processing sites; in contrast, influenza 
virus has a negligible requirement for splicing, indicating that redistributed 
snRNPs in influenza-virus infected cells may represent dysfunctional 
aggregates.
Finally, it is of interest to note that the Wilms’ tumour gene product, which 
has at least sixteen isoforms and is thought to be a transcriptional regulator 
acting at both the transcriptional and post-transcriptional levels (reviewed in 
Ladomery, 1997), also colocalises with the snRNPs suggesting a role in 
splicing. Furthermore, the different isoforms of the Wilm’s tumour gene 
product appear to have varying properties raising the possibility that different 
phosphoisoforms of IE63 may also act in different ways or exist at different 
cellular locations.
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(c) IE63 and nucleocytoplasmic transport of mRNAs
(i) Nuclear import and export o f  proteins and mRNA
In eukaryotic cells, the nucleus is separated from the cytoplasm by a double 
membrane system known as the nuclear envelope. Therefore the transport of 
various RNA and protein molecules between their sites of synthesis and 
function is required, and this allows the regulation of certain cellular 
processes by control of the nucleocytoplasmic distribution of these 
molecules.
Transport between the cytoplasm and the nucleus occurs through protein- 
lined aqueous channels called nuclear pore complexes (NPC). A 
diagrammatic representation of a nuclear pore is shown in Figure 1.8. The 
proteins that make up the NPC are called nucleoporins and they have a 
combined molecular mass of approximately 125 MDa (Rout & Wente, 1994). 
Current models for nucleocytoplasmic transport suggest that: (1) distinct 
types of cargo contain specific molecular signals; (2) translocation of cargo 
through the NPC is mediated by shuttling carrier proteins and; (3) most if not 
all transport processes require the small GTPase Ran.
The specific sequence motifs for import are called nuclear localization 
sequences (NLSs), and for export, nuclear export signals (NESs). The first 
NLS to be identified was a short stretch of basic amino acids (PKKKRKV) in 
simian virus 40 (SV40) large T-antigen (Kalderon et al., 1984). Similar
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sequences were later found in a large number of viral and cellular proteins. 
These import signals are commonly referred to as ‘classical’ NLSs as they 
were the first to be discovered. Recently, two NLSs have been identified 
during studies of heterogenous nuclear RNPs (hnRNPs). A subset of these 
proteins, including hnRNPs A l, A2, D, E, I and K, shuttle continuously 
between the nucleus and the cytoplasm. For hnRNP Al the shuttling signal 
is present in a glycine-rich segment of 40 amino acids (termed M9) (Siomi & 
Dreyfuss, 1995) and for hnRNP K the signal is an entirely different 40 
amino-acid signal (termed KNS) (Michael et al., 1997a). The snRNPs also 
have a unique signal that is composed of the Sm core protein and the 
trimethylguanosine cap (Fischer et al., 1991, Hamm & Mattaj, 1990).
Finally, Truant et al. have recently shown that the human Tap protein which 
mediates the sequence-specific nuclear export of RNAs contains an NLS 
which is transportin-specific but that lacks nuclear export signal function 
(Truant et al., 1999).
Two types of NESs have been identified. First, the nuclear import sequences 
in hnRNP Al and K also function as NESs (Michael et al., 1997a). Second, 
sequences rich in leucine residues act as NESs in the HIV-1 Rev molecule 
(LPPLERLTL) (Bogerd et al., 1995, Fischer et al., 1995) and in the cAMP- 
dependent protein kinase inhibitor, PKI (LALKLAGLDI) (Wen et al., 1995). 
These leucine-based export signals have been identified in a variety of 
exported proteins.
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Four independent protein import pathways have been identified which rely on 
interaction with carrier proteins called importins although some proteins 
without an NLS can be carried ‘piggy back’ through the nuclear pore 
complex via strong interaction with NLS-containing proteins. The importins 
that have been identified to date are listed in Table 1.4. The importin a/p 
complex recognises classical NLSs and the transportins mediate import of 
hnRNPs that contain a non-classical NLS. Independent pathways that are 
used to transport mRNA-binding proteins also exist but the NLSs responsible 
are so far unknown.
The export carrier proteins that have been identified to date are also shown in 
Table 1.4. The first export carrier to be identified was a nuclear protein 
termed RIP1 (also known as Rab) (Bogerd et al., 1995, Fritz et al., 1995). A 
family of importin related molecules has recently been identified and shown 
to be required for the export of proteins containing leucine-based NESs 
(Neville et al., 1997). These exportins may mediate the protein export of a 
wide variety of proteins. For the hnRNP-based export pathway it is likely 
that transportin, the receptor for nuclear import also mediates export.
(ii) IE63 affects the nuclear export o f virus intron-containing transcripts and 
shuttles between the nucleus and the cytoplasm
The regulation of the nucleocytoplasmic transport of mRNAs has been 
identified in a number of viral systems. For example, the HIV-1 protein Rev, 
in combination with the cellular factor, RIP1 (Rab), induces the accumulation
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Table 1.4. IMPORTINS AND EXPORTERS IDENTIFIED TO DATE.
Family name
Import
Importin a
Importin P
Transportin
Export
Exportin 1
Exportin 2
Transportin
CBC
Specific proteins
Rch 1
NPI-1
Qipl
hSRPly
ySRPl/Kap60
Transportin 1
Transportin 2
MtrlO
Karyopherin p3
Sxm 1 
Importin p
CRM1
Psel
CAS
Kapl23
Sxml
hRIP
Transportin 1
CBP20 
Exportin t
Homologues
hSRPl
p54/56
Karyopherin a  
0H031 
At IMPa 
NBP70 
PTAC58
p97
Karyopherin
p/Kap95
RSL1
PTAC97
Karyopherin p2
Kap 104 
MIP
Yrb 4
Xpol
Rab
Molecule(s) 
transported, e.g.
SV40 T-antigen 
nucleoplasmin
hnRNP A1,F
hnRNP K
mRNA-binding
proteins
Ribosomal proteins
Ribosomal proteins 
U snRNAs
HIV-1 Rev PKI
Importin a
HIV-1 Rev 
mRNA
U snRNA mRNA
tRNA
rRNA
Signal
‘Classical’ NLS 
basic basic 
bipartite
‘Nonclassical’ 
NLS/NES 
(glycine rich)
‘Nonclassical’ 
40-aa domain
Novel basic 
NLS
m3G cap Sm 
core protein
Leucine-based
NES
Leucine-based
NES
‘Nonclassical’ 
NES/NLS 
m7G cap
NES on protein?
of unspliced and partially spliced virus transcripts in the cytoplasm. In 
contrast, the influenza virus NS1 protein inhibits the transport of spliced 
polyadenylated RNAs and the adenovirus E1B protein has been shown to 
facilitate the export of viral mRNAs to the cytoplasm.
Hibbard and Sandri-Goldin (Hibbard & Sandri-Goldin, 1995), using 
Northern hybridisation assays, found that cellular mRNA levels were reduced 
and unspliced pre-mRNAs accumulated in the nucleus in the presence of 
IE63. This is to be expected since IE63 inhibits splicing. Unexpectedly, 
these workers also found that the inhibition of splicing resulted in the nuclear 
export of some unspliced RNAs suggesting that IE63 may also have a role in 
the regulation of RNA transport.
Further experiments have shown that intron-containing immediate-early and 
late transcripts (IE110 and UL15) increasingly accumulate in clumps in the 
nucleus as infection proceeded whereas intronless IE and late transcripts 
(IE63, UL38 and UL44) are detected predominantly in the cytoplasm (Phelan 
et al., 1996). IE63 was shown to be required for the nuclear retention of 
intron-containing transcripts since in the absence of IE63, all transcripts were 
predominantly cytoplasmic. Unspliced RNAs that are retained in the nucleus 
were shown to colocalise with both IE63 and the redistributed snRNPs.
These findings strongly indicate that IE63 inhibits the nuclear export of 
intron-containing transcripts in HSV-1 infected cells giving a distinct 
advantage to a virus that encodes few transcripts which contain introns.
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IE63 can bind RNA directly through an RGG box (Mears & Rice, 1996) and 
this RGG box is post-translationally modified by methylation. Methylation is 
a modification that is common to a number of hnRNP RNA-binding proteins 
suggesting that IE63 may have a similar role to hnRNP proteins. The hnRNP 
proteins A l, K and E and the HIV-1 protein Rev shuttle between the nucleus 
and the cytoplasm and it seemed likely that IE63 may also be a shuttling 
protein. Extensive studies have been carried out using HSV-1 infected cells 
treated with actinomycin D, a drug which prevents the nuclear import of 
shuttling proteins whilst allowing export to continue (Phelan & Clements, 
1997, Soliman et al., 1997). Such studies make it possible to visualize the 
cytoplasmic accumulation of shuttling proteins. These studies have shown 
that the IE63 protein does shuttle between the nucleus and the cytoplasm at 
late times postinfection. The shuttling ability of IE63 is not dependent upon 
viral infection or other viral proteins since the protein shuttles when 
expressed in uninfected cells (Mears & Rice, 1998).
Consistent with IE63’s shuttling function, the protein has recently been 
shown to bind intronless mRNA in both the nucleus and the cytoplasm 
(Sandri-Goldin, 1998). Interestingly, the binding of hnRNP Al to cellular 
mRNA is reduced significantly in wt infection. This suggests that IE63 
favours the export of viral, intronless mRNA whilst blocking the export of 
cellular mRNA via the hnRNP Al pathway.
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1.2.3 A number of herpesviruses encode IE63 homologues
The essential HSV-1 protein IE63 is the only HSV IE protein with 
homologues throughout the herpesviridae family. The varicella-zoster virus 
encodes ORF4, a multifunctional protein that transactivates gene expression 
by a number of mechanisms including a mechanism that appears to act at the 
posttranscriptional level (Defechereux et al., 1997). The herpesvirus saimiri 
encodes ORF57, a protein which activates and represses expression of viral 
genes and redistributes splicing products in the infected cell nucleus 
(Whitehouse et al., 1998). The human cytomegalovirus protein UL69 can 
transactivate a number of viral and cellular genes (Winkler et al., 1994) as 
can the Epstein-Barr virus protein BMLF1 which regulates gene expression 
at the post-transcriptional level via its effects on splicing and RNA export 
and which shuttles between the nucleus and the cytoplasm (Semmes et al., 
1998). Interestingly, BMLF1 interacts with CRM1 and this interaction is 
essential for its ability to shuttle (Boyle et al., 1999). Finally, bovine 
herpesvirus type 1 expresses BICP27, a protein which appears to increase the 
efficiency of mRNA processing at weak poly (A) sites (Singh et al., 1996).
1.2.4 Functional domains of IE63
IE63 and a number of other regulatory proteins encoded by nuclear- 
replicating DNA viruses have been shown to contain several functional 
domains. Such proteins are essential to these viruses since they have a 
limited coding capacity but must interact with multiple components of the
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cell. The functional domains that have been identified in the IE63 protein to 
date are illustrated in Figure 1.9.
(a) Potential zinc finger and activation and repressor regions
The regions for the activator and repressor activity of IE63 reside in the 
carboxy terminus of the IE63 protein. Metal chelate affinity chromatography 
has shown that IE63 binds zinc in vitro and that the region of IE63 which
binds zinc also resides in the carboxy terminal spanning a putative metal
binding motif (amino acids 407-512) (Vaughan et al., 1992). Zinc finger 
domains are associated with protein-nucleic acid and protein-protein 
interactions. Interestingly, the region of IE63 which is required for 
coimmunoprecipitation with anti-Sm antisera begins after amino acid 450 
and extends at least to residue 504 (Sandri-Goldin & Hibbard, 1996). This 
data indicates that the potential zinc finger domain of IE63 is required for 
interaction with a component of the cellular snRNPs.
(b) Essential acidic domain
IE63 contains a high proportion of acidic amino acid residues in its amino 
terminal region (amino acids 4 to 64). A deletion mutant lacking this domain 
was unable to complement an IE63 null mutant suggesting that the acidic 
domain is essential for IE63 function (Rice et al., 1993).
Similar highly acidic regions have been found in a number of transcription 
activators such as the HSV-1 virion protein VP 16 (Struhl, 1991). It has been 
proposed that these acidic domains stimulate transcription by interacting with 
one or more components of the RNA polymerase II transcription complex.
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The cluster of highly acidic residues in the amino terminal region of IE63 is a 
feature conserved within all of the IE63 alphaherpesvirus homologues 
suggesting that the acidic region of IE63 is involved in a function common to 
diverse herpesviruses.
(c) Nuclear localisation signals
Cell fraction and immunofluorescence studies have shown that IE63 is 
predominantly localised to the cell nucleus both during HSV-1 infection and 
in transfected cells. Evidence suggests that IE63 also interacts with the cell 
nucleoli and shuttles between the nucleus and the cytoplasm. Mears, Lam 
and Rice (Mears et al., 1995) have used fusion protein constructs to identify 
the specific regions of IE63 which can direct a normally cytoplasmic protein, 
pyruvate kinase, to the nuclei of transfected cells. These workers have found 
that IE63 contains multiple signals, both strong (aa 110-137) and weak 
(mapping to the C-terminal portion of the protein), which mediate its nuclear 
loclalisation. In addition they identified a region of IE63 which possesses a 
relatively short sequence that functions as a nucleolar targeting signal (aa 
110-152).
(d) Nuclear export sequence
IE63 contains a leucine-rich region (amino acids 7 to 27) which exhibits 
good homology with export signals of other proteins known to shuttle 
between the nucleus and cytoplasm such as the HIV-1 Rev protein (Kalland 
et al., 1994, Meyer & Halim, 1994, Richard et al., 1994), the heat-stable 
inhibitor of cAMP-dependent protein kinase (PKI) (Wen et al., 1995), the
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Rex protein of HTLV-1 (Bogerd et al., 1995, Kim et al., 1996, Palmer & 
Malim, 1996), the Rev proteins of visna virus and equine infectious anemia 
virus (Meyer et al., 1996), adenovirus E3-34-kD (Dobbelstein et al., 1997), 
transcription factor IIIA (Fridell et al., 1996), and the yeast mRNA transport 
protein Gle 1 (Murphy & Wente, 1996).
Sandri-Goldin (Sandri-Goldin, 1998) has constructed a mutant that lacks a 
region in the IE63 protein which resembles the putative leucine-rich NES. 
Cells were transfected with this mutant or wt IE63 and were either 
actinomycin treated or untreated. The wt IE63 moved to the cytoplasm 
following addition of actinomycin D. However, deletion of the NES resulted 
in a protein that remained nuclear in the presence of actinomycin D. Further 
experiments showed that the NES of IE63 was sufficient for export of a 
heterologous protein (Sandri-Goldin, 1998). These experiments suggest that 
the leucine-rich region of IE63 is both necessary and sufficient for the export 
of the IE63 protein.
Another group has used the interspecies heterokaryon assay to examine 
IE63’s shuttling function (Mears & Rice, 1998). This assay requires the 
fusion of HSV-1 infected Vero monkey cells that have been cycloheximide 
treated with uninfected mouse cells which have also been treated with 
cycloheximide. One hour later the localization of viral nuclear proteins can 
be assessed by immunofluorescence and, since protein synthesis is inhibited, 
the appearance of an HSV-1 nuclear protein in the mouse nucleus of a fused 
cell suggests that the viral protein has shuttled out of the infected monkey 
nucleus and has been re-imported into the uninfected mouse nucleus. The
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results of these studies show that deletion of the putative NES of IE63 (aa 7- 
20) has only a modest detrimental effect on shuttling. However, a mutation 
which alters amino acids 465 and 466 of IE63 from aa PG to LE completely 
abrogates shuttling.
The conflicting findings of these studies suggest that IE63 may contain at 
least two regions that enable the protein to shuttle between the nucleus and 
the cytoplasm. The leucine-rich NES does appear to promote shuttling but 
another domain which maps to the carboxy terminal 46 amino acids appears 
to be absolutely essential for shuttling. This carboxy terminal region may 
contain an additional NES or it may be required for the ability of IE63 to 
interact with a cellular shuttling protein which allows IE63 to access an 
alternative shuttling pathway utilised by the host cell.
(e) RGG box and KH domains
IE63’s Nucleolar Localisation Signal (NuLS) is similar to the short basic 
NuLSs of the HIV proteins Rex, Rev and Tat in that it is composed of an 
NLS (residues 110 to 137) and an arginine-rich basic region (residues 138- 
152) (Mears et al., 1995). The arginine-rich region in the IE63 NuLS is also 
very rich in glycine residues (Mears & Rice, 1996). The motif, termed the 
RGG box or GAR (glycine-arginine-rich) domain is particularly predominant 
in hnRNPs and proteins which function in pre-rRNA processing such as 
nucleolin and fibrillarin. One of the best matches with IE63’s RGG box is a 
sequence of the SmD protein which is a constituent of snRNPs (Mears & 
Rice, 1996). This observation suggests that IE63’s RGG box may mediate an
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interaction with a pre-mRNA or small nuclear RNA involved in mRNA 
processing.
IE63 also contains an RNA binding motif in the C-terminal half of the 
protein and this motif has homology to a series of hnRNP K homology (KH) 
domains (T B Soliman and S J Silverstein, Columbia University, New York, 
personal communication). It appears that IE63 contains three KH domains 
and that these are required for the expression of HSV-1 L genes.
Using IE63 RNA binding assays, Ingram et al (Ingram et al., 1996) have 
shown that IE63 binds to RNA in a weak and non-specific manner. This is in 
contrast to the findings of Brown et al. (Brown et al., 1995) who found that 
IE63 binds to certain RNAs specifically. The RGG box of IE63 appears to 
mediate this RNA binding and the RGG box is post-translationally modified 
by methylation (Mears & Rice, 1996).
(f) Regions of IE63 required for interaction with IE 175
In vitro pull down assays with GST fusion proteins have shown that IE63 can 
interact with the viral IE 175 protein directly and that this interaction is 
mediated by aa 27-103 and aa 179-406 of IE63 (Pangiotidis et al., 1997).
However, it should be noted that there was no interaction between IE 175 and 
IE63 in extensive co-immunoprecipitation experiments carried out by our 
group.
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1.3 OVERVIEW OF THE CELLULAR PROTEINS IDENTIFIED IN THIS
STUDY WHICH INTERACT WITH IE63
1.3.1 The hnRNP K Protein
(a) hnRNP K is a nuclear protein which exists in four isoforms
The K protein has an apparent molecular weight of 65 kDa and was 
originally discovered as a component of the heterogenous nuclear 
ribonucleoprotein (hnRNP) particle, hence its name (Matunis et al., 1992). 
The K protein can be recovered from both cytoplasmic and nuclear extracts 
but it is predominantly nuclear and it shuttles between the nucleus and the 
cytoplasm (Buchenau et al., 1997, Michael et al., 1997b). The gene which 
encodes the protein maps in humans to chromosome 9 and four different 
isoforms of the protein have been identified. The differences in the isoforms 
are due to the presence or absence of a 15 bp and a 60 bp exon (Dejgaard et
al., 1994). The presence of two different polyadenylation sites result in 
additional variants and the variation in the 3’ non-translated region together 
with the differences in the coding region may result in up to 12 different 
putative mRNAs. The four coding region variants separate into at least 3 
spots following 2-D gel electrophoresis and this is due to differences in 
phosphorylation (Dejgaard et al., 1994).
(b) hnRNP K is a phosphoprotein
All isoforms of hnRNP K contain potential phosphorylation sites for casein 
kinase II (CKII), protein kinase C and tyrosine kinase. The hnRNP K binds
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to and is phosphorylated by a serine/threonine inducible interluekin 1- 
responsive kinase termed K protein kinase (KPK) (Ostrowski et al., 1991, 
Seuningen et al., 1996) which recent evidence suggests may be protein 
kinase C8 (Schullery et al., 1999). The kinase itself is thought to be 
regulated by phosphorylation (Seuningen, 1995). Although hnRNP K can be 
phosphorylated by CKII in vitro (Ostrowski et al., 1994), the kinase which 
copurifies with the hnRNP K protein is not CKII [Seuningen, 1995 #145]. 
Phosphopeptide maps from in vitro and in vivo experiments overlap but are 
not identical, suggesting that hnRNP K may be phosphorylated by more than 
one kinase (Ostrowski et al., 1991).
(c) Functional Domains of hnRNP K
The functional domains of hnRNP K are illustrated in Figure 1.10. These 
include three KH domains which are involved in RNA binding (Siomi et al., 
1994), a bipartite-basic nuclear localisation signal, three proline-rich SH3- 
binding regions which consitute an SH3-binding domain (SBD) and interact 
in vitro with a subset of SH3-containing proteins such as Src and Vav 
(Bustello et al., 1995, Taylor & Shalloway, 1994, Weng et al., 1994). It is of 
interest to note that all three K proline-rich regions have an adjacent RGG 
motif, a site that is methylated by a specific methyltransferase and it has been 
suggested that the SH3 interactions might be regulated by the methylation of 
these residues (Liu & Dreyfuss, 1995). The K protein also contains a novel 
shuttling domain (termed KNS) which confers bi-directional transport across 
the nuclear envelope (Michael et al., 1997b). The N-terminus of the K
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protein is highly acidic and has been reported to contain transcriptional 
activity (Tomonaga & Levens, 1995).
(d) hnRNP K binds to DNA and RNA and may have a role in pre-mRNA 
processing and transport
The K protein has been shown to bind to specific sequences in RNA 
(Matunis et al., 1992), and to single and double-stranded DNA which, in at 
least some instances, occurs through distinct DNA motifs such as the kB  
motif (Ostrowski et al., 1994) and the homopurine/homopyrimidine tract of 
the CT motif, present in the c-myc promoter PI (Takimoto et al., 1993). 
Recent evidence suggests that the CT motif of the c-myc promoter adopts an 
under-wound and flexible conformation in the presence of hnRNP K 
allowing the DNA to bend bringing together cis elements which facilitate 
transcription (Tomonaga et al., 1998).
Binding to RNA diminishes when the K protein is phosphorylated indicating 
that binding may be modulated by phosphorylation (Dejgaard et al., 1994). 
Since the K protein binds to RNA and shuttles between the nucleus and the 
cytoplasm it is thought that the K protein may have a function in pre-mRNA 
processing or transport.
(e) hnRNP K interacts with a number of cellular proteins involved in 
transcription, translation and signal transduction
K protein has been shown to interact with the SH3 domains of a number of 
proteins involved in signal transduction such as the tyrosine kinases Src, Fyn
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and Lyn and the proto-oncoprotein Vav which is exclusively expressed in 
hematopoietic cells and is involved in expansion of T and B cells in antigen- 
mediated proliferative responses and in the induction of intrathymic T cell 
maturation (Bustello et al., 1995). Although the K protein can engage the 
tyrosine kinases Src, Fyn and Lyn, it is not itself tyrosine-phosphorylated 
(Ostrowski et al., 1991, Weng et al., 1994). However, in the presence of K 
protein, KPK can be reactivated by c-Src suggesting that the K protein may 
facilitate cross-talk between tyrosine and serine/threonine kinases 
(Seuningen, 1995).
The K protein also interacts with a number of proteins involved in gene 
expression. K protein co-immunoprecipitates with epitope-tagged TFIID 
TATA-binding protein (TBP) and [35S]TBP translated in vitro binds to 
recombinant K protein (Michelotti et al., 1996). The K protein acts 
synergistically with TBP and the association is DNase- and RNase-resistant 
(Michelotti et al., 1996). K protein also interacts with the zinc-finger 
transcriptional repressor Zik 1 (Denisenko et al., 1996). Interestingly, poly(C) 
RNA which binds K protein, abrogates the Zikl-K protein interaction, while 
poly(A) RNA which does not bind K protein has no effect on this interaction. 
The Zikl-K protein interaction can also be blocked by the kB motif which like 
poly(C) RNA also binds to the K protein (Denisenko et al., 1996). This 
suggests that the interaction of Zikl with K protein is regulated by cognate 
nucleic acid motifs.
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Recently, K protein has been shown to interact with and repress transcription 
factor C/EBPp, a factor which is know to regulate a number of genes including 
those involved in the acute-phase response (Miau et al., 1998). It has been 
suggested that K protein does this by disrupting the synergistic interaction with 
C/EBP*3 and its coactivator Noppl40 and that phosphorylation of hnRNP K 
may affect the stability and activity of the hnRNPK-C/EBP^ complex.
Functional studies also indicate that the K protein has a role to play in the 
regulation of transcription. The K protein increases transcription both in vivo 
(Michelotti et al., 1996) and in vitro (Gaillard et al., 1988). Since K protein 
both activates and represses transcription of a reporter gene linked to a 
heterologous promoter which does not contain any obvious K protein-binding 
sequence-specific DNA motifs, it is possible that the effect of the K protein on 
transcription may in some instances occur indirectly through interactions with 
cellular transcription factors (Gaillard et al., 1988).
Finally, K protein appears to have a role in translation since it interacts with 
the elongation factor-la (O N  Densienko and K Bomsztyk, Maria 
Sklodowska-Curie Memorial Centre and Institute of Oncology, Warsaw, 
unpublished observations) and, together with hnRNP E l, interacts with and 
confers translational silencing on erythroid 15-lipoxygenase (LOX) mRNA 
(Ostareck et al., 1997). LOX is a key enzyme during erythroid cell 
differentiation and it must be silenced in early erythroid cells in the bone 
marrow and the peripheral blood. Evidence suggests that hnRNP K and
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hnRNP El regulate the translation of LOX by interacting with a C+U-rich, 
repetitive sequence motif in the 3’ UTR of LOX mRNA.
(f) hnRNP K interacts with the Hepatitis C Virus Core Protein
The K protein has been shown to weakly suppress the human thymidine kinase 
promoter (Hsieh et al., 1998). The hepatitis C virus (HCV) core protein has 
recently been shown to interact with the K protein and to relieve the 
suppression effect of K on the activities of the human thymidine kinase gene 
(Hsieh et al., 1998). The promoter of the human thymidine kinase gene 
contains a C+T motif approximately 100 bp upstream of its TATA element. 
The HCV core protein is a component of the viral nucleocapsid and it is 
associated with the endoplasmic reticulum and the nucleus. It is 
phosphorylated and it binds to DNA, RNA and ribosomes. The HCV core 
protein can modulate the expression of several viral and cellular genes 
including c-myc and p53 indicating that the HCV core protein may, like IE63, 
alter normal cellular functions. The finding that HCV core protein binds K 
protein, which, itself stimulates the c-myc promoter but suppresses the TK 
promoter indicates that the core protein exerts its effects on gene expression 
via interactions with cellular factors.
(g) hnRNP K interacts with human papillomavirus L2
Recent studies have shown that hnRNP K can interact with human 
papillomavirus 16 (HPV-16) late viral protein L2 in a sequence-specific
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manner effectively inhibiting translation of L2 mRNA (Collier et al., 1998). 
The HPV life-cycle is intricately linked to the differentiation of the stratified 
epithelium and the L2 protein is restricted to terminally differentiated 
epithelial cells in the superficial layers of the squamous epithelium. It seems 
plausible that HPV-16 may control gene expression at the level of translation, 
at least in part, via its interaction with hnRNPK.
(h) hnRNP K may act as a docking platform to facilitate molecular 
interactions
That the K protein can interact with multiple proteins and nucleic acids has led 
some to suggest that it may act as a linker molecule between DNA and RNA 
and proteins that cannot bind nucleic acids directly, thus allowing cross-talk 
between these factors. If this were true it would explain the ability of K 
protein to act on such diverse cellular functions as transcription, translation 
and signal transduction.
1.3.2 Casein Kinase II
(a) Casein kinase II phosphorylates proteins required for cell growth, cell
division, signal transduction and transcription
Casein kinase II (CKII) phosphorylates serine or threonine residues that are N- 
terminal to acidic amino acids. CKII uses either ATP or GTP as phosphoryl 
donors and is located in the cytosol, nuclei and nucleolus. The holoenzyme
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(130 kDa) consists of two catalytic a  subunits and two regulatory p subunits in 
the tetrameric configuration a 2p2, a a ’p2 or a ’2p2 (See Table 1.5) (Allende & 
Allende, 1995). The a  and a ’ subunits are highly homologous but are the 
products of different genes. CKII can interact with its substrates either in its 
holoenzyme form or as individual subunits.
CKII is a regulator of cell growth, cell division and signal transduction 
pathways and it plays an important role in positive and negative transcriptional 
regulation by specific phosphorylation of the transcription factors Spl (Pugh & 
Tijian, 1990), Apl (Lin et al., 1992), serum response factor (Marais et al., 
1992), upstream binding factor (Voit et al., 1992) and steroid hormone 
receptor (Picard et al., 1990). Over 30 other cellular proteins have been 
identified which interact with CKII and these include nuclear proteins such as 
myc, p53 and Noppl40, cytosolic proteins such as ornithine decarboxylase and 
tubulin and membrane bound proteins such as the LDL receptor and the 
androgen receptor (Allende & Allende, 1995).
(b) Casein Kinase II phosphorylates and modulates the function of a number 
of viral proteins
Interestingly CKII also phosphorylates a number of viral proteins including 
influenza virus PA polymerase (Sanz-Ezquerro et al., 1998), adenovirus El A 
protein (Massimi et al., 1996) and human papilloma virus E7 (Phillips & 
Vousden, 1997). Furthermore, the HIV-1 protein Rev has recently been shown 
to be a potent activator of CKII and the activated CKII phosphorylated several
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cellular and viral proteins in HIV-1-infected cells (Ohtsuki et al., 1998). The 
binding of Rev to the Rev Response Element (RRE) is significantly reduced 
when it is phosphorylated suggesting that the HIV-1 Rev-RRE complex may 
be regulated by CKII (Ohtsuki et al., 1998). It also seems likely that 
interactions between Rev and its cellular mediators, such as RIP1 may also be 
regulated by CKII in HIV-1 infected cells. Clearly CKII is utilised by a 
number of viruses to phosphorylate viral regulatory proteins enabling their 
activities to be tightly regulated.
.3 The p 32 Protein 
p32 interacts with the essential splicing factor ASF/SF2 and regulates 
splicing
p32 was originally isolated as a protein tightly associated with the essential 
splicing factor ASF/SF2 (Krainer et al., 1991). ASF/SF2 is a member of the 
SR family of splicing factors and it has a role in the enhancement of splicing 
and the regulation of alternative splicing (reviewed in Fu, 1995). ASF/SF2 has 
also been shown to shuttle between the nucleus and the cytoplasm and the 
phosphorylation state of the protein appears to regulate this activity (Caceres et 
al., 1998). The phosphorylation status of other SR proteins has been shown to 
affect their function in pre-mRNA recognition (Cao et al., 1997), spliceosome 
assembly (Xiao & Manley, 1997) and splicing catalysis (Kanopka et al., 1998) 
as well as the subcellular localisation (Caceres et al., 1998) and sub-organelle 
distribution (Misteli & Spector, 1997).
Recent evidence suggests that p32 is not a general splicing factor but that it 
exerts its effect on splicing by modulating ASF/SF2 function (Petersen-Mahrt 
et al., 1999). In fact it appears that p32 inactivates ASF/SF2 as a splicing 
repressor or activator protein by inhibiting the ability of ASF/SF2 to bind 
RNA and hence its function in initiation of pre-spliceosome formation and 
also by blocking ASF/SF2 phosphorylation. Since this post-translational 
modification regulates the subcellular localisation and sub-organelle 
distribution of ASF/SF2 it has been suggested that p32 may exert its effect on 
this protein by sequestering it into an inhibitory complex. However, the exact 
mechanism by which p32 regulates splicing has yet to be determined.
(b) The cellular localisation of the p32 protein
There is some controversy as to the exact localisation of the p32 protein. 
Various groups have reported that it can be found in the mitochondria (Muta et 
al., 1997, Matthews & Russell, 1998), cytoplasm (Luo et al., 1994, Simos & 
Georgatos, 1994, Tange et al., 1996, Wang et al., 1997), cell surface (Eggleton 
et al., 1995, Ghebrehiwet et al., 1997, Guo, 1997, Peterson et al., 1997) and 
nucleus (Luo et al., 1994, Simos & Georgatos, 1994, Tange et al., 1996, Wang 
et al., 1997, Matthews & Russell, 1998). Recent work carried out by our 
group suggests that p32 exists predominantly in the cytoplasm of uninfected 
cells but that it redistributes to the nucleus in the presence of IE63 alone and 
during HSV-1 infection (H E Biyant, D A Matthews, S Wadd, J E Scott, S
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Graham, W C Russell, J B Clements, Institute of Virology, University of 
Glasgow, submitted for publication).
(c) p32 interacts with a number of diverse viral proteins
p32 interacts with a number of viral proteins including the HSV-1 ORF-P 
protein (Bruni & Roizman, 1996), the adenovirus polypeptide V (Matthews & 
Russell, 1998), Epstein-Barr virus EBNAI protein (Wang et al., 1997, Chen et 
al., 1991) and the HIV Rev (Luo et al., 1994, Tange et al., 1996) and Tat 
proteins (Yu et al., 1995). It has been postulated that the interaction of p32 
with Rev which is bound to ASF/SF2 at the 5’-splice site stabilises the 
interaction of U1 snRNP with the 5’-splice site and inhibits assembly of a 
functional spliceosome (Tange et al., 1996). The dysfunctional spliceosome 
could then function as a substrate for Rev-mediated nuclear transport. 
However, p32 also appears to bridge the HIV-1 protein Tat to the general 
transcription machinery via its interaction with TFIIB and appears to act 
synergistically with Tat to stimulate transcription (Yu et al., 1995), suggesting 
that p32 plays multiple roles in HIV-1 replication. Deletion of the regions of 
EBNA-1 required for interaction with p32 abrogated the transcriptional 
activity of EBNA-1, implicating p32 as a possible mediator of EBNA-1 - 
dependent transactivation. In addition, by examining infected cells using 
confocal microscopy and immunofluorescence, Matthews and Russell have 
concluded that p32 may play a role in importing cellular proteins to the 
nucleus and that adenovirus protein V hijacks this protein to deliver the 
adenovirus genome to the nucleus (Matthews & Russell, 1998).
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1.3.4 Spliceosomal Associated Protein 145
(a) Spliceosomal Associated Protein 145 is a subunit of the essential splicing 
factor SF3b
Subsequent to E-complex formation, prespliceosomes are formed by 
interaction of the U2 snRNP with the branch site. This interaction involves 
base pairing between the U2 snRNA and the branch-point sequence and is 
stabilised by a number of proteins (Figure 1.6). These proteins include the 
heteromeric splicing factors SF3a and SF3b, which are essential for 
prespliceosome assembly (Brosi et al., 1993b). SF3a is comprised of subunits 
of 60, 66 and 120 kDa (designated spliceosomal-associated proteins SAP61, 
SAP62, and SAP114, respectively) whereas SF3b contains subunits of 53,120, 
150 and 160 kDa which are thought to correspond to SAPs 49, 130, 145 and 
155 respectively (Brosi et al., 1993b, Brosi et al., 1993a, Hodges & Beggs, 
1994).
(b) Spliceosmal Associated Protein 145 is required for the binding of the U2 
snRNP to pre-mRNA
All SF3a and SF3b subunits, with the exception of SF3b120, can be cross- 
linked to a 20-nucleotide region just upstream of the branch site (Champion- 
Amaud & Reed, 1996, Gozani et al., 1996). Although the binding of these 
proteins occurs in a sequence-independent manner, the interaction of the SF3a
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and SF3b subunits with this site is absolutely essential for tethering the U2 
snRNP to the branch site. Therefore it appears that the primary role of 
SAP 145 is to mediate the binding of the U2 snRNP to the pre-mRNA.
1.3.5 ALY
(a) ALY stimulates transcription of the components of the T-cell receptor 
alpha enhancer complex
ALY is a ubiquitously expressed nuclear protein which associates with the 
proteins LEF-1 and AML-1 (Bruhn et al., 1997). These proteins are 
components of the T-cell receptor alpha enhancer complex and it is thought 
that ALY stimulates transcription by facilitating the collaboration of these 
proteins in this complex.
(b) ALY is a spliceosome-associated protein
A recent study using mass spectrometry and expressed-sequence tag databases 
(EST) has allowed the characterization of the mammalian spliceosome 
complex (Neubauer et al., 1998). This study has identified 19 proteins which 
were not previously thought to be associated with the spliceosome, one of 
which was ALY (mouse). This evidence strongly suggests that ALY has a role 
in mammalian splicing.
1.4 AIM AND SCOPE OF PROJECT
1.4.1 Evidence suggests that IE63 interacts with a number of cellular and viral
proteins
IE63 plays an essential role during HSV-1 infection. The preceding text has 
presented evidence that IE63 has an effect on:-
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(i) the transcription of viral and some cellular genes
(ii) polyadenylation
(iii) splicing
(iv) transport of viral and cellular mRNAs across the NPC
(v) viral DNA replication
Clearly, IE63 is not a simple protein with one function and a single domain 
required to carry out this function. It appears that IE63 has multiple effects 
on the infected cell nucleus and the protein requires many functional domains 
to perform its essential role in the virus life cycle. It is difficult to envisage a 
mechanism by which IE63 could carry out such diverse functions in the host 
cell. The most convincing explanation for this is that IE63 interacts with and 
modifies essential viral and cellular regulatory proteins involved in these 
processes.
The finding that IE 175 and the U1 SnRNP 70 kDa protein have an altered 
phosphorylation state and ICP8 exhibits a conformational modification in the 
presence of IE63 supports this hypothesis. Further, IE63 must interact with a 
number of cellular proteins to allow it to shuttle back and forth across the 
NPC. IE63 has been shown to interact with the IE 175 protein and to 
coimmunoprecipitate with anti-Sm antisera. It is likely that identification of 
the other proteins with which IE63 interacts will provide the key to 
determining the mechanism of action of this essential HSV-1 protein.
Considering this evidence, it seemed appropriate to investigate IE63-protein 
interactions. It is the aim of this study to identify the cellular proteins with
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which IE63 interacts. The yeast two-hybrid system is the method that has 
been chosen to carry out this project. This method and the reason for 
choosing this approach has been described in detail in Section 2.1 of this 
thesis.
1.4.2 The significance of interactions of IE63 with host-cell proteins
Since IE63 is essential for viral replication, determining the mode of action 
of this protein is clearly critical for an explicit understanding of HSV-1 
biology. In addition, any indispensable viral protein is a possible target for 
antiviral therapy. For a viral infection that is so widespread and that has, as 
yet, no definitive cure the value of such studies becomes obvious.
That IE63 has homologues in viruses such as the Kaposi’s sarcoma virus, 
varicella-zoster virus and Epstein-Barr virus suggests that determining the 
interactions of IE63 with cellular proteins may improve understanding of 
these viruses. Finally, as has been the case with many studies of viruses, it is 
possible that determining IE63 interactions with cellular proteins may shed 
light on some poorly defined or as yet unidentified cellular pathways.
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MATERIALS AND METHODS
THE YEAST TWO-HYBRID SYSTEM
Basic Principles
The two-hybrid system exploits the ability of a pair of interacting proteins to 
bring the activation domain (AD) of a transcription factor in close proximity 
with the DNA-binding domain (BD) of that same transcription factor bound 
to a cis-acting regulatory element, thus stimulating the expression of adjacent 
reporter genes (see Figure 2.1) (reviewed in Mendelsohn & Brent, 1999).
A schematic diagram of the two-hybrid system screening protocol is shown 
in Figure 2.2. In this study, the yeast transcription factor is GAL4. Two 
different cloning vectors are used to generate fusions of: (a) AD + gene 
encoding the target protein and, (b) BD + gene encoding the protein used to 
screen the library. The hybrid proteins are co-expressed in a strain of the 
yeast Saccharomyces cerevisiae that contains the reporter genes HIS3 and 
LacZ. Since the cloning vector that encodes the activation domain/target 
protein also carries the TRP1 gene and the vector that encodes the DNA- 
binding domain/bait protein encodes the LEU2 gene, yeast colonies 
containing both plasmids which encode interacting proteins can be selected 
for by culture on a medium lacking tryptophan, leucine and histidine. An 
assay for p-galactosidase activity (lacZ expression) confirms that colonies are 
candidates for interaction of the two-hybrid proteins.
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Figure 2.2
Schematic diagram o f  two-hybrid system. Plasmids encoding the bait are 
cotransformed into yeast cells with plasmids encloding a cellular library o f  proteins. Yeast 
colonies that grow on medium lacking histidine, leucine and tryptophan and that turn blue 
in a (3-gal assay contain putative interacting proteins.
The two-hybrid system has been extended to screen activation domain 
libraries for proteins that interact with a bait protein. cDNA sequences are 
fused to the DNA encoding an activation domain. This library and a plasmid 
encoding a the BD-bait protein fusion are co-expressed in yeast and the 
resulting transformants are screened for the two reporter genes. Plasmids 
responsible for reporter gene expression are then isolated from the yeast cells 
and DNA sequencing is used to identify the proteins encoded by the library 
plasmids. Figure 2.3 illustrates the procedures used to screen an activation 
domain/library.
2.1.2 Development of the Two-Hybrid System
(a) Historical perspective
Findings from three types of experiments led to the development of the two- 
hybrid system. First, the two functional domains of a number of 
transcription factors were identified. Certain transcription factors, such as 
the yeast GAL4 and GCN4 proteins, were shown to consist of two distinct 
and separable domains: a DNA-binding domain, and an acid region which is 
required for transcriptional activation (Fields & Song, 1989, Hope & Struhl, 
1986).
Second, the ability to generate hybrid transcription factors was demonstrated 
by generating a hybrid LexA-GAL4 fusion protein which was found to 
activate transcription in yeast cells containing a reporter gene under the
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Plate culture on SD/-His/-Leu/-Trp 
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Transform yeast with bait plasmid 
and test for reporter gene activation
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Titre and amplify AD fusion 
library
Test phenotype of yeast cells
Figure 2.3
Procedure used to screen an activation domain library using the yeast two-hybrid system.
control of LexA operator sequences (Brent & Ptashne, 1985). In these 
experiments, the DNA-binding activity was provided by the LexA 
component and the activation function was provided by the GAL4 
component.
Third, the concept of the DNA-binding and activation domains functioning 
when non-covalently joined via protein-protein interactions was recognized. 
The yeast protein GAL80 was shown to bind to the transcription factor GAL4 
in a process which obscured the activation domain of GAL4 (Ma & Ptashne, 
1988). Ma and Ptashne deleted the activation domain from GAL4 and fused 
an activation domain to GAL80. They showed that when the two proteins 
interacted, the modified GAL80 protein caused the inactive GAL4 to 
stimulate transcription.
As a result of these observations, Fields and his coworkers suggested that 
protein interactions could be detected if two potentially interacting proteins 
were expressed as fusion proteins (Fields & Song, 1989). They proposed that 
the first protein contain a DNA-binding domain which binds to DNA 
upstream of a reporter gene, and that the second protein contain an activation 
domain. Field’s group went on to demonstrate the feasibility of this concept 
using the two yeast proteins SNF1 and SNF4 which had previously been 
shown to interact in vitro. They fused SNF1 to a DNA-binding domain and 
SNF4 to an activation domain and together these proteins were shown 
activate transcription of a reporter gene.
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(b) Yeast two-hybrid systems
All two-hybrid systems developed to date share a number of common 
features. First, all use a plasmid which encodes a ‘bait’ protein that is 
brought to a specific DNA sequence by fusion to a DNA-binding domain. 
Second, they employ one or more reporter genes with upstream binding sites 
for the DNA-binding domain/bait protein. Third, they all use a plasmid that 
encodes ‘target’ proteins fused to an activation domain.
However, these systems also differ in a number of features. Bait proteins 
differ in their DNA-binding domains: some systems use baits that contain 
the E. coli LexA repressor protein which binds to appropriate operators, 
whilst other systems use bait proteins that contain a portion of the yeast 
GAL4 protein which binds to the GAL upstream activation sequence (UAS). 
Reporter genes used in two-hybrid systems also vary. The products of some 
reporter genes (e.g. HIS3 and LEU2) allow yeast cells expressing them to be 
selected by growth on appropriate medium, whereas the products of others 
(e.g. LacZ) allow cells expressing them to be visually screened. The number 
and affinity of upstream binding sites for the bait proteins can also differ and 
these differences affect the strength of protein interactions that can be 
detected.
Target proteins differ in their activation domains and whether they contain 
other useful regions such as NLS’s and epitope tags. Although some
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activation domains are stronger than others, their expression may damage 
yeast cells when strong activation domains come into contact with the DNA.
A number of developments in recent years have greatly improved the efficacy 
and viability of yeast two-hybrid systems. The first generation of DNA- 
binding domain and activation domain plasmids were driven by a truncated 
410-bp ADH-1 promoter which, at one point, was believed to be sufficient 
for high-level expression (Beier & Young, 1982). However, in most vector 
constructs this truncated promoter led to low or very low levels of fusion 
protein expression. The high-level expression reported by Beier & Young 
was apparently due to a segment of DNA derived from pBR322 which, by 
chance, enhances transcriptional activity in yeast (Tomow & Santangelo, 
1990). Therefore in the second generation of plasmids, strong constitutive 
fusion protein expression is driven by the 410-bp truncated ADH1 promoter 
adjacent to this enhancing pBR322 segment or by the full-length ADH1 
promoter. Fusion proteins expressed by the second generation of plasmids 
can be detected by Western blots and higher levels of expression allow the 
detection of weak or transient protein-protein interactions.
The development of a cycloheximide resistant yeast strain precludes the 
requirement for the lengthy recovery of the plasmids through yeast. The 
plasmid encoding the DNA-binding domain fusion protein has the CYH2 
gene conferring cycloheximide sensitivity and if the yeast are grown in 
cycloheximide, the plasmid expressing the DNA-binding domain fusion
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protein will be eliminated. The resulting strain can then be mated to a strain 
that has been transformed with all the appropriate control plasmids.
Finally, the commercial availability of Synthetic Dropout Media which 
contain all but one or more amino acids essential for yeast growth has 
abrogated the laborious and time-consuming task of preparing the different 
amino acid combinations for yeast culture.
(c) Derivatives of the yeast two-hybrid system
Although yeast cells are still used in the majority of two-hybrid sytems, a 
number of two-hybrid mammalian systems have recently been developed. In 
one system, the DNA binding domain of GAL4 and the activation domain of 
the HSV-1 VP 16 protein provide functional transcriptional activation (Fearon 
et al., 1992). This system utilises five GAL4 binding sites positioned 
upstream of the firefly luciferase gene to provide a sensitive reporter system 
in mammalian cells. In another system, the interaction of a VP16-tagged 
derivative with a GAL4 DNA-binding domain/bait protein drives the 
synthesis of simian virus 40 T antigen. This antigen in turn promotes the 
replication of the target plasmid which carries a SV40 origin (Vasavada et 
a l , 1991).
The mammalian two-hybrid system can be used to confirm putative protein- 
protein interactions that were initially identified either by the yeast two- 
hybrid system or by in vitro biochemical methods. A two-hybrid system for
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mammalian cells allows characterization of mammalian protein-protein 
interactions within a cellular environment that more closely mimics the 
native protein environment. In addition, differences exist between yeast and 
mammalian cells in post-translational modifications such as glycosylation, 
phosphorylation and acylation, as well as in the intracellular localization of 
proteins. These types of protein modifications may influence the ability of 
protein domains to interact. Therefore by using a mammalian two-hybrid 
system a number of false positives obtained with the yeast two-hybrid system 
can be eliminated and true positive results can be confirmed in a more natural 
environment. In its present state, however, the efficiencies of the mammalian 
two-hybrid system do not allow for screening of complete mammalian 
libraries.
The yeast-based system retains a number of advantages, including the ease of 
transformation of yeast cells and the availability of nutritional and well- 
characterized reporter genes for direct selection. Furthermore, yeast proteins 
are less likely to bind a mammalian target protein, preventing its interaction 
with a protein encoded by a library. Finally, mammalian cell-based systems 
require significant experimental resources whereas the yeast-based system is 
comparatively rapid and cost-effective.
The yeast one-hybrid system is an adaptation of the two-hybrid system and is 
used for studying DNA-protein interactions. In this system cDNA candidates 
that may encode the protein of interest are expressed as fusions with the 
activation domain. If the activation domain/target protein interacts with a
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DNA-binding sequence the HIS3 and LacZ reporter genes are expressed. 
DNA binding can then be confirmed independently by sequencing, database 
searches, and in vitro DNA-binding assays.
The yeast three-hybrid system (reviewed in Zhang et al., 1999) is used for 
studying RNA/protein interactions. Here, a known RNA-binding protein/Lex 
A fusion protein is used to tether an RNA containing the appropriate binding 
site. This hybrid protein brings the bound RNA to a reporter gene which is 
regulated by LexA binding sites. The RNA is bifunctional in that it also 
contains a binding site for a second RNA-binding protein. This protein is 
fused to a GAL4 transcriptional activation domain. Thus, the interaction of 
the RNA with both RNA-binding proteins should result in transcriptional 
activation of the reporter. This method is capable of defining domains that 
are necessary for RNA-binding proteins that have been previously 
characterized. It can also be used to identify the genes for RNA-binding 
proteins that recognize biologically important RNA sequences. Proteins that 
interact with such sequences may be identified using the large variety of 
existing libraries of genomic and cDNA sequences cloned into activation 
domain vectors.
Future developments
Future developments of the two-hybrid system are likely to involve the 
design of DNA-binding domain and activation domain plasmids with 
compatible and less restrictive cloning sites. In addition, a significant
development of the two-hybrid system would be to couple the two-hybrid 
system with a biochemical assay to test for hybrid protein interactions. One 
possibility would be to extend the fusion of the DNA-binding domain and 
target gene to include sequences encoding a region widely used in binding 
studies such as glutathione-S-transferase (GST) or maltose-binding protein 
The inclusion of bacterial promoter sequences in the constructs would allow 
the production of bacterial fusion proteins that could be assayed for 
biochemical interaction both in vivo and in vitro.
2.1.3 In Vitro or In Vivo - Why Choose the Two-Hvbrid System?
A variety of biochemical methods have been used to study protein-protein 
interactions. Some of these methods include protein affinity 
chromatography, affinity blotting, co-immunoprecipitation and chemical 
cross-linking.
However, the two-hybrid system is a very sensitive method for detecting 
protein-protein interactions and whilst it cannot be guaranteed to identify all 
proteins which interact with the bait protein, it can detect binding that is 
often beyond the limits of in vitro detection methods such as 
immunoprecipitation. For example, interaction of the mammalian Ras 
protein with the protein kinase Raf was detected in the two-hybrid system, 
but had not been detected by co-immunoprecipitation (Aelst, 1993). The 
sensitivity of the method is partly due to the fact that the hybrid proteins are 
generally produced at a high level by strong promoters on high-copy vectors
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and this favours complex formation. In addition, interaction of the activation 
domain with the basal transcription machinery may help stabilize a weak 
protein-protein interaction. In the two-hybrid system interacting complexes 
do not need to survive several washes which diminish the signal but are 
necessary to prove specificity in many in vitro methods. Furthermore, the 
detection method effectively amplifies the signal because it produces mRNA 
which generates multiple stable enzymes per transcript. The resultant 
phenotype, blue colour in the p-galactosidase assay and the synthesis of the 
HIS3 protein, is extremely sensitive.
As the two-hybrid system is performed in vivo, conditions are similar to those 
in which protein interactions normally occur. In addition, a number of 
protein-protein interactions are mediated by mRNA and this molecule will be 
present in the two-hybrid system but not in many biochemical systems. 
Perhaps the greatest advantage of the system is that when positive plasmids 
are identified, a portion of the gene encoding the interacting protein is 
immediately available for sequencing and the identity of interactors can be 
determined very quickly. Furthermore, purified target protein or antibody 
against the protein is not required for the two-hybrid assay and these may not 
be available to those studying proteins that are not well characterized.
The high sensitivity of the yeast two-hybrid system combined with the other 
advantages described above made it an attractive system for use in this study. 
However it is important to note that the system has a number of potential
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drawbacks and these were considered carefully before a decision was made to 
use the two-hybrid system here.
For example, some hybrid proteins may not be stably expressed in yeast cells 
or localized to the nucleus and a number of hybrid genes such as the cell- 
cycle regulators cyclin A and cyclin B are either harmful or lethal when 
expressed in yeast (reviewed in Estojak et al., 1995). In addition, since 
proteins are targeted to the nucleus, interactions which require post- 
translational modifications that take place within the endoplasmic retiticulum 
such as glycolysation and disulfide bond formation may not occur in this 
system. Proteins which require other modifications for association such as 
phosphorylation or aceytlation by non-yeast proteins also may not be 
suitable. Further, GAL4 domains may interfere with the ability of some tests 
proteins to interact. Although these factors can be problematic in the yeast 
two-hybrid system, in practice they rarely cause two-hybrid screens to be 
abandoned. A much more significant and common problem to be 
encountered is that some DNA-binding-protein hybrids activate transcription 
autonomously. Such proteins can of course be truncated to remove the 
regions of the protein which are causing transcription without disrupting the 
domains required for protein-protein interactions.
Finally, the high sensitivity of the two-hybrid system can create a large 
number of false positives. Screening assays can eliminate many of these but 
some proteins appear to have a low affinity for a large number of proteins 
and such proteins are frequently described as being ‘sticky’. Thus perhaps
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the greatest drawback of the two-hybrid system is the difficulty in 
determining whether positives are representative of in vivo cellular 
interactions.
Following careful consideration the two-hybrid system was chosen for the 
detection of protein-protein interactions in this project with the proviso that 
any putative positives arising from the this work would be screened 
independently using an in vitro method and that the two-hybrid system would 
be used only as a first step to determine biologically significant IE63-protein 
interactions.
2.1.4 Applications of the Two-Hvbrid System
The three principal uses of the two-hybrid system at present are the 
confirmation of protein-protein interactions between two known partners, 
detection of protein-protein interactions between a bait protein and a library 
of random proteins and the mapping of sequences required for a given 
protein-protein interaction.
In the future, two-hybrid systems may be used routinely to identify new 
targets for pharmaceuticals. For example a two-hybrid system has been used 
to identify new nuclear hormone receptors by expressing a LexA-retinoic 
acid receptor bait and coexpressing this with an activation-tagged liver 
cDNA library (cited in Mendelsohn & Brent, 1994). Four new retinoic acid 
interacting proteins were identified, two of which were novel nuclear
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hormone receptors. The ligands for these receptors are likely to be 
biologically active and may have a pharmaceutical significance.
An additional industrial use of the two-hybrid system is to find peptides or 
compounds that interact with a target protein to disrupt its normal 
interactions. This strategy was used to identify peptides that interact with 
cyclin-dependent kinase 2 to inhibit its kinase activity (Colas et al., 1996). In 
this study, an activation domain library was constructed that encoded a 
number of random peptides displayed in the active site of E. coli thioredoxin. 
The peptides that interacted with cyclin-dependent kinase 2 were identified, 
and biochemical analysis demonstrated the ability of these peptides to inhibit 
the kinase activity of this protein.
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2.2 MATERIALS
2.2.1 Yeast Cells
Table 2.1 describes the yeast cells used in this project. All yeast strains were 
purchased from Clontech.
In the absence of a positive two-hybrid interaction; CG-1945 and HF7C 
exhibit varying levels of constitutive leaky histidine expression. Leaky 
histidine expression can be controlled by including 5mM 3-amino-1,2,4- 
triazole (3-AT) in the medium which suppresses background growth. 3-AT 
is a competitive inhibitor of the yeast HIS3 protein.
2.2.2 Yeast Culture Medium
YPD Medium 2% (w:v) peptone, 1% (w:v) yeast
extract, 1.8% (w:v) agar (plates 
only), 2% (w:v) glucose. pH 5.8
Synthetic Dropout (SD) Medium 0.67% (w:v) yeast nitrogen base
without amino acids, 2% (w:v) agar 
(plates only), 2% (w:v) glucose, 
0.077% (w:v) -His dropout (DO)
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Dropout Supplements
supplement or 0.067% (w:v) -Leu 
DO supplement or 0.074% (w:v) - 
Trp DO supplement or 0.064% (w:v) 
-Leu/-Trp DO supplement or 
0.062% (w:v) -Leu/-Trp/-His DO 
supplement or 0.077% (w:v) -His 
DO supplement or 0.077% (w:v) - 
Ura DO supplement. pH 5.8.
Dropout supplement used depends 
on intended use of the medium.
Purchased from Clontech. Includes 
all but one or more of the amino 
acids adenine, arginine, aspartic 
acid, histidine, isoleucine, leucine, 
lysine, methionine, phenylalanine, 
threonine, tryptophan, tyrosine, 
valine and uracil depending on 
intended use of medium.
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2.2.3 Bacterial Cells
Escherichia coli K12 strain DH5a (hsd R \7, lac U 169, gyr A69, thi-1, rel 
A l, rec A l, end A l, supEAA, cp80, lacZ M l5) was used for the propagation 
of plasmids.
2.2.4 Bacterial Culture Media
Luria-Bertani (LB) Medium 1% (w:v) bacto-tryptone, 0.5%(w:v)
bacto-yeast extract, 177 mM NaCl2,
1.5% (w:v) agarose (plates only). 
pH 7.0.
Terrific Broth 1.2% (w:v) bacto-tryptone, 2.4%
(w:v) bacto-yeast extract, 4% (v/v) 
glycerol, 17 mM KH2P 0 4, 72 mM 
K2HP04.
2.2.5 Two-Hybrid System
The two-hybrid systems used were the Matchmaker Two-Hybrid System I 
and the Matchmaker Two-Hybrid System II both of which were purchased 
from Clontech.
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2.2.6 Plasmids
pGBT9 (Clontech) is a shuttle vector that can be propagated in E. coli and 
yeast. The plasmid was supplied with the Matchmaker Two-Hybrid System I 
and was used to generate fusions of IE63 with the GAL4 DNA-binding 
domain. pGBT9 carries the tryptophan gene for selection in yeast cells that 
lack the ability to produce this amino acid. This plasmid is under the control 
of the truncated ADH1 promoter.
pGAD424 (Clontech) is a shuttle vector that can be propagated in E. coli and 
yeast. The plasmid was supplied with the Matchmaker Two-Hybrid System I 
and was used to generate fusions of known proteins with the GAL4 AD. 
pGAD424 carries the leucine gene for selection in yeast cells that lack the 
ability to produce this amino acid. This plasmid is under the control of the 
truncated ADH1 promoter.
pAS2-l (Clontech) is a shuttle vector that can be propagated in E. coli and 
yeast. The plasmid was supplied with the Matchmaker Two-Hybrid System II 
and was used to generate fusions of IE63 with the GAL4 DNA-binding 
domain. pAS2-l carries the tryptophan gene for selection in yeast cells that 
lack the ability to produce this amino acid. This plasmid is under the control 
of the full-length ADH1 promoter and expresses protein at a higher level than 
pGBT9.
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pACT2 (Clontech) is a shuttle vector that can be propagated in E. coli and 
yeast. The plasmid was supplied with the Matchmaker Two-Hybrid System II 
and was used to generate fusions of known proteins with the GAL4 AD. 
pACT2 carries the leucine gene for selection in yeast cells that lack the 
ability to produce this amino acid. This plasmid is under the control of the 
truncated ADH1 promoter that is adjacent to a section of pBR322 which acts 
as a transcriptional enhancer in yeast. This plasmid expresses protein at a 
higher level than pGAD424.
pGAD GH (Clontech) is a shuttle vector that can be propagated in E. coli and 
yeast. The plasmid was used to generate fusions of a human HeLa cDNA 
library with the GAL4 AD. pGAD GH carries the leucine gene for selection 
in yeast cells that lack the ability to produce this amino acid. This plasmid is 
under the control of the full-length ADH1 promoter.
pCLl (Clontech) was used as a positive control plasmid in the two-hybrid 
system vector pACT2 and it encodes and expresses the full-length, wild-type 
GAL4 protein.
PTD1-1 (Clontech) encodes the SV40 large T-antigen protein fused to the 
GAL4 activation domain in pACT2. The protein was known to interact with 
the murine p53 protein which is expressed fused to the GAL4 binding 
domain of the plasmid pVA3-l. The two plasmids, cotransformed into yeast 
cells, were used as a positive control in the two-hybrid system.
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pLAM5’-l (Clontech) encodes the human Lamin C protein fused to the 
GAL4 binding domain in pAS2-l. The plasmid was known not to interact 
with the SV40 Large T-antigen which is encoded by the pTDl-1 plasmid. 
The two plasmids, cotransformed into yeast cells, were used as a negative 
control in the two-hybrid system.
pSG130 is a derivative of the pUC18 vector with the full-length IE63 gene 
cloned under the control of its own promoter. The plasmid was supplied by 
Rozanne Sandri-Goldin and was used as a template from which portions of 
the IE63 gene were generated by PCR.
The regions of hnRNP K required for interaction with IE63 were mapped 
using the following truncations (Tsieh et al., 1998) which were a kind gift 
from Tsai-Yuan Hsieh (University of Southern California School of 
Medicine, Los Angeles) pGAD424-hnRNP K (aa 327-463), pGAD424- 
hnRNP K (aa 1-327), pGAD424-hnRNP K (aa 250-463), pGAD424-hnRNP 
K (276-463), pGAD424-hnRNP K (aa 1-276).
The RIP1 (Rab) and CRM1 clones were a kind gift from Dr Bryan Cullen 
(Howard Hughes Memorial Institute, Durham, North Carolina) and were 
cloned into pGAD424 and pGBT9 respectively.
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2.2.7 cDNA Libraries
A human HeLa cDNA library cloned into the pGAD GH vector (Clontech) 
was used to generate target proteins in a two-hybrid screen where the bait 
protein was the IE63 truncation 502C expressed by pAS2-l. The library was 
a gift from Paul Yeo (Institute of Virology, Glasgow) and it had been 
amplified by Dr Yeo. The library contained an estimated 93% of colonies 
with inserts and the total number of independent clones was 6.0 x 106. The 
average cDNA size was 1.5 kb with a cDNA size range of 0.4-4.0 kb. The 
titer of the library was >10® cfu (of DH10B)/ml in LB broth and 25% sterile 
glycerol. The cloning sites used were ZscoRI and Xho I.
A BHK cDNA library cloned into pAD-GAL4 (Stratagene) was used to 
generate target proteins in a two-hybrid screen where the bait protein was the 
IE63 truncation 442C BD expressed by pGBT9. The library contained an 
estimated 90% of colonies with inserts and the titre was 2 x 106 pfu/ml. The 
cloning sites used were EcoRI and Sma I.
2.2.8 Enzymes
Restriction enzymes, Taq polymerase and Klenow were obtained from 
Boehringer Mannheim. Vent Polymerase was purchased from New England 
Biolabs and T4 Ligase was purchased from Gibco BRL.
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2.2.9 Antibodies
Mouse monoclonal anti-IE63 HI 113 (Ackerman et al., 1984) was supplied 
by the Goodwin Institute for Cancer Research.
GAL4 DNA-BD and AD monoclonal antibodies were purified from serum- 
free media of mouse hybridoma cultures and were purchased from Clontech.
2.2.10 Oligonucleotides
Oligonucleotides for PCR synthesis were obtained from Cruachem.
2.2.11 Sequencing Primers
The primer that was used for sequencing towards the junction of the GAL4 
DNA-binding domain and target proteins cloned into the plasmids pGBT9 
and pAS2-l was the 17-mer 5’-TCATCGGAAGAGAGTAG-3’ which binds 
59 bp from the multiple cloning start site. This primer was purchased from 
Clontech.
The primer that was used for sequencing towards the junction of the GAL4 
activation domain and candidate proteins cloned into pGAD424, pACT2 and 
pGAD GH plasmids was the 17-mer 5 ’ -T ACC ACT AC AATGG ATG-3 ’ 
which binds 107 bp from the multiple cloning start site. This primer was 
purchased from Clontech.
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2.2.12 Molecular Weight Markers
2.2.13
2.2.14
A 1 kb ladder DNA marker and a 220 kDa rainbow protein marker were 
obtained from Amersham.
Chemicals and Miscellaneous Reagents
Chemical/Reagent
3-amino-l,2,4-triazole (3-AT)
Cycloheximide
Herring Testes Carrier DNA
Ampicillin
5 -bromo-4-chloro-3 -indoly 1- p -D- 
galactopyranoside (X-GAL)
Zymolase
Manufacturer
Sigma
Sigma
Clontech
Smith Kline Beecham Research 
Melford Laboratories
ICN Biochemicals
Commonly used Buffers and Solutions
DNA loading buffer 50% (w:v) glycerol, 445 mM Tris,
10 mM EDTA, 445 mM boric acid, 
0.1% bromophenol blue, 0.1% 
xylene cyanol
2x Laemmli sample buffer 10% (v:v) 2 mercaptoethanol, 6%
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(w:v) SDS, 20% (v:v) glycerol, 0.2 
mg/mL bromophenol blue, 0.025 x 
Laemmli stacking buffer
2.5x Laemmli stacking buffer
STET buffer
Z buffer
PBS
TAE
Yeast protoplasting buffer
0.3 M Tris-HCl (pH 6.8), 0.25% 
(w:v) SDS
1% Triton X-100, 10 mM Tris-HCl 
(pH 8.0), 234 mM sucrose, 50 mM 
EDTA
113 mM Na2HP04, 40 mM 
NaH2P 04.H20 , 10 mM KC1, 1 mM 
MgS04.7H20
170 mM NaCl, 3.4 mM KC1, 10 mM 
NaHP04, 2 mM KH2P 0 4 (pH 7.2)
40 mM Tris, 0.1% acetic acid, 50 
mM EDTA
0.01% (v:v) 2 mercaptoethanol, 100 
mM Tris HC1 (pH 7.5), 10 mM 
EDTA (pH 7.5), 0.2 mg/ml
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Zymolase (20,000 units/mg)
2.2.15
Yeast lysis solution 
X-gal stock solution
Z buffer/X-gal solution
PEG/LiAc solution 
Tris-glycine electrophoresis buffer 
Protein transfer buffer
Miscellaneous
Gene Clean Kit 
90 mm filter paper #5
0.2 M NaOH, 1% (w:v) SDS
6% (w:v) X-gal in N,N- 
dimethylformamide (DMF)
0.27% (v:v) 2-mercaptoethanol,
1.67% (v:v)X-gal stock solution, 
98% (v:v) Z buffer
40% (w:v) PEG 4,000, lx  TE buffer, 
lx Li Ac
25 mM Tris, 250 mM glycine (pH 
8.3), 0.1% (w:v) SDS
39 mM glycine, 48 mM Tris base, 
0.037% (w:v) SDS, 20% (v:v) 
methanol
BIO-101 
Whatman
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Miniprep Kit 
Maxiprep Kit
QIAGEN
QIAGEN
2.3 METHODS
2.3.1 Yeast Culture and Manipulation
(a) Growth and maintenance of yeast host strains
Yeast host strains were stored in YPD medium with 25% glycerol at 
-70°C. To recover a strain, cells were scraped from the frozen stock with an 
inoculation loop and streaked onto YPD plates. The plates were inverted and 
incubated for 3-5 days at 30°C until the colonies reached approximately 2 
mm in diameter. The working stock plates were then stored at 4°C for a 
maximum of two weeks. After two weeks a single colony was taken from 
the plate and streaked onto a fresh YPD plate.
(b) Phenotype verification
The phenotypes of all of the yeast strains were verified before transforming
them with plasmids. A single colony was taken from the stock plate and 
streaked onto one of four SD plates lacking either tryptophan, leucine,
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histidine or uracil. Plates were incubated at 30°C for 3-5 days and scored for 
growth.
(c) Control transformations
To ensure that the two-hybrid system was working efficiently and to verify 
the transformation markers on the plasmids, the control transformations 
described in Table 2.2 were carried out using the small scale transformation 
method described in Section 2.2.1 (d). Plates were scored for growth and a 
filter lift was carried out to determine the LacZ phenotype of the 
transformants.
(d) Small scale transformation of yeast cells
The small scale transformation procedure was used to verify that the DNA- 
BD/target protein does not autonomously activate reporter genes, to perform 
control experiments and to do single plasmid transformations for subsequent 
mating assays.
To make yeast competent cells, several colonies of the appropriate yeast 
strain were inoculated into 1 ml of YPD medium and vortexed vigorously to 
disperse any clumps of cells. The yeast cells were then transferred into a 
flask containing 100 ml of YPD medium and incubated at 30°C for 16-18 h 
with shaking at 250 rpm to stationary phase (OD6oo> 1 .5). The overnight 
culture was added to 300 ml of YPD media to a final ODsooof 0.2-0.3 and
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incubated for 3 h at 30°C with shaking at 230 rpm. The cells were then 
centrifuged at 3,000 rpm for 5 min, the supernatant was discarded and the 
cells were resuspended in 25-50 ml of water by vortexing. The cells were 
centrifuged once more at 3,000 rpm for 5 min and the supernatant discarded. 
The cell pellet was resuspend in 1.5 ml of sterile lx TE/LiAc solution.
To transform the competent cells, 1 pg of DNA-BD vector construct, 1 pg of 
AD vector construct and 0.1 mg of herring testes carrier DNA were added to 
each reaction tube together with 0.1 ml of the yeast competent cells. 0.6 ml 
of sterile PEG/LiAc solution was added to each tube and vortexed to mix. 
The reactions were incubated at 30°C for 90 min with shaking at 200 rpm. 
DMSO was added to 10% and the cells were heat shocked for 15 min in a 
42°C water bath. The cells were then chilled on ice and pelletted by 
centrifugation at 14,000 rpm and 4°C for 5 sec. The supernatant was 
discarded and the cells were resuspended in 0.5 ml of lx TE buffer. 100 pi 
of the transformation mixture was plated onto each 100-mm SD agar plate. 
Plates were incubated for 5 days at 30°C.
(e) Library scale transformation of yeast cells
To make the yeast competent cells, several colonies of the appropriate yeast 
strain were inoculated into 1 ml of YPD medium and vortexed vigorously to 
disperse any clumps of cells. The yeast cells were then transferred into a 
flask containing 300 ml of YPD medium and incubated at 30°C for 16-18 hs
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with shaking at 250 rpm to stationary phase (OD6oo> 1 .5). The overnight 
culture was added to 1 L of YPD media to a final ODeooof 0.2-0.3 and 
incubated for 3 hs at 30°C with shaking at 230 rpm. The cells were then 
centrifuged at 3,000 rpm for 5 min, the supernatant was discarded and the 
cells were resuspended in 500 ml of water by vortexing. The cells were 
centrifuged once more at 3,000 rpm for 5 min and the superatant discarded. 
The cell pellet was resuspend in 8 ml of sterile lx  TE/LiAc solution.
To transform the competent cells, 1 mg of DNA-BD vector construct, 0.5 mg 
of AD vector construct and 20 mg of herring testes carrier DNA were added 
to 8 ml of the yeast competent cells. 60 ml of sterile PEG/LiAc solution was 
added to each tube and vortexed to mix. The reaction was incubated at 30°C 
for 90 min with shaking at 200 rpm. DMSO was added to 10% and the cells 
were heat shocked for 15 min in a 42°C water bath, with occasional swirling 
to mix the cells. The cells were then chilled on ice and pelletted by 
centrifugation at 14,000 rpm for 5 min. The supernatant was discarded and 
the cells were resuspended in 10 ml of lx TE buffer. 0.3 ml of the 
transformation mixture was plated onto each of 50 140-mm plates SD/-Trp/- 
Leu-His plates. In addition, 100 pL of a 1:1000,1:100 and 1:10 dilution 
were spread onto SD/-Trp/-Leu plates for co-transformation efficiency 
controls. 1 pL (diluted in 100 pL H20) was spread onto 100 mm SD/-Trp 
and SD/-Leu plates to check the transformation efficiency of each plasmid 
individually. Plates were incubated for 10 days at 30°C.
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Calculation of co-transformation efficiency and number of clones 
screened
To calculate the co-transformation efficiency of a library screen, the number 
of colonies (cfu) growing on the SD/-Leu/-Trp dilution plate that had 30-300 
cfu was counted and the number inserted into the following equation.
 cfu x total suspension vol. (pi)_____________  = cfii/pg DNA
Vol. Plated (pi) x dilution factor x amt. DNA used (pg)*
* In a cotransformation, this is the amount of the limiting plasmid
To estimate the number of clones screened:
cfu/pg x amt. DNA used (pg) = # of clones screened
False positive testing
In a yeast two-hybrid library screen, true positives exhibit reporter gene 
expression only when they contain both the DNA-BD/target plasmid and the 
AD/library plasmid which encode fusion proteins that interact with each 
other. False positives are His+ or LacZ+ cotransformant colonies that carry 
plasmids that do not encode hybrid proteins that interact. False positive were 
eliminated as described below.
Colonies growing on SD/-Leu/-Trp/-His/+3AT 10 days after a two-hybrid 
library screen were re-streaked onto a fresh SD/-Leu/-Trp/-His/+3AT plate 
and incubated at 30°C for 4 days. A colony-lift filter assay was carried out 
on these plates and any colonies with a LacZ+ phenotype were plated onto 
SD/-Leu/-Trp and incubated at 30 °C for 4 days to segregate multiple 
AD/library plasmids within a single colony. Colonies growing on the SD/- 
Leu/-Trp plates were streaked onto fresh SD/-Leu/-Trp once again and 
incubated at 30 °C for 4 days. Surviving colonies were then transferred back 
onto SD/-Leu/-Trp/-His/+3 AT and incubated at 30 °C for 4 days. A colony- 
filter lift assay was carried out to confirm the positive LacZ phenotype.
Following elimination of the DNA-BD/bait construct with cycloheximide 
(see Section 2.3.1, i) and isolation of the plasmid from the yeast plasmids 
were transformed back into yeast cells using the small-scale transformation 
method and yeast mating in the combinations described in Table 2.3.
(h) Colony-lift filter assay
Colony-lift filter assays were used to determine the LacZ phenotype of yeast 
cells.
Fresh colonies that were 1-3 mm in diameter were used for colony-lift assays. 
For each of the transformants to be assayed, a sterile Whatman #5 filter was
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pre-soaked in 2 ml of Z Buffer/X-gal solution in a sterile 100-mm plate. A 
clean , dry filter was placed over the surface of the plate of the colonies to be 
assayed and holes were cut in the filter in three asymmetric locations to 
orient the filter to the agar. The filters were then lifted from the agar plate 
with forceps and transferred, colony side up, into a pool of liquid nitrogen to 
permeabilize the cells. The filters were completely submerged in the liquid 
nitrogen for at least 15 sec and then removed and allowed to thaw at room 
temperature. The filter was then placed, colony side up, on the filter pre­
soaked in Z Buffer/X-gal solution and incubated at 30°C for up to 8 hs.
Blue colonies indicate a positive LacZ phenotype and white colonies indicate 
a negative LacZ phenotype.
Cycloheximide selection for colonies that had lost the DNA-BD/target 
plasmid
The yeast host strain CG-1945 is cycloheximide resistant (CyhR) because it 
carries the cyhr2 mutant allele. The wild-type CYHS2 gene is dominant to the 
cyhr2 mutant allele. Therefore, when transformed with the DNA-BD target 
plasmid which contains the wild-type CYHS2 gene, CG-1945 becomes 
sensitive to cycloheximide. CG-1945 cotransformed with the DNA-BD 
target plasmid and the AD/library plasmid will also be sensitive to 
cyclohexmide. Thus, it is possible to select for yeast cells that have 
spontaneously lost the DNA-BD target plasmid while retaining the 
AD/library plasmid by plating the cotransformants onto medium containing
cycloheximide as described below. This allows quick isolation of yeast 
containing AD/library plasmids only which can then be isolated and 
sequenced.
Colonies that were 1-3 mm in diameter were restreaked onto SD/-Leu/+ 0.3 
mM cycloheximide plates and incubated for 5 days at 30°C until individual 
CyhR colonies appeared. The loss of the DNA-BD target plasmid was 
verified by plating the putative CyhR colonies onto SD/-Trp, where colonies 
lacking the DNA-BD target plasmid should not grow, and SD/-Leu where 
growth indicates that the DNA-BD target plasmid has been successfully 
eliminated. A colony-filter lift assay was then carried out on colonies 
growing on SD/-Leu to ensure that the AD/library constructs could not 
activate gene expression autonomously.
Yeast mating
Yeast mating allows the introduction of two different plasmids into the same 
host cells. It can therefore be used to verify that candidate AD/library 
proteins identified in the two-hybrid library screen can activate the reporter 
genes only in the presence of the DNA-BD/target protein. It can also be used 
to test for an interaction between two previously cloned proteins and to map 
regions of the proteins required for interactions.
The yeast host strain Y187 was transformed with plasmids that express 
DNA-BD truncation proteins and the host strain CG-1945 was transformed
with plasmids expressing DNA-AD truncation proteins. One colony of each 
type was picked and inoculated together into 0.5 ml of YPD medium in a 1.5- 
ml microcentrifuge tube. Each tube was then vortexed and incubated at 30°C 
with shaking at 250 rpm overnight. 50 pi of each mating culture was plated 
onto SD/-Leu/-Trp/-His/+3-AT to select for interacting proteins and also onto 
SD/-Leu/-Trp to ensure that the mating had been successful. Plates were 
incubated at 30°C for 5 days and scored for growth. A colony-filter lift assay 
was performed on the diploid cells to assay for p-galactosidase activity.
(k) Plasmid isolation from yeast cells
A yeast culture was grown overnight in 2 ml of YPD at 30°C to early 
stationaiy growth phase (~2 x 108 cells/ml). 1.3 ml of the culture was 
transferred to a 1.5 ml microfuge tube and the cells were harvested by 
centrifugation at 6,000 rpm for 3 min. The supernatant was discarded and 
the cells resuspended in 1 ml of sterile water by vortexing. To lyse the yeast, 
cells were harvested once again by centrifugation at 6,000 rpm for 3 min and 
the supernatant was discarded. The cells were resuspended in 0.2 ml of 
protoplasting buffer by vortexing and incubated at 37°C for 1-2 h with 
occasional inversion of the tube to prevent sedimentation of the cells. 0.2 ml 
of lysis solution was added and the cells were mixed gently by inversion.
The sample was then incubated at 65°C for 20 min and cooled rapidly on ice. 
0.2 ml of 5 M potassium acetate (pH 5.4) was added to the solution and 
incubated on ice for 15 min. Insoluble potassium dodecylsulphate and
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denatured proteins precipitate from the solution at this stage and these were 
removed by centrifuging for 3 min in a microcentrifuge at room temperature.
The superantant was transferred to a fresh tube without disturbing the pellet 
and 0.6 vol. of isopropanol was added to the tube and mixed gently by 
inversion. The solution was allowed to stand at room temperature for 5 min 
to allow complete precipitation of DNA. DNA was isolated by 
centrifugation for 30 sec and the supernatant was discarded. 1 ml of 70% 
ethanol was added to the pellet and mixed by inversion of the microfuge 
tube. The tube was allowed to stand at room temperature for at least 10 min 
for salt ions entrapped in the DNA aggregate to diffuse out. The solution was 
once more centrifuged for 30 sec in a microfuge tube and the supernatant was 
discarded. The pellet was dried briefly and the DNA was dissolved in 20-50 
pi of TE buffer.
Preparation of yeast extracts for SDS-PAGE
Hybrid-proteins were isolated from yeast cells and run on SDS-PAGE gels to 
show that they were being expressed in yeast and that no degradation was 
occurring.
A fresh yeast colony for each bait being tested together with a positive 
control for protein expression, was inoculated into 5 ml of the appropriate 
selective medium. The colonies were incubated with shaking at 30°C 
overnight. The cultures were added to fresh selective medium to an ODww =
0.15 and then incubated at 30°C until OD«x> = 0.7 (~ 7 hs). The culture was 
then spun at 3,000 rpm for 5 min and the supernatant was removed. 100 pi 
of 2x Laemmli sample buffer was immediately added to the pellet. The 
mixture was vortexed and stored at -70°C until required. Prior to analysing 
by SDS/PAGE/Westem blotting, the frozen samples were boiled for 5 min. 
Samples were then spun at 13K for 5 sec to pellet large debris immediately 
before loading onto the gel.
Mapping regions of proteins required for interactions
Having determined that the bait protein IE63 interacts with a cellular protein 
it is of great interest to identify the regions of IE63 which mediate this 
interaction. This permits previously identified functional domains IE63 to be 
associated with interactions of specific proteins thus allowing a putative 
function to be attributed to the interaction. Disruption of the interaction by 
using truncated IE63 proteins which do not contain the domain required for 
interaction acts as a convincing negative control.
The small scale transformation method was used to transform yeast with 
plasmids encoding truncated IE63 proteins and the full-length protein 
identified to interact with IE63. The same method was also used to transform 
yeast with the positive control plasmids pVA3-l and pTD-1 and the negative 
controls pAS2-l and pLam5’-l. The LacZ phenotype of the yeast cells was 
determined using a colony-lift filter assay, the strength of the blue colour 
being indicative of the strength of protein-protein interaction. True
2.3.2
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quantitative comparison of the intensity of blue colour is not justifiable as it 
depends on colony size and degree of expression of the fusion protein. 
However, here a semi-quantitative scale was used with the strength of the 
blue colour being graded by comparison to the positive and negative controls 
with *++’ being equivalent to the positive control, ‘+’ being less than the 
positive control and being equivalent to the negative control.
To determine the regions of proteins required for interactions, truncations 
were analysed in seven separate experiments.
Nucleic Acid Manipulation and Cloning Procedures 
Preparing bacterial calcium chloride competent cells
A colony of DH5a bacterial cells was inoculated into 2ml of LB and 
incubated overnight at 37°C with shaking. The entire overnight culture was 
then added to 100 ml L-broth and grown to an ODsoo of 0.2 (aproximately 2 
hs). The culture was centrifuged at 3,000 rpm for 5 min and the supernatant 
discarded. The pellet was resuspended in a half volume of 50 mM calcium 
chloride and was centrifuged once more at 3,000 rpm for 5 min. The 
supernatant was discarded once more and resuspended in a half volume of 75 
mM calcium chloride. The cells were incubated on ice for 30 min. Cells 
were then centrifuged at 3,000 rpm for 5 min and resupended in 3 ml of 75 
mM calcium chloride or 50 mM calcium chloride + 15% glycerol if the cells 
were to be stored at -70°C. Cells were aliquoted into 0.2 ml volumes and
86
either used immediately or frozen immediately on dry ice for storage at - 
70°C.
(b) Bacterial cell transformations
5-10 jag of plasmid DNA was added to a 0.2 ml aliquot of bacterial 
competent cells and incubated on ice for 30 min. The bacterial cells were 
heat shocked at 42°C for 2 min and transferred to a sterile universal 
containing 2 ml of L-broth. The cells were incubated at 37°C for 2 h with 
shaking. 1.5 ml of the culture was centrifuged at 13,000 rpm for 5 min and 
resuspended in 100 pi of TE buffer for ligations or low copy number plasmid 
or 500 pi of TE buffer for high copy number plasmids. 100 pi of cells were 
plated onto LB-agar plates containing the appropriate antibiotic and 
incubated overnight at 37°C.
(c) Glycerol stocks of bacterial cultures
For cultures growing in liquid media, 0.85 ml of bacterial culture was added 
to a 1.5-ml microfuge tube containing 0.15 ml of sterile glycerol. The culture 
was vortexed to ensure that the glycerol was evenly dispersed and 
immediately frozen on ethanol-dry ice for storage at -70°C. To recover the 
bacteria, the frozen surface of the culture was scraped with an inoculation 
loop and immediately streaked onto LB-agar plates containing the 
appropriate antibiotic.
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For cultures growing on agar plates, a single colony of bacteria was scraped 
into 2 ml of L-broth in a sterile 1.5-ml microfuge tube. An equal volume of 
L-broth containing 30% sterile glycerol was added and the mixture vortexed 
to ensure that the glycerol was completely dispersed. The cells were then 
dispensed into aliquots and frozen and revived as described above.
DNA gel electrophoresis (minigels)
100 ml of 1% (w:v) agarose and TAE was prepared and heated to boiling. 
The molten agarose was cooled to ~50°C and 5 pi of ethidum bromide 
solution (10 mg/ml) was added. The agarose was swirled to mix, poured into 
a gel cast and allowed to cool. 5 pi of loading buffer was added to each 
sample and gels were run at 100 V for 30-60 min in 1 x TAE. Gels were 
visualized under either short-wave UV light for visualization only or long 
wave UV light if the DNA was to be removed from the gel and used in 
subsequent experiments.
Small scale preparations of DNA (minipreps)
The method used for small-scale preparation of DNA was dependent upon 
the intended use of the DNA. The STET preparation method described 
below was used when the DNA was to be used for diagnostic digests and 
DNA gel electrophoresis only. The alkaline-lysis/PEG precipitation method 
was used to yield high-quality, super-coiled plasmid DNA which was
relatively free of contaminating chromosomal DNA and RNA which was 
used for sequencing. QIAGEN miniprep kits were used for quick DNA 
preparation for transformation into yeast or bacterial cells. The QIAGEN 
minipreps were carried out in accordance with the manufacturer’s 
recommended protocol.
To isolate DNA using the STET preparation method, a single colony of 
bacteria was inoculated into 2 ml of LB containing the appropriate antibiotic 
and incubated at 37°C for 5-6 hs. 1.5 ml of this culture was centrifuged at
13,000 rpm for 1 min and the supernatant was removed by aspiration. The 
bacterial pellet was resuspended in 200 pi of STET buffer and 20 pi of 
lysozyme (10 mg/ml) was added. The mixture was boiled for 40 sec and 
centrifuged for 10 min at 15,000 rpm. The supernatant was then removed to
tha clean 1.5-ml microfuge tube and the DNA was precipitated with 1/10 
volume 3 M sodium acetate and an equal volume of 100% isopropanol on 
dry ice for 5 min. The DNA was pelleted by centrifugation at 15,000 rpm for 
10 min and the DNA was allowed to dry. DNA was then resuspended in 20 
pi of water. For restriction enzyme digestions, 5 pi of the sample was 
digested and RNase A was added to a final concentration of 20 pg/pl during 
the last h of the digest.
To isolate the DNA using the alkaline-lysis/PEG precipitation method, a 
single colony of bacteria was inoculated into 2 ml of Terrific Broth 
containing the appropriate antibiotic overnight at 37°C with shaking. 1.5 ml
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of the overnight culture were centrifuged at 13,000 rpm for 1 min. The 
supernatant was removed by aspiration and the pellet was resuspended in 200 
pi of GTE buffer. 300 pi of freshly prepared 0.2 M NaOH/1% SDS solution 
was added and the contents of the tube were mixed by inversion until the 
solution cleared. The mixture was then incubated on ice for 5 min and the 
pH of the solution was neutralised by adding 300 pi of 3.0 M potassium 
acetate, pH 4.8. The mixture was incubated on ice for 5 min and the cellular 
debris was removed by centrifugation at 15,000 rpm for 10 min and the 
supernatant removed to a clean tube. DNase-free RNase was added to a final 
concentration of 20 pg/pl and the tube was incubated at 37°C for 20 min. 
After the RNase treatment, the supernatant was extracted four times with 400 
pi of chloroform, mixing the layers by hand for 30 sec after each extraction. 
The tubes were centrifuged for 1 min to separate the phases and the aqueous 
phase was removed to a clean tube. DNA was precipitated by adding an 
equal volume of 100% isopropanol and immediately centrifuging the tube at
15,000 rpm for 10 min at room temperature. The DNA pellet was then 
washed with 500 pi of 70% ethanol and dried under vacuum for 3 min. The 
pellet was dissolved in 32 pi of deionized H20  and the DNA was precipitated 
by adding 8.0 pi of 4 M NaCl and 40 pi of autoclaved 13% PEG and 
incubating on ice for 20 min. The DNA was pelleted by centrifugation for 15 
min at 15,000 rpm at 4°C in a fixed-angled rotor. The supernatant was 
removed by careful aspiration and the pellet was rinsed with 500 pi of 70% 
ethanol. The DNA was dried under vacuum for 3 min and resuspended in 20 
pi of H20.
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Large scale preparations of plasmid DNA (maxipreps)
Maxipreps were carried out using QIAGEN columns. QIAGEN Maxipreps 
were carried out in accordance with the manufacturer’s recommended 
protocol. In brief, bacterial cells were lysed under alkaline conditions and the 
crude lysates were cleared using centrifugation. The cleared lysate was then 
loaded onto the QIAGEN column where plasmid DNA bound to the 
QIAGEN resin. RNA, proteins, metabolites, and other low molecular weight 
impurities were removed by a medium salt wash. Plasmid DNA was eluted 
in high salt buffer and subsequently concentrated and desalted by isopropanol 
precipitation.
Nucleic acid purification
Proteins were removed from aqueous solutions of nucleic acids by extracting 
with phenol xhloroform and chloroform.
An equal volume of phenol xhloroform was added to the nucleic acid sample 
and the contents of the tube were mixed until an emulsion formed. The 
mixture was then centrifuged at 15,000 rpm for 15 sec and the aqueous phase 
was removed to a fresh tube. An equal volume of chloroform was added to 
the solution and the cells centrifuged once more at 15,000 rpm for 15 sec.
The aqueous phase was removed to a fresh tube and the nucleic acid was 
precipitated by precipitation with ethanol as described below.
(h) DNA precipitation
Nucleic acids were concentrated by precipitation with ethanol. 1/10th volume 
of 3 M sodium acetate (pH 5.2) and 2.5 volumes of ice-cold ethanol were 
added to the DNA solution. The solution was incubated on dry ice for 10 
min and the DNA was recovered by centrifugation at 15,000 rpm for 10 min. 
The supernatant was removed by aspiration and 500 pi of 70% ethanol was 
added to the pellet. The sample was re-centrifuged at 15,000 rpm for 2 min 
and the supernatant was once again removed by aspiration. The DNA was air 
dried and dissolved in the desired volume of buffer.
(i) DNA quantification
The amount of DNA in a solution was measured by spectrophotometric 
measurement of the amount of UV irradiation absorbed by the bases or more 
approximately by running the sample on a minigel and comparing the 
intensity of ethidium bromide fluorescence of the unknown DNA to the 
fluorescence of a series of standard DNA solutions.
For spectrophotometric determination readings were taken at wavelengths of 
260 nm and 280 nm. The reading at 260 nm allowed calculation of the 
concentration of the nucleic acid in the sample since an OD of 1 corresponds 
to approximately 50 pg/ml of double-stranded DNA. The ratio between the
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readings at 260 nm and 280 nm provided an estimate of the purity of nucleic 
acid since pure preparations of DNA have an OD26o/OD2*0 reading of 1.8.
Minigel analysis was carried out as described in Section 2.3.2 (d).
(j) Isolation of DNA from agarose gels
DNA to be isolated was run on a minigel as described previously and 
visualized using long-wavelength UV irradiation . The band of interest was 
cut from the gel using a scalpel and the DNA was isolated from the gel 
fragment using the BIO-101 gene clean kit according to the manufacturer’s 
protocol.
(k) Restriction endonuclease digestions
Restriction endonuclease digests were performed using the buffers and 
conditions recommended by the supplier, the volume of enzyme never 
exceeding 10% of overall reaction volume.
(1) Ligation reactions - cohesive termini
The plasmid and insert DNA were digested with appropriate restriction 
enzymes. The DNAs were then purified by extraction with 
phenol xhloroform and ethanol precipitation as described in sections 2.3.2 (g) 
and 2.3.2 (h). The DNAs were redissolved in lx TE and approximately 0.5
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pg of plasmid DNA and an equimolar amount of insert DNA were added to a 
1.5-ml microfuge tube. 2 pi of lOx bacteriophage T4 DNA ligase buffer and 
2 pi of T4 DNA ligase were added to reaction and the final reaction volume 
was made up to 20 pi with H20 . The reactions were incubated overnight at 
room temperature and 5 pi of the reaction mix was used to transform 
competent E. coli.
(m) Sequencing
Sequencing reactions were carried out on an automated ABI -Prism 
sequencer (Perkin-Elmer) using 4 pm of 1 pm/pl primer and 0.5pg of DNA.
2.3.3 Polymerase Chain Reaction (PCR)
PCR was used to generate IE63 deletion mutants which, when cloned into the 
two-hybrid system expression vectors, would be expressed as truncated IE63 
proteins. Seven mutants were constructed (N400, N250, N397, 270C, 346C, 
440C, 502C) and these are illustrated diagramatically in Figure 2.4. All 
mutants were sequenced to ensure that they did not contain mutations and 
that they lay in the same reading frame as the two-hybrid system expression 
vectors.
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(a) Primers
Oligonucleotide primers were designed so that they would amplify specific 
regions of IE63 and restriction enzyme sites were incorporated into the 
primers to allow them to be cloned into the two-hybrid system expression 
vectors. Restriction enzyme sites were chosen which would allow the PCR 
product to be inserted into the same reading frame as the GAL4 DNA-BD or 
AD thereby creating the appropriate fusion protein once translated. The 
primers used are described in Table 2.4 and were obtained from Cruachem.
(b) Reaction conditions
The IE63 mutants 270C and 346C were amplified by PCR using Taq DNA 
polymerase and the IE63 expression plasmid pSG130 was used as a template, 
The reaction mixture consisted of PCR buffer (no MgCl2), 100 pM of each 
dNTP (dATP, dCTP, dGTP, dTTP), 100 ng DNA template, 40 pmol of each 
oligonucleotide primer, 2.5 mM MgCh and 2 units of Taq DNA polymerase 
in a total volume of 100 pL sterile H20 .
The PCR programme used was as follows:-
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Temp (°C) Time
Stage 1 (1 cycle)
Step 1 95 5 mins
Step 2 55 1 min 30 secs
Step 3 72 2 mins
Stage 2 (30 cycles)
Step 1 95 1 min 30 secs
Step 2 55 1 min 30 secs
Step 3 72 2 mins
Stage 3 (1 cycle)
Step 1 72 10 mins
The IE63 mutants 440C and 502C were amplified by PCR using Vent DNA 
polymerase and the IE63 expression plasmid pSG130 was used as a template. 
The reaction mixture consisted of PCR buffer, 200 pM of each dNTP (dATP, 
dCTP, dGTP, dTTP), 50 ng DNA template, 80 pmol of each oligonucleotide 
primer, 5 % DMSO and 2 units of Vent DNA polymerase in a total volume 
of 100 pL sterile H20.
The PCR programme used was as follows
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I
Stage 1 (1 cycle)
Step 1 94 1 min
Stage 2(15 cycles)
Step 1 
Step 2 
Step 3
Stage 3 (10 cycles)
Step 1 
Step 2 
Step 3
Stage 4 0 5  cycles)
Step 1 96 35 sec
Step 2 67 30 sec
Step 3 68 4 min
Stage 5 (1 cycle)
Step 1 72 30 min
96 35 sec
67 30 sec
68 4 min
96 35 sec
67 30 sec
68 4 min
All PCR reactions were covered with a layer of mineral oil to prevent 
evaporation and amplification was carried out on an automated PCR machine 
(Hybaid, Omnigene).
2.3.4 SDS-PAGE and Western Blot Analysis of Proteins
Proteins were separated by electrophoresis on 10% SDS-polyacrylamide mini 
gels. Transfer of the proteins to a nitrocellulose membrane was carried out 
for 2 hs at 200 mA in transfer buffer, using a Bio-Rad blotting apparatus 
according to the manufacturer’s protocol. To prevent non-specific binding of 
the antibody, the membrane was blocked by incubation in PBS containing 
5% dried milk and 0.1 % tween-20 at 4°C overnight. The membrane was 
then washed 6x in PBS with 0.1% tween-20, prior to incubation for 2-4 hs 
with the appropriate dilutions of specific primary antibodies in fresh blocking 
buffer with gentle agitation. Six 5 min 0.1% PBS-tween washes removed 
excess primary antibody and the membrane was incubated for 1 h at room 
temperature with a 1:1000 dilution of the appropriate HRP conjugated 
secondary antibody in PBS-tween containing 2% dried milk with gentle 
agitation. A further six 5 min TBS-tween washes removed excess secondary 
antibody and detection of antibody labelled proteins was performed using the 
ECL detection kit of Amersham in accordance with the recommended 
protocol.
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RESULTS AND DISCUSSION
3.1 PRE-LIBRARY SCREEN ASSAYS ON YEAST STRAINS. 
EXPRESSION PLASMIDS AND cDNA LIBRARIES
3.1.1 The Yeast Strains CG1945 and Y187 have a phenotype suitable for use 
in the yeast two-hybrid system
A critical step in two-hybrid system library screens requires the 
transformation of the yeast strain CGI 945 with plasmids expressing the 
GAL4 AD fused to a cDNA library together with plasmids expressing the 
GAL4 BD fused to the gene encoding the bait protein. Yeast colonies that 
have been successfully transformed with both plasmids and which contain 
interacting proteins are selected for on medium lacking histidine, leucine and 
tryptophan. Clearly it is essential that the phenotype of the yeast be -Leu - 
Trp, -His. Therefore untransformed yeast cells were plated onto 
combinations of selective media lacking these amino acids to ensure that they 
were unable to replicate.
Table 3.1 shows the results of these experiments. These clearly show that 
CGI945 had the phenotype -Leu, -Trp - His demonstrating that CG I945 was 
suitable for screening a library with the bait protein.
In addition, testing for interaction between two individual proteins 
necessitates that the yeast strain Y187 be transformed with plasmids 
expressing the GAL4 AD fused to the target gene together with a plasmid 
expressing the GAL4 BD fused to the gene encoding the bait protein. Yeast 
colonies that have been transformed with both plasmids are selected for on 
medium lacking leucine and tryptophan. The phenotype of this yeast strain 
must, therefore, be -Leu, - Trp, -His. The yeast were plated onto 
combinations of selective media lacking these amino acids to verify that they 
were of the correct phenotype.
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Table 3.1 also shows the results of these experiments. These clearly 
demonstrate that Y187 had the phenotype -Leu, -Trp , -His and was suitable 
for these experiments.
3.1.2 Full-length IE63 causes transcriptional activation of the two-hybrid 
system’s reporter genes and cannot be used to screen for interacting 
proteins
A variety of proteins which have a role in vivo in the regulation of gene 
expression have been shown to activate the expression of the reporter genes 
LacZ and HIS3 which are used as markers of interacting proteins in the two- 
hybrid system (Bartel et al., 1993). These proteins cannot be used in the two- 
hybrid system because detection of interacting proteins in the system is based 
entirely on assays of reporter gene activity. Clearly, a protein which 
autonomously activates reporter genes would produce multiple false positives 
and it would be impossible to differentiate between false positives and true 
interacting proteins.
Since IE63 is known to up-regulate HSV-1 gene expression and function at 
the level of transcription, a plasmid encoding full-length IE63 fused to the 
GAL4 BD was transformed into the yeast cells in the absence of a target 
plasmid alongside a series of positive and negative controls to test if the IE63 
protein could autonomously activate reporter gene expression. The yeast 
cells were plated onto medium lacking tryptophan to select for yeast clones 
which contained the IE63 plasmid and these cells were allowed to grow for 3 
days before testing for activity of the LacZ reporter gene using a filter-lift 
assay.
P-galactosidase activity was detected. This experiment demonstrated that 
full-length IE63 can induce transcription of the two-hybrid system’s reporter 
genes. This result was consistently reproducible and demonstrated that the 
two-hybrid system could not be used to detect proteins which interact with 
the full-length IE63 protein.
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Table 3.1. Results of experiments to determine the phenotype of yeast strains 
CG1945 and Y187; ‘+* indicates growth of yeast, indicates no 
growth
-TRP -LEU -HIS YPD
Strain
CGI 945 +
Y187 +
3.1.3 The N-terminal ten amino acids of the IE63 protein are responsible for
activation of the two-hvbrid system’s reporter genes
The two-hybrid system is a powerful and attractive method for identifying 
interacting proteins. Therefore it seemed appropriate to identify the region of 
the IE63 protein which was transactivating the LacZ reporter gene and delete 
it, thereby enabling the largest possible truncated form of IE63 to be used to 
screen for interacting proteins.
Seven truncated IE63 proteins were synthesised using PCR, each one 
deleting or disrupting one or more of the identified functional domains of 
IE63 (see Figure 2.4). The PCR products of the clones are shown in Figure 
3.1. Next, the truncations were cloned into a plasmid expressing the GAL4 
BD and were sequenced to ensure that they were in frame.
Each truncation was subsequently transformed into yeast cells and plated 
onto medium lacking tryptophan to select for yeast clones which contained 
the IE63-truncation plasmids. The plates were incubated for 3 days before 
testing for activity of the LacZ reporter gene using a fllter-lift assay.
The results of these experiments are illustrated in Figure 3.2. The 
interpretation of these results is that the N-terminal ten amino acids of IE63, 
which includes the first seven amino acids of IE63’s essential acidic domain, 
was responsible for the reporter gene activation and that deleting this region 
in construct 502C entirely abrogated p-galactosidase activity. The IE63 
protein with the N-terminal 10 amino acids deleted was, therefore, suitable 
for screening. This truncation was designated 502CBD since it encoded the 
C terminal 502 amino acids of IE63 fused to the BD of GAL4.
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3.1.4 The Matchmaker Two-Hybrid System I expression plasmids did not
express protein at a level high enough to be detected bv Western Blotting
The expression plasmids pGBT9 and pGAD424 represent the BD and AD 
vectors respectively of the Matchmaker Two-Hybrid System I. It was 
necessary to check via western blotting that the bait protein was expressed in 
vivo and that it was not degraded by proteolytic enzymes within the yeast cells.
IE63 truncations 346C, 440C and 502C ligated into pGBT9 were transformed 
into HF7C cells and the samples were analysed in a western blot alongside 
lysed untransformed HF7C cells as a negative control and infected cell extract 
as a positive control (data not shown). This experiment clearly showed that 
little or no protein was expressed or detected by these expression plasmids. 
Further western blots also failed to detect IE63 protein.
Subsequently the Matchmaker Two-Hybrid System II was developed by 
Clontech and it became evident that pGBT9 and pGAD424 express protein at 
a very low level and that the small quantity of protein cannot be detected by 
western blot despite previous information to the contrary. In view of this and 
the fact that plasmids supplied with the Matchmaker Two-Hybrid II kit were 
reportedly high-expression vectors, a decision was made to excise the IE63 
truncations from pGBT9 and ligate them into pAS2-l with the Matchmaker 
Two-Hybrid System II kit being used for all subsequent experiments.
3.1.5 An IE63 truncation cloned into the Matchmaker Two-Hybrid System II 
expression plasmids was expressed in yeast cells
Figure 3.3 (A) shows a western blot to examine expression of IE63 subclones 
using anti-IE63 HI 13 antibody. There is a significant amount of cross­
reactivity using this antibody, therefore figure 3.3 (B) shows a western blot 
using CGI945 yeast cells transformed with either 502C-pAS2-l or 346C- 
pAS2-l and blotted with GAL4 DNA-BD mAb. pAS2-l is the high 
expression BD plasmid which is supplied with the Clontech Matchmaker
102
<D
m>
G
c o  ^
<d ^  
G  C  
O  -T3
O  §  o  03
0 0  I
vo 52pj <  
K  O h
^  CO .5
c  m  
O  vo
•s W
CO l“ H
<Di-H
O-
0 )>
UCN
olo
GO
CD 
C  
J D
o
hO
S  73
ro *g 
o
W  ? >
GO
O
Oh
£
<D-t-*
(/)
GO
X
<D
CD
g
o3
X
<d
m
m
vO
O
+->
o
o
o
<d
>
co
O
O -
DU
C
o
W  o3
c  g jo3 C/3 
7=  <2 exV— I
5  U
o  VOo g- c  rn
C03
m
m
<d
CO 1
G  1O <N 
G  ^  
b  <  
O ,  
G  1
•Eo U  
3 2  
o  ^
£ <N<3 C/3
CO
CD
<+-H
O
G
.2
GO
<D*-H
O h
X
<D
<L>
C
£
03
X
<D
hC
o
<D 
•4—>
c_o
U
hO  
. <
V  ^
f e §X  <
h2  £
<d  Q
2  3CO >— I 
cd < i-
> >  o
" O  &u
£ .£
CO
G
O
£-t—>
CD
G
4—>
" O
G
03
7  u
< n  r - .
<  X
CL w
. £  —
1 3  
o
4—* GO
03 
<D
2  ^
<G
VO
W
c
o
o
<d
>
<d
< 
<D " >
S >  U
J > ^ 8tG w  vn
£
CO
C
o3^H-*->
c
G
O
Vh4—»
C
o
o
o
hO
£
<d-4-»
CO
CD
£
CO
< 2
CO
G
03
co £0 C 
O h  G
hC  O h"
.ts  O
^  c :  
c  8
- 2  CD
03 >
•r-H >
1 03
<N DU 
C/3 «
<  ^
VO ccS 
G "m cg
GD < !  C >
-  23 2
1 3
I - lS V d -D9^£
I-CSVd\}£05
I‘3SVd'£9HI
£VAd
DZ.3H
PQ
t i
I-£SVd-D9K
I-3S V d -D0t7f
l-£SV d-330S
|-SSVd-£93I
3Z.3H
Two-Hybrid System II. The lane loaded with the 502C-pAS2-l sample 
contains a protein band of approximately 71 kDa which is the anticipated size 
of the 502C-pAS2-l construct, indicating that the fusion protein is being 
expressed in yeast cells and that it is not degraded. However, there was no 
band in the 346C lane of approximately 55 kDa, nor could the truncations 
440C and 270C be visualised using the same procedure (data not shown). 
Considering that the sequence of these constructs had been confirmed and the 
502C construct was expressed from pAS2-l a decision was made to screen a 
library with 502CBD. It seemed likely that 440C, 346C and 270C were 
genuinely being expressed from pAS2-l but that the concentration of protein 
was too low to be visualised on the Western blot.
3.1.6 The BHK cDNA Library did not represent a full complement of BHK cell
proteins and could not be used to screen for IE63 interactions
A HSV-1 infected BHK cDNA library was the original material for a library 
screen to determine IE63 protein-protein interactions. On construction, the 
library had been titred by a co-worker and contained an estimated 90% of 
colonies with a titre of 2 x 106. However, two library screens were performed 
using this library and 502CBD as a bait but in both instances, no positive 
clones were identified. Further experiments by a co-worker revealed that on 
storage the titre had declined to 2 x 104 prior to use in the library screen. For 
this reason an uninfected HeLa cDNA library which had been synthesised by 
Clontech and which had an estimated 93% of colonies with inserts and a total 
number of independent clones of 6.0 x 106 was used for further library screens.
3.2 SCREENING A cDNA LIBRARY WITH TRUNCATED IE63 PROTEIN
IDENTIFIED FIVE PROTEINS WHICH INTERACT WITH IE63 AND 
WHICH ARE LIKELY TO BE BIOLOGICALLY SIGNIFICANT
To identify the proteins which interact with IE63, the yeast strain CGI945 was 
simultaneously transformed with the IE63 bait plasmid 502CBD and the target 
plasmids encoding the HeLa cDNA library fused to the AD. A total of 2.3 x 
106 independent clones were screened. Colonies which had a Trp+Leu+His+
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phenotype were selected and assayed for p-galactosidase activity. (3- 
galactosidase activity combined with the ability to grow on a medium lacking 
histidine indicated interacting proteins. Colonies with a His+LacZ+ phenotype 
were further screened to identify false positives as described below.
3.2.1 150 yeast colonies grew on the medium lacking histidine indicating that
they were expressing interacting proteins
9 days post-transformation there were 150 colonies on the -Trp,-Leu, -His 
plates. As the yeast strain used in these experiments has a -His phenotype only 
histidine-expressing yeast cells could be cultured on the histidine deficient 
medium. Histidine is expressed if the bait protein IE63 interacts with a protein 
from the HeLa cDNA library. Clearly, any colonies growing on this medium 
were candidates for expressing proteins that interact with IE63. These 
colonies were picked and re-plated onto -Trp,-Leu, -His medium. Following 5 
days of incubation, 6 (4%) of the 150 colonies no longer grew on this medium 
indicating that they were false positives.
A filter lift assay was then carried out to assay for the reporter gene LacZ. 123 
(85%) of the remaining 144 colonies had a LacZ+ phenotype. These colonies 
were picked and further screened for false positives as described in Section 
2.3.1 (g).
3.2.2 99 yeast colonies passed a screen for false positives
False positives are an inherent problem in the yeast two-hybrid system and it is 
essential to carry out tests which will eradicate the majority of these. They 
may be due to library proteins which can autonomously activate the reporter 
genes or they may be due to two different library proteins being expressed in 
one yeast colony, one of them being a true interacting protein and another 
which does not interact with the bait.
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The yeast colonies with a His+LacZ+ phenotype were replated onto -Leu-Trp 
medium and allowed to grow for three days. These colonies were transferred 
once more onto fresh -Leu-Trp plates and allowed to grow for a further three 
days. This replating onto -Leu-Trp medium was performed to aid the 
segregation of any yeast colony which may contain two plasmids encoding 
different library proteins. The yeast colonies were then replated onto -Leu- 
Trp, -His medium and incubated for three days to check that the His+LacZ+ 
phenotype was retained. Colonies that grew on this medium were tested for p- 
galctosidase activity. 109 (89%) of the remaining 123 colonies retained their 
His+ LacZ+ phenotype.
Next, the IE63 bait plasmid 502CBD was deleted from the yeast cells by 
cycloheximide selection and the yeast were plated onto both -Leu medium and 
-Trp medium to ensure that the 502CBD plasmids had been deleted and that 
the library plasmids had been retained in the yeast cells. As expected, no 
colonies grew on the -Trp medium showing that they had not retained the 
502CBD plasmid. 4 (4%) of the remaining 109 colonies would not grow on 
the -Leu medium indicating that these colonies no longer contained a library 
plasmid. These colonies were discarded.
A definitive test for p-galactosidase activity was carried out on the remaining 
105 colonies to ensure that the library plasmids alone could not activate the 
LacZ and HIS3 reporter genes. None of these colonies exhibited p- 
galactosidase activity demonstrating that the target plasmids could not 
autonomously activate the two-hybrid system's reporter genes.
The library plasmids were successfully isolated from all but six of the yeast 
colonies. Therefore 99 (66%) plasmid DNAs isolated from the original 150 
colonies were sequenced.
Interestingly, an entire library screen which was carried out with a 440C 
truncation which later proved to be out of frame identified only 15 positive 
colonies and subsequent testing revealed all of these were false positives. This
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clone was discarded and a 440C clone which was in-frame was used for all 
future experiments.
3.2.3 Sequence analysis identified five positive clones with a putative biological 
sigificance
The 99 remaining plasmids were sequenced using a 19 oligonucleotide 
sequencing primer. 16 either could not be sequenced or gave inadequate 
sequence for further analysis. This was probably due to a contaminating factor 
in the DNA. The sequences from the remaining 83 plasmids were entered into 
the EMBL/Genbank database using GCG Fast A.
The results of the EMBL/Genbank database screen showed that six of the 83 
plasmids had no homology to any proteins in the database. A further plasmid 
was an empty expression vector.
One clone had a 99.5% homology with a human quinone oxidoreductase over 
388 bp. Another had 87.8% homology with L Apoferritin over 303 bp and a 
further two had homology to the BiP protein (a member of the heat shock 
protein family) with the highest homology being 97.5% in 406 bp. A number 
of human proteins are known to form non-specific protein-protein interactions 
in the two-hybrid system although the mechanism for this is not yet fully 
understood. Mitochondrial proteins such as human quinone oxidoreductase, 
ferritins and heat shock proteins are proteins which frequently give this type of 
false positive (http://www.fccc.edu/research/labs/golemis/ 
InteractionTrapInWork.html, 1999). For this reason these clones were 
discarded.
A further two clones were identified as Gallus Gallus Glutamine Rich Protein 
(80.6% identify in 453 bp) and another as human JTV-1 (85.8% identity in 387 
bp). These clones did not have an immediately obvious biological significance 
according to current understanding of the IE63 protein (see Section 4.1.1 and 
4.1.2. For this reason these clones were set aside for follow-up studies.
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Sequence analysis identified five other proteins which interact with IE63 and 
the previously determined function of these prote ins suggested that their 
interaction with IE63 may have a critical biological function in HSV-1 
infected cells. Comparisons of the sequences of these clones to the genes with 
which they have homology can be found in Appendix 1. These clones and the 
possible significance of these interactions are discussed below. The results of 
the library screen are summarised in Table 3.2.
3.2.4 The IE63 protein interacts with the human hnRNP K and CKII B Subunit
Analysis of the sequences of the positive clones using the GenEMBL database 
revealed that one of the clones, containing an 1.3 kb insert, had a sequence 
which precisely corresponded to aa 215-464 and the 3’ UTR of human hnRNP 
K and was present in the vector in the correct reading frame. A further fifty- 
one of the clones could be identified as the casein kinase II beta subunit 
(CKIip). Full sequence analysis of 5 clones showed 4 independent clones, 
each of which contained the entire CKIip gene but beginning at different 
positions in the 5’ UTR.
(a) The C terminal half of the IE63 protein is sufficient for the interaction 
with hnRNP K
In order to map the region of IE63 which mediated the interaction with hnRNP 
K a series of IE63 truncations was expressed as hybrids with the GAL4 BD. 
Yeast cells transformed with plasmids encoding the truncations were mated 
with yeast cells transformed with the clone identified as hnRNP K from the 
library screen. Figure 3.4 illustrates the region of IE63 encoded by each 
construct and the degree of activation of the two reporter genes HIS3 and LacZ 
in the presence of the hnRNP K protein relative to the positive control pVA3-l 
and pTD-1 and the negative control pAS2-l and pLam5’l.
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The results show that sequences within aa 242-397 of IE63 were both 
necessary for the interaction with hnRNP K. However, the binding of aa 242- 
512 was weaker than that of aa 166-512 suggesting that aa 166-242 also 
contribute to the interaction. Although this latter region does not include the 
RGG domain necessary for RNA binding it does include adjacent proline-rich 
sequences. Interestingly, Rice and Lam have shown that point mutations 
within the region absolutely required for interaction with hnRNPK abolish the 
ability of wt virus to grow suggesting that the interaction may be essential for 
HSV-1 function (Rice & Lam, 1994).
The putative zinc finger of IE63 together with amino acids in the N- 
terminus of the IE63 protein are essential for the interaction with Casein 
Kinase II
To map the region of IE63 required for interaction with CKIip, the IE63 
truncations were used in mating assays with the clone identified as CKIip from 
the library screen. Figure 3.5 shows the region of IE63 present in each 
construct and the degree of activation of the two reporter genes HIS3 and LacZ 
in the presence of the CKIip protein relative to the positive control pVA3-l 
and pTD-1 and the negative controls pAS2-l and pLam5’ 1.
By comparison of truncations 270C and 346C, the results demonstrate that a 
portion of the argine-rich region (aa 166-242) and aa 397-512 which includes 
the zinc finger of IE63 and the region required for inhibition of splicing were 
sufficient for the interaction. However, the binding of aa 166-512 was weaker 
than that of aa 10-512 and this indicates that aa 10-166 also contribute to the 
interaction. Interestingly, the IE63 truncation 440CBD (aa72-512) did not 
interact with CKIip in contrast to the smaller IE63 truncation 346BD (aa 166- 
512) which interacted with CKIip weakly. The reason for disruption of the 
binding of the larger protein could be due to conformational changes in the 
protein masking an IE63 binding site which is exposed in the smaller 
truncation.
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(c) Mapping the regions of hnRNP K required for interaction with IE63
In order to map the region of hnRNP K required for interaction with IE63 a 
series of hnRNP K truncations was expressed as hybrids with the GAL4 AD. 
This exact series of hnRNP K truncations was also used by Tsieh et al. (Tsieh 
et al., 1998) to map the regions of hnRNP K which interact with the hepatitis 
C virus core protein. Yeast cells transformed with these truncations were 
mated with cells transformed with the IE63 bait 502CBD fused to the GAL4 
DNA-binding domain. Figure 3.6 illustrates the region of hnRNP K present in 
each construct and its relative strength of activation of the reporter gene LacZ 
in the presence of the IE63 bait protein relative to the positive control pVA3-l 
and pTD-1 and the negative controls pAS2-l and pLAM5’ 1. Interpretation of 
these results is that regions within aa 250-276 and aa 327-463 are required for 
the interaction. Interestingly, the region of hnRNP K required for interaction 
with IE63 contained the RGG box and the C-terminal portion known to bind 
the hepatitis C virus core protein whose expression has been shown to relieve 
hnRNP K supression of the cellular thymidine kinase promoter (Tsieh et al., 
1998) and also is required for interacting with the transcriptional repressor Zik 
1 and the hnRNP K protein kinase. Although the Xenopus hnRNP K RGG 
box is not required for poly(rC) binding (Ladomery, 1997) a contribution to 
RNA binding is possible. Therefore, it is possible that G+C rich viral RNA 
(HSV-1 DNA is 68% G+C overall) could contribute to the interaction of IE63 
and hnRNP K and this could occur in yeast two-hybrid assays and co- 
immunoprecipitations where RNA:protein binding may protect against RNase 
treatment.
Further evidence that IE63 interacts with hnRNP K and Casein Kinase II 
p subunit
The interaction of IE63 with both hnRNP K and CKII has since been 
independently confirmed by Helen Bryant using GST-pull down and 
immunoprecipitation experiments (Wadd et al., 1999). Helen has also used
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GST and MBP fusions with different truncations of CKIip to map the region 
of CKII which interacts with IE63. These experiments demonstrated that aa 
150-215 of CKIip are required for the interaction with IE63 and this is the 
region of the protein involved in a:p subunit heterodimerisation.
(e) Casein Kinase can phosphorylate IE63 and the form of hnRNP K which 
co-immunoprecipates with IE63
Interestingly, Helen Bryant has also shown that the predominant form of 
hnRNP K which co-immunoprecipitates with IE63 using mouse monoclonal 
anti-IE63 serum migrates more rapidly in gels than hnRNP K recognised by 
rabbit anti-K serum raised against a synthetic peptide representing the C- 
terminal aa 452-464, conserved in the murine and human hnRNP K (Wadd et 
al., 1999). Similarly, GST-IE63 pulled down forms of hnRNP K present in 
cells infected with HSV-1 wt which migrated faster in gels than the 
predominant band of hnRNP K found in mock-infected extracts. This indicates 
that the form of hnRNP K which interacts with IE63 is a less processed or 
possibly a smaller form. Phosphorylation of the slower-migrating form of 
hnRNP K precipitated by hnRNP K antiserum was not inhibited in vitro by the 
CKII specific inhibitor 5,6-dichloro-l-p-D-ribofuranosylbenzimidazole 
(DRB). In contrast, phosphorylation of the hnRNP K fraction 
immunoprecipitated by anti-IE63 serum from wt-infected cells was capable of 
being partially inhibited by DRB. These in vitro phosphorylation data further 
demonstrate a difference between the fraction of hnRNP K 
immunoprecipitated with anti-hnRNP K serum compared with anti-IE63 
serum.
Finally, the phosphorylation of IE63 was decreased significantly in the 
presence of DRB indicating that IE63 can itself be phosphorylated by CKII in 
vitro.
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3.2.5 The proposed role of IE63-hnRNPK and Casein Kinase II interactions in
the HSV-1 infected cell
There are striking similarities between the structures and functions of hnRNP 
K and IE63. IE63 and hnRNP K are of similar size, IE63 consisting of 512 
amino acids and hnRNP K 464 amino acids. Both proteins form oligomers, 
are phosphorylated, contain RGG motifs which in both instances are 
methylated and both have a highly acidic N terminus. hnRNP K contains three 
KH regions that are required for RNA binding activity and three KH domains 
have recently been identified towards the C terminus of IE63 (T M Soliman 
and S J Silverstein, Columbia University, New York, unpublished data). 
Furthermore, the two proteins bind RNA, shuttle between the nucleus and the 
cytoplasm, have a classical NLS in addition to a shuttling domain(s) and both 
interact with multiple molecular partners. Finally, IE63 and hnRNP K have a 
role in the regulation of transcription and both proteins are thought to be 
required for pre-mRNA processing and transport.
However, IE63 and hnRNP K also have dissimilar characteristics. For 
example, hnRNP K binds to DNA whilst there is no evidence of IE63 binding 
DNA. Additionally, hnRNP K is thought to exert some of its effects at the 
level of translation and IE63, apparently unlike hnRNP K, has an effect on 
polyadenylation and splicing.
The similarities between the structures and functions of IE63 and hnRNP K 
suggest that they may utilise common pathways in the infected cell. This 
raises the possibility that IE63 interacts with hnRNP K preventing its access to 
these pathways so that IE63 can implement its effect on the cell without 
having to compete with hnRNP K. Alternatively, it is plausible that many of 
the functions previously attributed to IE63 may in fact be mediated by its 
interaction with hnRNP K. The merits of both the proposed scenarios are 
considered in the text below.
Il l
(a) IE63 may repress hnRNP K activity in the HSV-1 infected cell
(i) IE63 may disrupt the transport o f cellular mRNA by hnRNP K
Work carried out in our group demonstrates that hnRNP K can be 
phosphorylated by CKII in the presence of IE63 but not in its absence and 
Dejgaard et al have shown that phosphorylation of hnRNP K diminishes its 
ability to bind RNA (Dejgaard et al., 1994). A number of workers have 
proposed that hnRNP K may transport cellular mRNAs from the nucleus into 
the cytoplasm for translation to occur. Therefore in principle, the IE63- 
mediated phosphorylation of hnRNP K by CKII may disrupt hnRNP K-mRNA 
binding, effectively abrogating the transport of cellular mRNAs into the 
cytoplasm via this pathway. In support of this is the observation that intron- 
containing cellular mRNAs accumulate during HSV-1 infection in the nucleus 
only in the presence of IE63. The transport of cellular mRNAs out of the 
nucleus and into the cytoplasm is essential for cell protein synthesis and 
therefore critical for host-cell function. Interestingly, the binding of hnRNP 
Al to mRNA is also reduced significantly in the presence of IE63 raising the 
possibility that IE63 may also disrupt the transport of cellular mRNA by 
hnRNP Al (Sandri-Goldin, 1998).
(ii) IE63 may alter the ability o f hnRNP K to act as a transcriptional regulator
hnRNP K also has a role in the regulation of transcription of a number of 
cellular genes and interaction with IE63 may either relieve the repressive effect 
of hnRNP K on certain genes or inhibit the activation of other genes by 
hnRNP K. Indeed, the expression of some cellular proteins has been shown to 
be up-regulated during HSV-1 infection whilst others are down-regulated.
This latter observation, known as the host-shut-off effect can be divided into a 
primary and secondary phase, the secondary phase requiring the presence of 
IE63 (see Section 1.1.6).
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Presumably IE63 could alter the transcriptional activity of hnRNP K by 
disrupting its interactions either with transcription factors or promoter 
sequences.
(iii) The sub-cellular localisation o f hnRNP K may be altered by IE63
Finally, phosphorylation of hnRNP K by CKII in the presence of IE63 may 
alter the sub-cellular localisation of hnRNP K, perhaps sequestering it to 
inactive sites within the nucleus. Immmunofluoresence studies which look at 
the localisation of hnRNP K in the presence and absence of IE63 will be 
carried out in our laboratory to investigate this possibility. Facilitating the 
removal of hnRNP K into inactive sites would enable IE63 to fully utilise a 
shuttling pathway which it may share with hnRNP K.
(b) hnRNP K may be critical for IE63 function
(i) IE63 may ‘hitch a ride ’ from hnRNP K to cross the nuclear pore
Both IE63 and hnRNP K shuttle between the nucleus and the cytoplasm. It 
may be that the ability of IE63 to shuttle relies on its ability to bind to hnRNP 
K and subsequently to ride ‘piggy-back’ on the hnRNP K protein to cross the 
nuclear pore. Against this is the finding that the NES of IE63 has been shown 
to be sufficient for export of a heterologous protein (Sandri-Goldin, 1998) and 
this study shows that the NES of IE63 does not bind hnRNP K. However, the 
possibility remains that binding to hnRNP K is required for optimal shuttling 
of IE63 or shuttling via a specific pathway.
(ii) hnRNP K may transport IE63 to specific nuclear domains or create a ‘bridge ’ 
between IE63 and other molecules
The interaction between hnRNP K and IE63 may be required to target IE63 to 
specific nuclear domains or to allow IE63 access to one of the hnRNP K’s 
molecular partners such as DNA or another cellular protein. Interestingly,
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DSEF-1, a member of the hnRNP H family of RNA-binding proteins, has 
recently been shown to increase the level of cross-linking of the 64 kDa 
protein of cleavage stimulation factor (CstF) to polyadenylation substrate 
RNAs (Bagga et al., 1998). During HSV-1 infection, binding of this 64 kDa 
component of CstF to poly(A) sites of all temporal classes of viral mRNA is 
increased and this binding is dependent upon the expression of IE63 
(McGregor et al., 1996). Whether hnRNP K has a similar role in 
polyadenylation to the hnRNP H protein DSEF-1 or whether IE63 may also 
interact with DSEF-1 is a topic for further investigation.
(iii) IE63 may recruit hnRNP K for viral gene expression
Perhaps the most probable biological role for the interaction between hnRNP 
K and IE63 is that IE63 recruits hnRNP K to facilitate viral gene expression. 
This study shows that the region of IE63 which interacts with hnRNP K is the 
region which confers its ability to activate and repress viral genes. It is also 
interesting that hnRNP K interacts with and represses C/EBPP, a transcription 
factor which is active during acute-phase or immune response (Miau et al., 
1998). The co-activator of this transcription factor, Noppl40, is 
phosphorylated by and interacts with CKII. Therefore hnRNP K and CKII 
colocalize at sites of transcription. That IE63 interacts with both proteins 
supports the hypothesis that hnRNP K-CKII-IE63 complexes may have a role 
in the regulation of transcription of HSV-1 genes.
In addition, hnRNP K interacts with TBP (Michelotti et al., 1996) and the 
hnRNP K:TBP:IE63 complex may be crucial for viral transcription. In 
support of this theory, tandem copies of a CT-rich DNA sequence similar to 
known hnRNP K DNA binding sites are present in a HSV-1 domain that has 
been proposed to act as a transcriptional regulator of virus immediate early 
genes (Quinn et al., 1998).
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(c) The role of CKII in the function of IE63
Phosphorylation regulates the function and localisation of many viral as well 
as cellular proteins. The text above has hinted at the possible significance of 
the interaction between CKII and IE63 with relation to the CKII-mediated 
phosphorylation of the hnRNP K protein. However, a number of viral and 
cellular proteins such as IE175 and the U1 snRNP 70 kDa protein also have an 
altered phosphorylation state in the presence of IE63 although IE63 itself does 
not exhibit kinase activity. Therefore, CKII may be ‘hijacked’ by IE63 to 
phosphorylate these and other viral and cellular proteins. Phosphorylation of 
IE 175 may be one of the mechanisms by which IE63 regulates viral 
transcription. In addition, the phosphorylation state of the U 1 snRNP has been 
proposed to alter the localization of this protein which in turn may be 
associated with splicing repression in HSV-1 infected cells. Since 
phosphorylation of U1 70 kDa protein by CKII may inhibit splicing, it is of 
interest to note that the region of IE63 that binds CKII is also the region of 
IE63 responsible for splicing repression.
What is the significance of phosphorylation of the IE63 protein itself by CKII? 
IE63 contains several consensus sites for phosphorylation by CKII and other 
cellular kinases. Two serine residues located at aa 16 and 18 have been shown 
to serve as targets for CKII phosphorylation in vivo and the serine at aa 114, 
which lies within the nuclear localisation signal, was phosphorylated by 
protein kinase A (Zhi & Sandri-Goldin, 1999). Phosphorylation of serine 114 
seemed to modulate the efficiency of IE63 nuclear import, however plasmids 
containing these kinase consensus site mutants were still capable of 
complementing the growth of an IE63 null mutant virus. Since IE63 is 
capable of being phosphorylated in vitro by co-immunoprecipitated CKII 
activity (Wadd et al.y 1999) CKII could modify IE63 activity or modify partner 
proteins in the complex. Interestingly CKII activity has been reported in 
preparations of HSV-1 virions (Steveley et al., 1985) and several other HSV-1 
proteins are phosphorylated by CKII (Guerra & Issinger, 1999).
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A number of other viral proteins are phosphorylated by CK II. For example, 
phosphorylation of Simian Virus 40 large T antigen by CKII is required for 
import into the nucleus (Vancurova et al., 1995) whereas phosphorylation of 
the Sendai virus P protein by CKII is required to maintain its structural 
integrity (Byrappa et al., 1996). Furthermore, the HIV-1 protein Rev has been 
shown to be down-regulated by CKII phosphorylation at late times in infection 
(Meggio et al., 1996). Finally, work carried out by Helen Bryant suggests that 
phosphorylation of IE63 may be important for the interaction between IE63 
and hnRNP K (Wadd et al., 1999).
It is interesting that in HSV-1 infected cells, the partner kinase of hnRNP K is 
altered such that a fraction of K is associated with CKII. In uninfected cells 
hnRNP K forms a complex with an interleukin-1 responsive kinase shown to 
be the protein kinase C delta isoform (Schullery et al., 1999) and not with 
CKII although K protein is capable of being phosphorylated by CKII in vitro 
(Seuningen et al., 1995). Thus phosphorylation by CKII could influence the 
molecular partners interacting with hnRNP K as well as those interacting with 
IE63. Further studies must be carried out to determine the role of 
phosphorylation in vivo in modulating IE63 activity.
Finally, CKII has been shown to nucleotidylate the HSV-1 protein IE68 
(Mitchell et al., 1997) and IE63 contains nucleotidylation consensus sites 
(Blaho et al., 1993) raising the possibility that this modification is carried out 
by CKII. Although, Helen Bryant has shown that CKII does not nucleotidylate 
IE63 in vitro (unpublished data) it remains possible that CKII may be 
involved in the processing of HSV-1 proteins and that this processing is not 
limited to phosphorylation.
3.2.6 The IE63 protein interacts with the Spliceosomal Asociated Protein 145
Analysing the sequences of the positive clones using the GenEMBL database 
revealed that one of the clones could be identified as the Spliceosome 
Associated Protein 145 (SAP 145). The clone had a 89.4% homology in 499
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bp of this 2,839 bp gene. The sequence of this clone lay in the same reading 
frame as the SAP 145 gene. Helen Bryant has gone on to confirm the 
interaction between IE63 and SAP 145 by both co-immunoprecipitation and 
GST pull down assays. hnRNP K and CKII were also found in the complex, 
but were not associated with SAP 145 in the absence of IE63. Significantly, 
the interactions of SAP 145 and p32 with IE63 appear to be mutually exclusive 
of each other. Helen has also shown that SAP 145 and IE63 co-localise and 
that SAP 145 co-localises with the splicing factor SC35 which itself co- 
localises with IE63. These findings confirm that IE63 interacts with SAP 145 
and the spliceosome.
The proposed zinc finger of IE63 is essential for the interaction with 
Spliceosomal Associated Protein 145
To map the region of IE63 required for interaction with SAP 145, a series of 
IE63 truncations was expressed as hybrids with the GAL4 DNA-binding 
domain. These were mated into host cells transformed with the clone 
identified as SAP 145 from the library screen. Figure 3.7 shows the region of 
IE63 present in each construct and the degree of activation of the two reporter 
genes HIS3 and LacZ in the presence of the SAP 145 protein relative to the 
positive control pVA3-l and pTD-1 and the negative controls pAS2-l and 
pLam5’l.
The results show that sequences within aa 397-512 of IE63 which encode the 
zinc finger and the region required for splicing inhibition were essential for the 
interaction with SAP 145. However, the binding of the smaller IE63 
truncations to SAP 145 was noticeably weaker than the binding of the larger 
truncation 502CBD. This may be because other sites of IE63 are involved in 
the interaction or there may be a change in conformation of the smaller 
truncations which affect the ability of these subclones of IE63 to bind to 
SAP 145.
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(b) The proposed role of IE63-SAP145 interactions in the HSV-1 infected cell
IE63 promotes the redistribution of splicing factors and inhibits splicing in the 
HSV-1-infected cell. However, Sandri-Goldin et a l have shown that an IE63 
temperature sensitive mutant which contains a base substitution in the 
repressor region (aa 480) causes a redistribution of the snRNPs but splicing 
was not significantly inhibited (Sandri-Goldin et al., 1995). Thus whilst the 
redistribution of snRNPs may inhibit splicing, additional as yet unidentified 
mechanisms contribute to the disruption of splicing.
This study shows that IE63 interacts with SAP 145 - a subunit of the splicing 
factor SF3b and that the region of IE63 which interacts with SAP 145 maps 
between amino acids 397-512. This region contains the putative zinc finger of 
IE63 and also encompasses amino acid 405-512 of IE63 which are essential 
for splicing inhibition and for the redistribution and interaction with the 
snRNPs (Sandri-Goldin et al., 1995). That IE63 mutated at amino acids 480 
redistributes the snRNPs but does not inhibit splicing, suggests that an 
additional interaction - likely being mediated between amino acids 405 and 
480 of the IE63 protein, is also critical for the inhibition of splicing. We 
propose that this interaction is the interaction with SAP 145. The principal role 
of SAP 145 is to tether the U2 snRNP to the pre-mRNA which is a critical step 
in pre-spliceosome formation. By disrupting this interaction IE63 could 
effectively inhibit splicing as illustrated in Figure 3.8.
Why then does IE63 interact with so many splicing regulatory proteins? This 
study has shown that IE63 interacts with the splicing proteins SAP 145, ALY 
and p32. Other workers (K S Sciabica, R M Sandri-Goldin, University of 
California, Irvine, unpublished observations) have shown that IE63 interacts 
with the splicing regulatory protein Srp20 (reviewed by Kramer, 1996) and 
have confirmed the interaction with p32. Presumably by targeting a number of 
points in the splicing process, IE63 could impose maximum disruption of this 
cellular process. Efficient inhibition of splicing in HSV-1 infected cells may 
be necessary as splicing signals are highly degenerate and cryptic splice donor
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and acceptor signals are therefore likely to appear by chance in HSV 
transcripts that lack efficient or bona-fide introns. Although insufficient for 
splicing, such signals are predicted to promote non-productive interactions 
with the splicing machinery, leading to nuclear retention (Chang & Sharp, 
1990) or degradation through the discard pathway. IE63 could counteract this 
effect acting to ‘rescue’ virus transcripts. Intriguingly, a small fraction of 
HSV-1 glycoprotein C mRNA is unspliced, indicating the presence of weak 
splicing signals in this transcript (Frink et al., 1983). As gC protein is 
translated from the unspliced form of the mRNA, it is perhaps significant that 
accumulating of (unspliced) gC mRNA stringently requires IE63 (Rice & 
Knipe, 1990).
In this regard, Buisson et al. have shown that the Epstein Barr virus IE63 
homologue BMLF1 inhibited the cytoplasmic accumulation of mRNA 
generated from precursors containing weak (cryptic) 5’ splice sites but had no 
effect on the cytoplasmic accumulation of mRNA generated from precursors 
containing constitutive splice sites (Buisson et al., 1999). Additional 
interactions of IE63 with the splicing machinery could be mediated by a 
recently identified aa sequence motif (T M Soliman and S J Silverstein, 
Columbia University, New York, unpublished observations) located just 
upstream of the zinc finger region which is homologous to the Sm motif 
conserved in the eight human proteins common to snRNPS U2, U2, U4/U6 
and U5 (reviewed in (Luhrman et a l , 1990)). The Sm motif, which is also 
present in non-spliceosomal proteins, potentiates Sm protein-protein 
interactions (Hermann et al., 1995).
3.2.7 The IE63 protein interacts with the spliceosome associated protein ALY
Checking the sequences of the positive clones against the GenEMBL database 
revealed that four clones of similar size could be identified as the splicing 
factor ALY, the largest of which contained an insert of 990 bp. The clone with 
the highest homology has 91.9% homology in 456 bp of this 1,100 bp gene.
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Previous ALY studies have been on the murine gene, however recently 
Wichmann et a l cloned the 1.1. kb human ALY cDNA which encodes a 28 
kDa protein. This protein has 94% amino acid homology with murine ALY, 
and autoantibodies to ALY were found in a patient with systemic Lupus 
Erythematosus (Wichmann et al., 1999).
(a) Significance of the interaction between ALY and IE63
Since IE63 inhibits splicing and ALY is a spliceosome associated protein 
(Neubauer et al., 1998) it is possible that IE63 may mediate this effect via 
interaction with ALY. However, at present little is know about the role of 
ALY in splicing and further studies of ALY will be required before any 
definite biological role for this interaction can be determined.
Alternatively, evidence suggests that ALY is a cellular transcription factor 
(Bruhn et al., 1997) and it is plausible that IE63 either recruits ALY for viral 
transcription or disrupts the transcription of cellular genes by removing ALY 
from sites of cellular transcription.
3.2.8 The IE63 protein interacts with the splicing factor p32
Checking the sequences of the positive clones against the GenEMBL database 
revealed that twelve independent clones could be identified as the splicing 
factor p32, the largest insert of which was 1,100 bp. The clone with the 
highest homology had 99.3% homology in 446 bp sequenced of this 1,163 bp 
gene. Helen Bryant has confirmed that IE63 interacts with p32 using co- 
immunoprecipitation and has also shown that p32 is phosphorylated in vitro by 
coimmunoprecipitated CKII activity and is redistributed in the presence of 
IE63 (H E Bryant, D A Matthews, S Wadd, J E Scott, S Graham, W C Russell, 
J B Clements, Institute of Virology, University of Glasgow, submitted for 
publication).
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(a) A region in the N-terminus of IE63 is responsible for the interaction with 
p32
In order to map the region of IE63 required for interaction with p32 a series of 
IE63 truncations were expressed as hybrids with the GAL4 DNA-binding 
domain. These were mated into host cells transformed with the clone 
identified as p32 from the library screen. Figure 3.9 shows the region of IE63 
present in each construct and the degree of activation of the two reporter genes 
HIS3 and LacZ in the presence of the p32 protein relative to the positive 
control pVA3-l and pTD-1 and the negative controls pAS2-l and pLam5’l.
The results show that sequences within aa 166-242 of IE63 are essential for the 
interaction with p32. However, the binding of the smaller IE63 truncations to 
p32 was weaker than the binding of the larger truncation 502CBD indicating 
that other regions of IE63 may contribute to the interaction with p32. 
Interestingly, the IE63 region aa 166-242 was also necessary for the interaction 
with hnRNP K and CKIip.
(b) Significance of the interaction between p32 and IE63
p32 has putative roles in splicing, regulation of transcription and the transport 
of proteins across the nuclear pore. These are all functions which it apparently 
shares with IE63. However, the region of IE63 which appears to be critical for 
the interaction with p32 (aa 166-242) is not thought to be required for splicing 
inhibition, activation and repression of viral genes or nuclear transport. Using 
immunofluorescence with a standard fixation method, workers in our 
laboratory saw p32 predominantly in the cytoplasm of uninfected cells but on 
HSV-1 infection and with expression of IE63 alone, the distribution altered 
with the bulk of p32 no longer being present in the nucleus (H E Bryant, D A 
Matthews, S Wadd, J E Scott, S Graham, W C Russell, J B Clements, Institute 
of Virology, University of Glasgow, submitted for publication). A similar 
redistribution was observed in adenovirus infected cells where p32 has been 
suggested to play a role in adenovirus splicing regulation (Matthews &
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Russell, 1998). Furthermore, the HIV-1 protein Rev which upregulates the 
cytoplasmic appearance of singly and unspliced viral RNAs during infection 
interacts with p32 and it has been proposed that p32 functions as a link 
between p32, Rev and the cellular splicing apparatus (Tange et al., 1996). This 
raises the possibility that during HSV-1 infection the IE63-dependent 
redistribution of p32 may contribute to the disruption of splicing and the 
region of IE63 required for interaction with p32 (aa 166-242) may modulate 
this effect representing a further mechanism of IE63-induced splicing 
inhibition.
THE REGIONS OF IE63 THAT INTERACT WITH hnRNP K. SAP145 
AND CKII ARE CONSERVED THROUGHOUT THE 
ALPHAHERPESVIRINAE
Figure 3.10 (A) shows the amino acid conservation of IE63 and its seven 
alphaherpesvirus homologus as aligned using the Pileup program. This Figure 
shows that IE63 aa 242-397, essential for the interaction with hnRNP K, is the 
most conserved region throughout the alphaherpesviruses with twenty two 
amino acids in this region being absolutely conserved throughout the group.
Of particular interest in this region is the sequence SADET (IE63 aa 355-359) 
which is well conserved throughout the alphaherpesviruses. This sequence is 
homologous to part of the KNS domain
(GFSADETWDSAIDTWSPSEWQMAY) located between hnRNP K aa 338- 
361 and shown to be sufficient for its NES activity (Michael et al., 1997a).
The data presented here show that this region was not required for interaction 
of IE63 with CKIip, p32 and SAP145.
The IE63 region aa 397-512 containing the putative zinc finger was required 
for the interaction with CKIip and SAP 145. This region contains fourteen 
amino acids which are completely conserved through the alphaherpesviruses, 
six of which form the zinc finger and, strikingly, their relative spacing is 
completely conserved (C-X10-H-X3-C-X4-C-X14-H-X6-C) located between IE63 
aa 468-508. Zinc fingers are well known to be involved in DNA binding
Figure 3.10 (A ) Amino acid conservation of IE63 and homologues in the alphaherpesviruses. Conserved amino 
acid in bold. Amino acids coloured blue represent aa 166-242 which contributes to the interaction of  1E63 with 
hnRNP K, CKII(3 and p32. Amino acids coloured red represent aa 242-397 which is the region required for 
interaction with 1E63 and hnRNP K. Amino acids marked in green represent aa 397-512 and this region is required 
for interaction of IE63 with CKIip and SAP145, and for IE63 self-dimerization.
(A) A l p h a h e r p e s v i r u s e s
H S V -1  MATDIDMLIDLGLDLSDSDLDEDPPE. PAESRRDDLESDSSGECSSSDEDMEDPHGEDGPEPILDAARPAVRPSRPEDPG 7 9
H S V -2  MATDIDMLIDLGLDLSDSELEEDALERDEEGRRDDPESDSSGECSSSDEDMEDPCGDGGAEAI. DAAIPKGPPARPEDAG
EH V -1  MALSSVSSCEPMEDEMSIMGSDTEDNFTGGDTCA
EH V -4  MALSSVSSCEPMDDEMSIMGSDTDDTL. GGSCVE
BHV-1 MADPEIA TLSTASESDDLSLFGSDRE
PRV
VZV M ASASIPTD
MDV MSVDAFSRESDDMMSLLDYDFIEGSSSDENAEVTEMETSAK
H S V -1  VPSTQTPRPTERQGPNDPQPAPHSVWSRLGARRPSCSPEQHGGKVARLQPPPTKAQPARGGRRGRRRGRGRGGPGAADGL 1 5 9
H S V -2  TPEASTPRPAARRGADDPPPATTGVWSRLGTRRSASPREPHGGKVARIQPPSTKAPHPRGGRRGRRRGRGRYGPGGADST
EH V -1  EATRGLVNKSAFVPTQTVGTVSALRNVVGDPPKSVVVSFSASPQRAQPSNPKSERPAFGHGRRNRRRPFRRNNWKQQQRG
EHV-4 AAQSAVVNKRAFEMSESTGTMSTIRNVVSEVPKSLVVSFAASPKNPKPQNTTSERSAFPHGRKNRRRPFRRNNWK. . QRA
BHV-1 EDDEAPSLAPALRSVVGQVRKRKLEGAEDEPMPAEPPGEGAASGDGGPAEAPPARRARVRPRRPRRRPRRRQPAGEQRSR
PRV MEDSGNSSGSEASRSGSEERRPVRERLGSRPPERRPVRARLGAIRRRRGGRGGRAARQALRQRRRQQQQQQRQQQHQR
VZV PDVSTICEDFMNLLPDEPSDDFALEVTDWANDEAIGSTPGEDSTTSRTVYVERTADTAYNPRYSKRRHGRRESYHHNRPK
MDV TANNKNEVLFAPPCTQELLTERPSPDSKNSQGDDDSNSIYGNVIRDAQHSASRYATRCLDNAIPRKRLRLANLTVDSACI
H S V -1  SDPRRRAPRTNRNPGGPRPGAGWTDGPGAPHGEAWRGSEQPDPPGGQRTRGVRQAPPPLMTLAIAPPPADPRAPAPERKA 2 3 9
H S V -2  PKPRRRVSRNAHNQGGRHPASARTDGPGATHGEARRGGEQLDVSGGPRPRGTRQAPPPLMALSLTPPHADGRAPVPERKA
EH V -1  WEKPEPENVPARQSAGSWPKRSSLPVHMRLGQRGGDSSSADSGHGGAGPSDRWRFKTRTQSVARVHRNRRRGNANHGSNT
EHV-4 WEKQSQEAAPANQGSRNWPKRSSMPVHMRLGHRSGDFQSADAGHCTAGPSGGWRFKTRTHSASRVYHNRQRGNTNKSGNA
BHV-1 GPAAKREAALATSSHGGGGAAARSIGSSLRLARSLAEAAQ RATAERVTAVFAGARLDLMRPVQNGGFRAAGV....................
PRV RRQEADRPDGGPD APPDRLSESARAAVSATHA RVGATRVNELFASARHDLSRPVFNDGFRAAGS.........................................
VZV TLVVVLPDSNHHGGRDVETGYARIERGHRRSSRSYNTQSSRKHRDRSLSNRRRRPTTPPAMTTGERNDQTHDESYRLRFS
MDV SQTKRPHGTGNRKQYHRRNFPMSPTSQEKIHLRLHNRLGSRSEKQQRSLNYDRRLQEGHHRRRFYSERRIYDQNHSHHRT
H S V -1  PAADTIDATTRLVLRSISERAAVDRI SESFGRSAQVMliDPFGGQPFPAAN............................. S PWAPVLAGQGG . PFDAETR 3 0 8
H S V -2  PSADTIDPAVRAVLRSISERAAVERISESFGRSALVMQDPFGGMPFPAAN............................. SPWAPVLATQAG . GFDAETR
EH V -1  PGRSAGDRLNAAAASSIADVCRRVTSSRIGEMFHGARETLTTPVKNGGFRAENS................. SPWAPVLGFGSD . QFNPEAR
EH V -4  SS  S RSGDRLN AAAAN AIADVSKRVT S S R I  S DMFHGARETLT S PVKNGGFRAEHS.................SPWSPVLNFGLE. QFNPEGR
BHV-1 .......................................................................................................................................................... SPWAAVLDFGAE . QFVPEGR
PRV .................................................................................................................................................................................S PWAAVLEFGAE . QFTPDGR
VZV KRDARRERIRKEYDIPVDRIT GRAIEVVSTAGASVTIDSVRHLDETIEKLVVRYATIQEGDSWASGGCFPGI................. KQ
MDV HDIRVPLEK YRVSRQHDLPVHEELNEILQREKHRLASISNECDFRVSSK................................ NRWAAVLTFSSNAESTLCGP
H S V -1  RVSWETLVAHGPSLYRTFAGNPRAASTAKAMRDCVLRQENFIEALASADETLAWCKMCIHHNLPLRPQDPIIGTTAAVLD 3 8 8
H S V -2  RVSWETLVAHGPSLYRTFAANPRAASTAKAMRDCVLRQENLIEALASADETLAWCKMCIHHNLPLRPQDPIIGTAAAVLE
EHV-1 RITWDTLVF.HGVNLYKLFEVRSHAAEAARSLRDAVMRGENLLEALASADETLSWCKMIVTKNLPMRTRDPIISSSVALLD
EHV-4 RT TWDTLVTHGENLYKLFEVRSHAAEAARSLRDLVMRGENLLEALASADETISWCKMIITKNLPMRTRDPIIHSSIALLE
BHV-1 RVTWETLMFHGRDLYRMFEVRPHAAQAARALRDLVLRSANLVDALASADECLTWCKFIATKNLRLRTKDPIVATAGAVLE
PRV RVTWETLMFHGADLHRLFEVRPHATEAARVLREMVLLNEGLTESLASADETLTWVKLILTKGLTLRTLDPIVATAGAVLQ
VZV NTSW!ELMI Y6HELYRTFESYKMDSRIAR R RV1F 3ESLIEALESADELLTW IKM LAAKNLPIYTNNPIVATSKSLLE
MDV QITWEYLLHAGPELRNTFEIRPRISLQASAAREAVLRGESFIAALGSAEETLSWLKLHAVLKLRLVNHDPIFKTAGAVLD
H SV -1  NLATRLRPFLQCYLKAR. . . . GLCGLDELC SRRRLADIKDIASFVFVILARLANRVERGVAEIDYATLGVGVGEKMHFYL 4 6 4
H S V -2  NLATRLRPFLQCYLKAR. . . . GLCGLDDLCSRRRLSDIKDIAS F V L V ILARLANRVERGVSEIDYTTVGVGAGETMHFYI
EHV-1 NL; KLEPFM RCYLSSS. . . . GSPTLAELCDHQRLSDVACVPTFMFVMLARIARAVGSGAETVSRDALGPD. GRVLADYV
EHV-4 NLRL KLEPFM RCYLSSS. . . . GSPTLAELCDHQRLSDVACVPTFMFVTLARIARAVGSGAEAVSPDALGPA. GHALANYV
BHV-1 NLRLKLAPFLRCYLRGR.. . . GLPSLEELCAARRLSLATCPASYMFVMLARLSRAVRSGAECVPLLEVTVG. DAPFEEYI
PRV NLRLKLGPFLRCYLRDT....................PVDELVRRRRLRDVRCIVT YTLVMLARIARVVERGSSCVLPEDLGDS . PVPLEEYV
VZV NLKLKLGPFVRCLLLNRDNDLGSRTLPELLRQQRFSDT TCITTYMFVMIA R IA N IV VRGSKFVEYDDISCN. VQVLQEYT
MDV NLRLKLAPIMMCKYGTE KRSMGDM LRRSAPEDINDSLTLCLILLSRIRRVMHRTSGSKYSYMIDPR. .GCMIDYV
H S V -1  PGACMAGLIE l LDTHRQECSSRVCEL. T A S H IVAPPYVHGKYFYCNSLF 5 1 2
H S V -2  PGACMAGLIE l LDTHRQECSSRVCEL. T A S H T IAPLYVHGKYFYCNSLF
E H V -1 PGACLAGTLEAIDAHKRRCKADTCSL. VSAYTLVPVYLHGKYFYCNQIF
EHV-4 PGTCLAGTLEAIDLHKRRCKESTCSL. VSSYTLVPVYLHGKYFYCNQIF
BHV-1 PGTCVAGLIDALDTHKQACDSMTCKL. VANFTLVPVYMHGKYFYCNEIF
PRV PGACLGGIMDALDSHKTGCDAPTCRL. TCSYTLVPVYMHGKYFYCNHLF
VZV PGSCLAGVLEALITHQRECGRVECTLSTWAGHLSDARPYGKYFKCSTFNC
MDV PGECMTNILRYVDAHTRRCSDPACNL. Y IS C T L M P 1 Y IHGRYFYCNTLFGM
HSV H e r p e s  s i m p l e x  v i r u s
EHV E q u i n e  h e r p e s v i r u s
BHV B o v i n e  h e r p e s v i r u s
PRV P s e u d o r a b i e s  v i r u s
VZV V a r i c e l l a  z o s t e r  v i r u s
MDV M a r e k ' s  d i s e a s e  v i r u s
(B)Amino acid conservation of HHV8-ORF 57 and homologues in the gamma herpesviruses.
HHV-8 MVQAMIDMDIM.KGILE/DSVSSSEFDESRDDETDAPTLEDEQLSEPAEPPADERIRGTQSAQGIPPPLGRIPKKSQ
HVS MAQAMVTNCQM.EDIIE/GISSDDDFDSSDSSSDEEESDTSPQIMKSDVTMASPPSTPEPSPDVSASTSNLKRERQR
BHV-4 MAQAMLTMDCM.REIIE/DLSSDIDSFSGGESIDMESELEEGEIESDTNSSKPPPPQDLSKPPMMRIPRKRVASPDN
AHV-1 MAQQAIVTMSALRRTME/VSDSGDVSIDISAEDSNDS FHLEESVDDCMDDCKPNNRPNPISMKPAKRRVFMVPKRER
MHV-68 MAQQMLEAGAL.DQMME/GLPSDFDFDTSDEEGELSDSPPVEEPTGPVRDVVYEPDPLFDDPPPTPSPDVKPPSPKA
EBV MVPSQRLSRTSSISSNEDPA/ESHILELEAVSDTNTDCDLDPMEGSEEHSTDGEISSSEEEDEDPTPAHAIPARPSSVVI
HHV-8 GRSQLRSEIQFCSPLSRPRSPSPVNRYGKKIKFGTAGQNTRPPPEKRPRRRPRDRLQYGRTTRGGQCRAAPKRATRRPQV
HVS SPITWEHQSPLSRVYRSPSPMRFGKRPRISSNSTSRSCKTSWADRVREAAAQRRPSRPFRKPYSHPRNGPLRNGPPRAPP
BHV-4 ERMEYRSPLNRTYPPPFTERYGKRRRLTAGRPNWSGRVNEDKGRYRRRGLSDNKTIRHTQASIKDEVAVSLRKMKIPTGM
AHV-1 SKTPVQHTSPLNRLYPNVVLGKQHGYKQRPAPSARSRRPQPYSARKDSAAKPQSTPSNQNPLTELLKNVDPAIASRITEM
MHV-68 RKRALSPEIVHNSPLLRDTTKYEPAPKRSYSYHPRRSPQRENANQKQKRGPDSRRPNRWNQKSQKQYWSPKPLLDYSKIP
EBV TPTSASFVIPRKKWDLQDKTVTLHRSPLCRDEDEKEETGNSSYTRGHKRRRGEVHGCTDESYGKRRHLPPGARAPRAPRA
HHV-8 NCQRQDDDVRQGVSDAVKKLRLPASMIIDGESPRFDDSIIPRHHGACFNVFIPAPPSHVP.................EVF
HVS LLKLFDISILPKSGEPKLFLPVPSLPCQEA...............................................EKT
BHV-4 IRRAGEKPFDETLLSSGGPGRYSVFLPRAPEFKL........................................... ERY
AHV-1 RIPRSMLRTPSGQPFAHWLMPSAEDSSKFINVNPVNMEV......................................EEH
MHV-68 RAEYKNAKLLVPTTGKLRP..........................................................EFY
EBV PRVPRAPRSPRAPRSNRATRGPRSESRGAGRSTRKQARQERSQRPLPNKPWFDMSLVKPVSKITFVTLPSPLASLTLEPI
HHV-8 TDRDITALIRAGGKDDELIN .KKISAKKIDHLHRQMLSFVTSRHNQAYWVSCRRETAAAGGLQTLGAFVEEQMTWAQTVV
HVS NDKYVLAMAQRAMHDVPISS .KQLTANLLPVKFKPLLSIVRYTPNYYYWVSMRKETIASANLCTVAAFLDESLCWGQQYL
BHV-4 TDKLVSSLVEKGGENGAGIS. KKLSHLKLSSNFSVIHSFLNKSINYHYWVCLRKETMGSCGLTSLMLFLEETCCWAQLCT
AHV-1 VNVVVRRCTEWALISSRLQD. KSISTKYLAENFYDLRDFAQRSINKSAWINLRREAIANAGFVNLCAFADEMMMWLQLNL
MHV-6 8 TDRFVDAIIQNAARNCPVSE. KAVSLKNIEESFKLLNSFFNSGINKDHWLSTRYFAIFNNGLVVLTHMLDEQLAWAYACL
EBV QDPFLQSMLAVAAHPEIGAWQKVQPRHELRRSYKTLREFFTKSTNKDTWLDARMQAIQNAGLCTLVAMLEETIFWLQEIT
HHV-8 RHGGWFDEKDIDIILDTAIFVCNAFVTRFRLL. HLSCVFDKQSELALIKQVAYLVAMGNRLVEACNLLGEVKLNFRGGLL
HVS KNDFIFSENGKDIILDTSSALLSQLVHKIKMLPFCHCLMQTTPQDHIVKQVCYLIASNNRILDAVRYLQTSVIKSPIVLL
BHV-4 SNDVSINGFSNDIILNSANFLSVQIMFKLRSL. VMPCFAREAHNISLVKQLGYLVSTTNKIQTAASLIRELKLDTKLCLL
AHV-1 NNQGSWKACREDIILTGAPDMCFHALQKVRAF. . IKCFLRERHQRALVNALCHIICFEGGIKQAATLCQELFFDFKVGLM
MHV-68 KHGRELP. . TDDILMSTSEKLSQQLVIKLIEV. . IKCIEKDGIFSRILKGVADAVCLKAQFLRGMITLKRTPCSLPMYTL
EBV YHGDLPLAPAEDILLACAMSLSKVILTKLKEL. . APCFLPNTRDYNFVKQLFYITCATARQNKWETLSSSYVKQPLCLL
HHV-8 LAFVLTIPGM. QSRRSISARGQELFRTLLEYYRPGDVMGLLNVIVMEHHSLCRNSECAAATRAAMGSAKFNKGLFFYPLS
HVS LAYAVCLPAA.IICTKNETQLYSHCMRILKEYRPGDVMNILHESLTQHLNKCPSSTCAYTTRAIVGTKANTTGLFFLPTQ
BHV-4 AAFAIVVPTL.LETDKTEHGTYAFFMQYINRYRPGCIMSLYNDVISSHSRECTSRLCIANTRALAGTKDKTKGLFFCPI
AHV-1 VLYFLTPYAFLYSHTIPQCNFGGYFSKCVAQYTPGAVTGLLNSAIEDHYKDCTSQDCTNLITAIVSPETSNKGLLFFPLPM
MHV-68 FVYVLTIPTL..RTRVIRDPLLTQCKDVVLKYQPGDCITLLKAALNCHQCNKDCDKCKYILDPLLGQTHRTKGVFFVCE
EBV AAYAAVAPAYINANCRRRHDEVEFLGHYIKNYNPGTLSSLLTEAVETHTRDCRSASCSRLVRAILSPGTGSLGLFFVPGLNQ
HHV Human herpesvirus
HVS Herpesvirus saimiri
BHV Bovine herpesvirus
AHV Avian herpesvirus
MHV Murine herpesvirus
EBV Epstein-Barr virus
Thanks to Dr Andrew Davison for help with the amino acid alignments using Pileup programme.
(reviewed by Choo & Klug, 1997) and in interactions with RNA and DNA- 
RNA hybrids. In addition, zinc fingers can mediate protein-protein 
interactions, potentiating interactions with other proteins as well as self 
interaction (reviewed by Mackay & Crossley, 1998). The yeast genome 
contains some 500 zinc finger proteins and estimates are that some 1% of all 
mammalian genes encode zinc fingers.
These findings suggest that other alphaherpesvius homologues of IE63, such 
as varicella-zoster virus (VZV) ORF4 and bovine herpesvirus-1 (BHV-1) 
BICP27, will have a similar function to IE63, and that these proteins will 
engage some cellular partner proteins in common. Indeed the VZV ORF4 
homologue is an immediate-early protein with transcriptional and 
posttranscriptional regulatory properties (Defechereux et al., 1997) although 
unlike IE63, ORF4 is a component of the VZV virion (Kinchington et al., 
1995). The bovine herpesvirus BICP27 homologue, while expressed with 
early kinetics, like IE63 acts post-transcriptionally to increase RNA 3’ 
processing efficiency at weak poly(A) sites (Singh et al., 1996).
The data presented here, show that sequences within IE63 aa 166-242 
contributed to the interaction with hnRNP K and CKIip and this was the only 
region required for the interaction with p32. This region is not conserved 
among the alphaherpesviruses but in HSV-1 and HSV-2 it contains runs of 
prolines similar to the hnRNP K SH3 binding domain, a region of hnRNP K 
known to potentiate interactions with partner proteins (Bomsztyk et al., 1997).
3.4 IE63 INTERACTS WITH A NUCLEOPORIN-LIKE PROTEIN IN 
YEAST CELLS
3.4.1 IE63 interacts with the nucleoporin-like RIP1 protein in the yeast two- 
hybrid system but not the nucleoporin CRM1
Although the yeast two-hybrid library screen should theoretically identify all 
of the cellular proteins which interacts with IE63, other workers frequently
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report that screens fail to identify interactions with proteins that are known to 
interact with their bait protein. In other words although a screen is an 
excellent method for identifying protein-protein interactions, it does not 
guarantee that all proteins which interact with the bait protein in vivo will be 
identified. The reason for this is not as yet not known but it may be due to the 
fact that the portion of the library screened is not always 100% representative. 
For this reason and considering that a protein directly implicated in RNA 
transport had not been identified in the yeast two-hybrid assay, we decided to 
test for an interaction between IE63 and; (i) the cellular nuclear protein RIP1 
(Bogerd et al., 1995, Fritz et al., 1995) which contains a series of 
phenylalanine-glycine repeats (FG repeats) present in the FG nucleoporin 
family of proteins and is implicated in the process of nucleocytoplasmic 
transport (Davis, 1995) (ii) the nucleoporin export factor hCRMl (Neville et 
al., 1997, Stutzefa/., 1997).
The expression plasmids 502CBD and 502CAD were simultaneously 
transformed into the yeast strain Y187 with an expression plasmid encoding 
either RIP1 fused to the GAL4 AD or CRM1 fused to the GAL4-BD 
respectively. Following three days of incubation, a beta-galactosidase assay 
was performed. Experiments showed that beta-galactosidase activity was 
present in the presence of RIP 1 (++) but not in the presence of CRM1 (-), 
indicating an interaction with RIP1 but not with CRM1.
3.4.2 The significance of the interaction between IE63 and RIP1 and the lack of 
interaction with CRM1
Several lines of investigation have demonstrated that CRM1 is the HIV-1 Rev 
leucine-rich NES receptor (reviewed in Stutz & Robash, 1998). The FG repeat 
region of RIP 1, initially identified as a Rev NES interacting region in a two- 
hybrid screen, was shown to interact via the bridging activity of CRM1. Since 
IE63 contains a leucine-rich NES, it seems puzzling that an interaction with 
CRM1 was not found. However, the cytotoxin leptomycin B, shown to target 
the CRM1 protein and prevent shuttling of Rev, does not efficiently inhibit
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cytoplasmic shuttling of IE63 (T F Soliman and S J Silverstein, Columbia 
University, New York, unpublished observations), indicating that IE63 may be 
exported by an alternative pathway.
RIP1 is absolutely required for the selective export of heat shock RNAs 
(Saavedra et al., 1997) with no substantial contribution from the FG repeat 
regions (Stutz et al., 1997) and is a nuclear pore component. It is possible that 
both IE63 and hnRNP K could directly recognise a common nuclear pore 
component (such as RIP1), via the SADET and KNS sequences respectively, 
to facilitate nucleocytoplasmic transport. The influenza virus NS2 protein 
mediates the nuclear export of virion RNAs and interacts with several cellular 
nucleoporins including RIP1; however the interaction of NS2 with CRM1 was 
not examined (O'Neill et al., 1998).
3.5 hnRNP K. SAP145. CKII AND p 32 CLONES IDENTIFIED IN THE 
YEAST TWO-HYBRID SCREEN DO NOT INTERACT WITH THE 
KAPOSPS SARCOMA IE63 HOMOLOGUE
Human herpesvirus-8 (HHV-8), or Kaposi’s sarcoma (KS) associated 
herpesvirus is a gammaherpesvirus (reviewed in Schuly, 1998). KS is a 
neoplasm found predominantly in AIDS patients. HHV-8 expresses an IE63 
homologue from the ORF57 gene, and this gene product, like IE63, can 
regulate viral gene expression at the post-transcriptional level (Gupta et al., 
2000), exhibits a punctate nuclear distribution that co-localises with the 
cellular splicing factor SC35 and shuttles from a transfected monkey nucleus 
to a recipient mouse nucleus in an interspecies heterokaryon assay (Bello et 
al., 1999). ORF57 of the gammaherpesvirus herpesvirus saimiri acts post- 
transcriptionally to repress gene expression, dependent on the presence of an 
intron in the reporter gene (Whitehouse et al., 1998) and causes the clumping 
of splicing factor SC35 and spliceosome components and co-localises with 
these redistributed components (Cooper et al., 1999). CRM1 appears to 
mediate the function and the shuttling of the Epstein-Barr virus IE63 
homologue (Boyle et al., 1999). These findings suggested that HHV-8 ORF57
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may function in a similar manner to IE63. For this reason, a two-hybrid screen 
was set up to test for interactions of HHV-8 ORF578 with the proteins 
expressed from the hnRNP K, CKIip, SAP 145 and p32 clones which had been 
shown to interact with IE63 in the library screen.
The expression plasmid encoding the full ORF57 coding sequence of 455 
amino acids fused to the GAL4 BD was constructed from ORF57 cDNA (a 
kind gift of Dr L Bello) as the ORF57 gene contains a single intron (Bello et 
al., 1999). This plasmid was simultaneously transformed into the yeast strain 
Y187 with an expression plasmid encoding either hnRNP K, CKIip, SAP 145 
or p32 fused to the GAL4 AD. The ORF57-GAL4 BD construct was not 
sequenced to ensure that it lay in the same frame as the GAL4 BD or tested for 
expressed in yeast cells due to time limitations. Following three days of 
incubation, a p-galactosidase assay was carried out. The results of the 
experiment demonstrated that there was no P-galactosidase activity (-) 
detected in any of the assays compared to the positive control of pVA3-l and 
pTD-1 (++) indicating that HHV-8 ORF57 does not interact with the cellular 
proteins identified in this study to interact with IE63. However, since the 
construct had not been sequenced or tested for expression it is not possible to 
say conclusively that HHV-8 ORF57 does not interact with these proteins.
3.5.1 Interpretation of the finding that the Kaposi’s Sarcoma IE63 homologue 
does not interact with hnRNP K, CKII. SAP145 or p32
HHV-8 is a gammaherpesvirus and the ORF 57 gene, unlike IE63, contains a 
single intron and shuttles in a heterokaryon assay but not after actinomycin D 
treatment of transfected cells suggesting that protein re-import into the nucleus 
is not transcription dependent (Bello et al., 1999). Figure 3.10 (B) shows a 
Pileup analysis of the ORF57 amino acid sequence together with the sequences 
of the other gammaherpesviruses. ORF57, like other gammaherpesviruses, 
contains an N-terminal exon of 16-17 amino acids (with the exception of EBV 
which is 20 amino acids in length). A feature of the ORF57 extreme N 
terminus is the absence of an acidic region as compared to IE63 and this is a
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feature of all gammaherpesvirus homologues. Full length ORF57 did not 
cause transcriptional activation of the two-hybrid system’s reporter genes and 
this may reflect the absence of this acidic region which in IE63 did cause 
transcriptional activation in this assay system.
Comparison of the HHV-8 ORF57 sequence with that of HSV-1 IE63 showed 
little amino acid conservation. The arrangements of cysteine and histidine 
residues in the putative zinc finger of the gammaherpesvirus homologues are 
positionally conserved, with the exception of one cysteine in MHV-68, but the 
arrangement (H-X3-C-X4-C) located between HHV-8 ORF57 aa 423-432 is 
very different from the zinc finger arrangement of the alphaherpesviruses. 
These findings suggest that although IE63 and HHV-8 ORF57 proteins share a 
number of functional similarities, these distantly related homologues are likely 
to possess certain different properties. Studies of molecular evolutionary 
history indicate that branches giving rise to the alpha- and 
gammaherpesviruses diverged around 200 million years ago (McGeoch et al., 
1995) while lines giving rise to HSV-1 (a-1) and VZV (a-2) have been 
separate for some 75 million years.
3.6 IE63 DIMERISES IN YEAST CELLS
A number of viral regulatory proteins such as hnRNP K , the HIV-1 Rev and 
HSV-1 IE175 and IE110 form dimers or multimers (Ciufo et al., 1994, 
Gallinari et al., 1994, Hope et al., 1992). Therefore the expression plasmid 
502CBD was simultaneously transformed into the yeast strain Y187 with the 
expression plasmid 502CAD to determine whether or not IE63 could also 
oligomerise. After three days a filter lift assay showed that p-galactosidase 
was present (++) indicating that IE63 is able to dimerise in vivo. These 
findings have recently been confirmed by Zhi et al. using 
coimmunoprecipitation and the yeast two-hybrid system (Zhi et al., 1999) and 
these workers postulate that IE63 may function in vivo as a multimer.
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3.6.1 The putative zinc finger of IE63 mediates its dimerisation
In order to map the region of IE63 required for its dimerisation a series of IE63 
truncations were expressed as hybrids with the GAL4 DNA-binding domain. 
These were mated into host cells transformed with the IE63 truncation 502C 
AD. Figure 3.11 shows the region of IE63 present in each construct and the 
degree of activation of the two reporter genes HIS3 and LacZ in the presence 
of IE63 fused to the activation domain relative to the positive control pVA3-l 
and pTD-1 and the negative controls pAS2-l and pLam5’ 1.
These results show that it is the zinc finger region of IE63 which is essential 
for its ability to form oligomers, a result recently confirmed by Zhi et al (Zhi 
et al., 1999) who showed that an insertion within but not outside the zinc 
finger resulted in a loss of interaction. However, the data presented here show 
that interaction of the mutants 346CBD and 270CBD is weaker than the 
interaction between 502CBD and 502CAD. This suggests that amino acids 
72-166 also contribute to the self-interaction of IE63.
3.7 SUMMARY
This project has found that IE63 interacts with the cellular proteins hnRNP K, 
CKII, SAP 145, p32 and ALY. Identification of the regions of IE63 which 
interact with these proteins and comparison with previously identified 
functional domains of IE63 has enabled putative functions to be attributed to 
each interaction but these will need to be investigated further. Disruption of 
these interactions using truncated forms of IE63 has confirmed the authenticity 
of these interactions in yeast cells.
In addition, sequence analysis has shown that certain regions of IE63 which 
mediate the interaction between hnRNPK, CKII, SAP 145 and p32 are well 
conserved in IE63 homologues throughout the alphaherpesviruses indicating 
that these proteins may share common molecular partners. The HHV-8 
ORF57 protein which has some similar properties to IE63 has been shown
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here not to interact with the same cellular proteins. This is likely due to the 
fact that HHV-8 is a gammaherpesvirus, with ORF57 exhibiting little 
sequence homology to IE63 and probably possessing certain different 
functions in viral infection.
Finally, this study has indicated that IE63 may use the nucleoporin RIP1 to 
cross the nuclear pore. In addition, IE63 appears to form dimers in yeast cells 
and this function may enable the protein to interact with multiple partners in
vivo.
It should be noted that although this thesis describes a screen for IE63-protein 
interactions in an uninfected-cell library, a screen of an infected-cell library 
would confirm that these interactions exist in HSV-1 infection where cellular 
protein levels can be increased or decreased. This approach would make an 
interesting future study.
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GENERAL DISCUSSION
4.1 THE YEAST TWO-HYBRID SYSTEM HAS BEEN EFFECTIVE IN
IDENTIFYING 1E63-PROTE1N INTERACTIONS
The HSV-1 protein IE63 has several, previously defined effects on the cell in 
which it replicates and on HSV-1 lytic infection itself. IE63-deficient viral 
mutants show alterations in transcription, polyadenylation, splicing, mRNA 
transport and viral DNA replication. That IE63 has such diverse effects on the 
cell and on viral replication led us to propose IE63 functions by interacting 
with and modifying the cellular proteins involved in these processes. 
Consequently, the aim of this study was to identify the cellular proteins that 
interact with IE63. It was anticipated that this would, at least in part, elucidate 
the mode of action of this protein.
Evidence presented here shows that IE63 interacts with the cellular proteins 
hnRNP K, CKIip, SAP 145, p32, ALY and RIP1. The interactions between 
IE63 and hnRNP K, CKIip, SAP 145 and p32 have been confirmed 
independently using biochemical methods by colleagues. Therefore, the 
supposition that IE63 interacts with cellular proteins has been proven and the 
aim of this study has undoubtedly been satisfied by the results obtained.
On the whole, the yeast two-hybrid system has been an excellent ‘first step’ 
towards determining IE63 function. Indeed, this system has shown that IE63 
interacts with SAP 145, p32 and ALY and these interactions may be the 
mechanism by which IE63 inhibits splicing. Testing for an interaction with the 
hundred or so proteins required for splicing using traditional biochemical 
methods would of course have been enormously time consuming. Other 
methods which can screen for interactions of a single protein with the entire 
set of cellular genes do not give immediate access to part of a gene and its 
cDNA for ready sequencing and identification and are not performed in vivo. 
Nevertheless, this study has highlighted a complication of the yeast two-hybrid 
system, ie how can biologically relevant interactions be distinguished from 
irrelevant ones and what criteria should be adopted to identify a protein which 
warrants further investigation.
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In this study, no less than eight proteins, SAP145, p32, hnRNP K, CKII, RIP1, 
Gallus Gallus Glutamine Rich Protein, human JTV-1, and transcriptional 
activator ALY interacted with IE63 and survived false-positive screening 
experiments. Why then were the latter three proteins reserved for future 
studies? In short, to fully investigate all of these interactions at any one time 
would require an enormous amount of manpower. Each interaction would 
have to be confirmed using an independent biochemical method and this 
requires antibodies to be obtained or generated for each protein. Once any 
interaction was confirmed independently, the lengthy process of determining 
the function, if any, of that interaction in vivo would need to be initiated. 
Therefore the investigation of the interactions identified in this study only in 
part was unavoidable. SAP 145, p32, hnRNP K and CKII were chosen as the 
first batch of proteins to be examined primarily because it was evident that by 
interaction with these proteins IE63 could, conceivably mediate some of its 
previously identified roles in viral infection.
However, many critical scientific discoveries would not have been made had 
the investigators accepted results that ‘made sense’ and discounted the 
unexpected. Indeed the interaction of IE63 with ‘transcriptional’ activator 
ALY identified in this project did not initially appear to be of interest but 
recent work has suggested that ALY is a splicing factor (Neubauer et al., 1998) 
and therefore the interaction may have a role in IE63 function. For these 
reasons the proteins Gallus gallus Glutamine Rich Protein and human JTV-1 
are discussed below and will be investigated at a later date.
4.1.1 The Gallus Gallus Glutamine Rich Protein
Gallus gallus is a species of chicken and as the library being screened was a 
human cell cDNA library the protein that interacts with IE63 cannot be Gallus 
gallus Glutamine Rich Protein (sequenced by S Niu, C A Adamson, E Morkin, 
University of Arizona, 1997, Accession Number U90567). However, the 
similarity between the clone identified in the library screen and Gallus gallus
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Glutamine Rich Protein was 80.6% over 453 bp and two such clones were 
identified in the library screen. This suggests that IE63 may interact with a 
human homologue of this protein. Glutamine/Glutamic acid-rich proteins are 
frequently transcription factors and it is plausible that this clone is a novel 
transcription factor. Extensive sequencing of this clone is to be done.
4.1.2 Human JTV-1
Finally human JTV-1 is a protein which has been sequenced (Nicholaides et 
a l, 1995) but no function or characteristics have been attributed to this protein 
at the present time. One clone was identified in this study which had a 85.8% 
homology over 387 bp of the JTV-1 gene. In these circumstances, no putative 
function can be assigned to an interaction between IE63 and JTV-1 until the 
function of this protein is further investigated.
4.2 THE FINDINGS OF THIS STUDY IN CONTEXT
How do the findings of other workers accord with the findings of this study 
and how do the interpretations made here integrate with existing 
knowledge/beliefs. This study was novel in that it used the two-hybrid system 
to screen a library of cellular proteins with IE63 to identify protein-protein 
interactions. The results in general integrated very well with existing 
knowledge of the IE63 protein. We anticipated that IE63 would interact with 
multiple cellular partners and that one or more of these partners would likely 
play a role in the regulation of splicing, transcription, mRNA transport and 
phosphorylation. However, since IE63 also plays a role polyadenylation it was 
anticipated that IE63 might interact with a polyadenylation factor, a likely 
candidate being the 64 kDa CstF component, a protein which exhibits 
increased binding to weak viral poly A sites at late times during infection only 
in the presence of IE63. It may of course be that the effect of IE63 on CstF is 
an indirect one. Alternatively, Huang et al. (Huang et al., 1999) have shown 
that cis-acting RNA elements can promote histone 2a transcript 
polyadenylation and it is possible that such elements exist in virus intronless
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RNAs, allowing IE63 to polyadenylate viral RNAs with no interaction with 
cellular polyadenylation factors. In addition, since the phosphorylation state of 
the U1 snRNP 70 kDa protein is thought to be altered in the presence of IE63 
why was this interaction not identified? It is possible that this interaction 
exists in the cell but that that it has not been demonstrated in the two-hybrid 
system or that IE63 up-regulates/modulates CKII activity (as is the case of 
HIV-1 Rev, Ohtsuki et al., 1998) facilitating phosphorylation of the U1 70 kDa 
protein. In this respect it is interesting that Dr Margy Koffa in our laboratory 
has shown that the activity of CKII a  subunit declines whilst the a l  subunit is 
activated following HSV-1 infection.
Since this work was carried out, Sciabica and Sandri-Goldin have also used 
IE63 to screen a cellular cDNA library using the yeast two-hybrid system (K S 
Sciabica, R M Sandri-Goldin, University of California, Irvine, unpublished 
work). These workers found that IE63 interacts with the cellular splicing 
factor SRp20 and propose that IE63 impairs splicing by affecting the 
phosphorylation of this protein. Sciabica and Sandri-Goldin have also shown 
that ALY and p32 interact with IE63 in a two-hybrid screen. We did not 
identify SRp20 as interacting with IE63. This demonstrates that whilst the 
two-hybrid system is a powerful tool for identifying protein-protein 
interactions, a library screen is not exhaustive and not all proteins that interact 
with the bait will necessarily be identified in any one screen. Zhi et a l have 
also recently confirmed the findings of this study by showing that IE63 can 
form oligomers and also that it is the putative zinc finger of IE63 which is 
required for its multimerisation (Zhi et al., 1999). Finally Helen Bryant in our 
laboratory has confirmed that IE63 interacts with CKII, hnRNP K, SAP 145 
and p32 using independent biochemical methods. Clearly this work is now 
supported by others working in this field and has allowed important new 
insights into how this key herpesvirus protein exerts its various activities.
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4.3 FUTURE DIRECTIONS
Work in our group was initially focused on using independent biochemical 
methods to confirm the results of this study, and has also demonstrated that 
CKII can phosphorylate hnRNP K in the presence of IE63 and that CKII can 
phosphorylate IE63 itself (Wadd et al., 1999). Future studies will include:
(a) Examining the effect of phosphorylation on IE63/ hnRNP K functions in 
HSV-1 infected cells using kinase inhibitors and IE63 viral mutants in 
CKII phosphorylation sites. These studies will examine nucleocytoplasmic 
shuttling using the heterokaryon assay, the cellular partner proteins present 
in the IE63 protein complex, and whether or not virus transcripts are 
exported and intron-containing RNAs still accumulate in the nucleus using 
in situ hybridisation. Effects on the phosphorylation/shuttling of hnRNP 
Al will be examined in the presence of expressed IE63. Studies will be 
performed on the upregulation of CKII activity in HSV-1 infected cells, 
determining the viral gene products required and examining for 
phosphorylation of CKII sites on hnRNP K.
(b) The possible significance of interactions between IE63 and the Glutamine 
Rich Protein and protein JTV-1 will be examined.
(c) Immunofluorescence will be carried out to determine whether or not 
hnRNP K co-localises with IE63 at sites of viral transcription and effects 
of phosphorylation on the cellular distribution of IE63/hnRNP K.
(d) The identity of the export receptor which IE63 uses to cross the nuclear 
pore will be investigated. Mutations in the CKII consensus site present in 
the IE63 SADET sequence will be introduced into viruses and effects on 
IE63/hnRNP K shuttling examined.
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(e) The ability of SAP 145 to participate in splicing complex formation in 
vitro will be examined using splicing extracts from infected cells and 
from uninfected cells with added recombinant IE63.
(f) Various IE63 mutant viruses located throughout the protein will be used to
infect cells and examine for effects on the partner proteins in the IE63 
complex by immunoprecipitation.
4.4 IE63 IS A HIGHLY PLEIOTROPIC PROTEIN
To conclude, the evidence presented here suggests that IE63 is a protein with 
many diverse functions which it carries out via interactions with host cell 
proteins. There is a close inter-relationship between the processes of 
transcription and RNA processing as reflected in interactions between RNA 
polymerase II and cellular factors involved in pre-mRNA splicing and RNA 3’ 
processing (Hirose & Manley, 1998). Some proteins such as WT1 protein 
(Davies et al., 1999) and hnRNP K appear to co-ordinate transcription and 
RNA processing/export (reviewed in Ladomery, 1997) by interacting with 
cellular proteins and nucleic acid. Similarly, IE63 is a multifunctional protein 
which enables HSV-1 to efficiently utilise host cell mechanisms and replicate 
efficiently. The proposed role of IE63 on the HSV-1 lytic cycle is illustrated 
diagrammatically in Figure 4.1. This study has not only greatly improved 
understanding of the functions of the essential HSV-1 protein IE63, but as is 
so often the case, has opened many new avenues of research for further 
investigators to explore. This promises to be an exciting era in the study of 
IE63.
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Appendix 1
Sequence comparison of clones 
identified in library screen with genes 
that they have homology with
Homo sapiens' pre-mRNA splicing factor p32 
subunit
:w97.Seq
Eni_Huni2:Hs5f 2p32a
ID HSSF2P32A standard; RNA; HUH; 1163 BP.
AC L04636;
NI g338044
DT 21-0CT-1992 (Rel. 33, Created)
jT 19-FEB-1994 (Rel. ,38,, Last updatEd, Version Z)
OE Hoso sapiens. pre-aRNA splicing factor 2 p32 subunit tSF2p32/ ntftHA, . . ,
iCORES Initl: 1910 Initn: 19B8 Opt?, 2042 s-score: 1734.5 El): 0
98.8i£ identity-in 421 bp overlap
50 ' 60 r 70 ’ “80 -0 1:0 10:
*97,Seq ATCNCCC6B6CTBCH6BAATTCBeCACBfi6*GCBCieCt6CBCCC6CCTCGCCTTTCC65C
1 ! ! ! ! I I I ! I I ! I I ! I I ! I I !l M 1 M I I I, I I I I I if I •. II \ \ I l » I I » I I I I I ! I II I .
H=si2pJ2a 6TGT6CTBBBCTCCTCC8fCBCCE6eCTCC6C6CTBCCGCBCCCGCCTCcCCTTTCCBBC
110 120 1*0 • 140 150 160 ■
110 120 130 140 150 1 M  169
Sw97.3sq •AfiCTCCT6CA6CCG6CACCCCGSCTGT6CACCCSSCCCTTCBQSCT6CTCA5C6TGCC-C8
II I I II I I I II I I II II I I S 1 I I I I M  I I I \ I I I I i \ » I 1 M  1 1 • » t i I I M  \ \ ! t M  •
I I I If I I I I I f II I I II I I II I I I I M  II I I I I t I I 1 I t I 1 I l I 1 T ! 1 » 1 I I ; S l. I 1 I s
Hssf2p32a AGCTCCT6CA6CCGGCACCCC6GCTGTGGACCCB3CiC7TCSGeCTGCTCAGC0reCC-C<:
'170 180 • 190 200 210 220
170 • 180 , 190 200 210 220 22°
:w97,Seq CA66TTCC6AGCG&CGBCCGGeCCTCCTGC66CCTCGCeSACCCTGC6CCTGT6GCT0TG
I I I M  I I I I I I I I I I I I II I! I I ! 1 ) II • I ! • I ! I ' I : l i 1 I I I ! ! ! I ! ! I "  I I ! I! I I
I I I I I I » I I I I I I i II I II I I II I I I II II I J I I II I I I I I M  I 1 I > I I I I I I M  I M  I I
Hssf2p32a''' ■ CAeBTTCCBABCGeCG6CCD6GCCTCCTSCe8CCTCBCBGACCCT6C6CCTGTB6CTGTB
230 240 250. 260 270 ' 280
'■ 230 240 250 260 ’ 270 280 28?
> 5 7 . Seq 6CT6CGGC TCGC TGCACACCGACG8ABACAAAQC T TTTS T TGftTT TCCTGAG TGATSAAA
1 I I I I I I II I I I I I I! ' I I I I! 1 I I I I I tl I I I I ! I I I I I I I I I II I I M  I I I I II I i I I
I I I I I ! M  II t M  I M  I I II I II I II I I I I I I II I I I I 11 I I I I M  I II I I I I r I I I I I I
V ,f2p 3 2 a  GCTECSGCTCGCTGCACACCGACGGAGACAAAECTTTTGTTGATTTCCTGAGTGATGAAA
290 300 310 320 330. 340
290 300. .310 320 330' 340 349
Lw97’. Seq . TTAAGGAGGAAAGAAAAATTCAGAAGCATAAAACCCTCCCTAAGATGTC'TGGAGBTTGGG
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Hssf2p32a TTAA6GAG6AAAGAAAAATICAGAA6CATAAAACCCTCCCTAA6ATBTCTG6ABGTTGG6
• 3 5 0 / ^ - 3 6 0  '370 380 390 400'
350 ;56o T; 370 : 380 390 . 400 409
‘Sw97.Seq \ ; A 6 C | 6 & ^ ^ I 6 6 6 A C A 6 A A 6 C G A A A T T A G T 6 C G 6 A A A 6 T T 6 C C 6 6 6 6 A A A A A A T C A
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; Hssf2p32a A6CT66AACT6AAT66GACA6AA6CGAAATTA6T6C66AAAGTT6CC66GGAAAAAATCA
. 410f ; ; ^ 4 2 0 .  - 4 3 0  440 450 460
410 420 430 440 450 460 '46?
SH?7.5eq CGGTCACTTTC aM t TAACAACAGCATCCCACCAACATTTGATGGTGAGGAAGGAACCC
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;Hssf2p32a CGGTCACTTTCAACATTAACAACAGCATCCCACCAACATTTGATGGTGAGG-'AGGAACCC
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Casein Kinase II beta subunit
LU HbLKII standara; RNA;' HUH; 561 BP.
hl, X133l b ;
Ni g69964
DT 63-N0V-1989 (Rel. 61, Created;
lh 16--SEP-1993 (Rei. 36, Last updated, Version 6;
BE Human mRNft for phosvit in/case in kinase li beta subunit . . .
BLUREB Initls 1950 Initn: 1950 Opts 1953 z-score: 1856.6 Ei):
99. £34 identity in 396 bp overlap
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I I I I I I I I I II I I I I I I I I I I I I I I I I I I I II I I I II I I I I II I I I I I I I I I I I I II I I I 
Hsckii AGAGJGACCTGA rTGAGCAGGLAGCCGAGA7'GC7T7 ATGGA ITGATCCACGCCCGCThCA
340 350 360 370 380 '390 .
500
61.Beq TCC7TA ■
I I 1 I I I
HsCki i 7 CCTTACCAACCBT'bGCA TCbCLCAGATbTTGGAAAAbTALCAGCAAGGABACTT'TGGT'J
' \ 400 4i0 4b0 430 440 450
* 7 Human Spliceosome Associated Protein 145
|fD flS4137ilj#sfcandard| RNA; BP.
a c
NI g l i 7 3 9 0 ^ ! ^ p § y . ' .  •
DT 03-FEB-i99&viRfel.' 46, Created)
DT 19-APR-1996.(Rel. 47* Last updated, Version 2) ,•
DE Hunan spliceosone associated protein (SAP 145) «RNA, complete cds, . . .
SCORES Initl: 879 Initn: 1144 Opt: 1907 z-score: 1943.2 E(): 0-
8 9.4Z identity in 499 bp overlap
10 20 30 ' 40
B « 3 4 .Seq CCCAAAAAAAGABATCCTAAG-AACTABTGGNTC-CCCCGGG
# 4 I 1 I 11 I I I I 1 I I I I t 1 tl» t I Ml \ II Mil M 1l«l
Hs41371.1 TTGC6CCGAATGAACC6CTTCACT6TGGCTGA.ACTCAAGCAGCTGGTGGCTCG6CCCGAT
1340 1350 • 1360 lj70 1380 1390
50 * 60 ‘ 70 . GO 90 99
3 « 3 4 .Seq CTGCAGGAATTCGGCACGA-GTGACA8CGCAG6ACCCTAAGCTCTTGGTTCACCTCAAGG
r m i . i Mini ii f 11 i i i i it i m 11* 11 .i i t i ii m i i 11 i ii ii ii  iiI III I I II I f I I I I ) I it I! II II I I M I I I I I I I I I I I I | I | M M I M
Hs41371i GTCGTG6AGAT--6CAC6ATGTGACAGC8CA66ACCCTAAGCTCTTGGTTCACCTCAAGG
1400 1410 1420 1430 1440 1450 "
100 110 ‘ 120 130 ' 140 150 159
5 w 3 4 .Seq CCACTCGGAACTCTGTGCCTGTGCCACGCCACT6GTGTTTTAAGCGCAAATACCTGCANG
I I II I I I I I I M M I I I I I I I I I I I II II ( I I I I I I I I I I (I I II I I I I I I I I I M III I I I » I » I If tl II I I I I I I II II M M I II M II I I I I  I II I I I II I I I I I II I I l
Hs413711 CCACTCGGAACTCT6TGCCTGT6CCACGCCACTG3TGTTTTAAGCGCAAATACCTGCAG6
• 1460 1470 ‘ 1480 1490 1500 . 1510
160 170 . 180 190 ■ 200 210 219
S*34.Seq GCAAACGG6GCATTGASAA6CCCCCCTTCGAGCTGCCAGACTTCATCAAACGCACANGCA
11 m i it m i »111111 ii i m 111111 m i • 1111M11 ii i M1111 m 11 m i mi  I I I I I I I M I I I M tl I I I II II I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I III • ■
H s 4 1 3 7 U  GCAAACG6GGCATTGAGAAGCCCCCCTTCGA6CTGCCA6ACTTCATCAAACGCACAGGCA
1520 1530 .1540 1550 1560 1570
220 230 240 250 260 270
TCCAAGA6ATGC6AGA6G-CCT6CA66A6AAG6AAGAACA6AA6ACCATGAA6TCAAAAA
Mil II I I I M I I I I I I M I I I I M I I I I I I II I I I I I I I I I I I II M I M M It II M I I I I I I I M • I I I I I II I M If I 1 I I I M I I II M M I I I II M I I I » M I I I
TCCAG6A6AT6C6AGA66CCCTGCA6GA6AAGGAA6AACA6AAGACCAT6AA6TCAAAAA 
1580 1590 1600 1610 1620 1630
280 .290 300 310 320 330
TGCGAGA6AAAGTTC6GCCTAAGATNGGCAAAATTGACATCGACTACCGGAAACTGCATG
I I I M I I I II I M I I I I I I I I I II I I I I I I I I I I M I I I M I I II IMMlllillII I I II I II t I If I I II I I II I If II I II II I II I I II II II I II I II I 11 1 I I I I I
TGCGAGA6AAAGTTCGGCCTAAGATGGGCAAAATTGACATCGACTACCAGAAACTGCATG 
1640 1650 1660 1670 1680 . 1 6 9 0
340 . 350 360 370 380 390
ATGCCTTCTTCAANTG6CAAGACCAAGCCAAAGCTGA-CATCCATGGGGA-0TGT-CTAT
I I I I I I I I I I I I I I I I I I I I I I » I I I I I II I I I 1 II II II III M till I I I II I II I I I I II I I I I I I I I I I I I I I I I  I I II I I I I I I I I I I I I I I I I I I I I I I I
ATGCCTTCTTCAAGT66C-AGACCAAGCCAAAGCTGACCATCCATGGG6ACCTGTACTAT 
1700 • . 1710 . 1720 1730 1740 1750
400 410 420 430 440 450
GAGGGGAAGG-TTTCCANACACNANTGAAGGANAANAACCCAGGAAATCTNTCTGATNAC
I II I M I I I I I I I I II II I M I I I I I I | | f M I I I II I I I II I I I III I f II II I I III I II I I I I I I I II II II 11 M I I I I II • I I II I I t
GA6G6GAA6GA6TTCGA6ACACGACTGAAG6AGAAGAA6CCA6GAGATCT6TCF6AT6A6 
1760 1770 .1780 1790 1800 1810
460 470 480 490 500
CTAAG6AJT--CTTG6GGATNCCCATTNGGGCCAAAT6-CCANAA66TC . . .
i t i ii i i i»j ii ii i ii i i i'm i it i i ii i i i ill i i i i iiit i i i i ii V, i i i i i i i ii i i i i ii i ii i i i i mi ii i i i i
S « 3 4 .Seq 
Hs413711
Sw34.Seq
Hs413711
3*34.Seq 
Hs413711
Sw34.Seq
Hs4l371l
5*34.Seq
Heterogenous nuclear ribonucleoprotein K
AC S74678;
Nl gZ41477
DT 20-MAY-1993 (Rel. 36, Created)
DT 20-HAY-1993 (Rel. 3 6 } Last updated. Version i)
DE heterogeneous nuclear ribonucleoprotein compis* L [human, isRNA. , . .
SCORES Initl: 1663 lnitn: 1738 Opt: 2007 z-score: 1949.5 E ( ): 0
?6,3Z identity in 432 bp overlao
40 50 60 ’0 SO 90
3*73.Sep ’ 6SATCCCCC6G5CTGCA66AATTCG6CftL3A6CTBA0TCTCCCfiTCAAA6'::AC8TGCACA
1 ’ | ! ! ! l  I I I I I I I : ! ! I I  ! ! 1 I i I I « I I 1
t 5 * I • I I \ \ 1 I M  I I » 1 I M  M  1 5 M  I » \
5746.78 AGAGTGCATAARGATCATCCTTGATCnATATCTGAGICTCCCATCAAfifiSACGTBCACA
720 730 .740 1 750 760 770
100 110 120 170 140 150
3w73,Seq 6CCT7AT6ATCCCAArTTTTAC8AT8AAfiCCFATSHTTHT6S7SGrrrTACAArSArsrT
I I I I I I I I I I I I I I I I I  I I I I I I I I  I M  I I • I 1 I ! !  I I I I I  ! I ! I I I I I I i I I ! I I  I I i I
| I I | 1 | M  II I I I • II 1 II I II 1 I I 1 M  I ; I » I •. »•! 1 » J I » I 1 I I t 1 1.1 I I I I * » M  I M
374678 GCCrTATGATCCCAArTTrTACGA[5AAACCTAr€ATTArGSrGSTr rTAMArSArSTr
780 790 • 800 810 820. * 830
160 170 ISO 190 200 210
5*73.Seq • TBATGACCGTCBCeGACGCCCAaTGGGATTTCCCATGCGGGGAA&ABGTBGTTTTBACAG
! I I I 1 I M  I » I \ I : I 1 I ». I M  I ! M  » ! 1 t I ' I I I t I I I I ! ! * I I I I V  « • M  ! ! I 5 • I I
I I i i ! i r M  i i i »i ii ' i 1 I i * •; i i i I i ‘ 1 M  i I I i i i : i • i f T i i J  1 i i f » M  ; « • I
37467B t5ATBACCGTCGCGGACGCCCAGTB6SATTTCCCATGCBES5AABABBTBSTTTTSACA5
840 850 . 860 870 980 990
' 220 230. 240 250 260 2/0
5w73.5eq AATGCCTCCTG6TCB6SBT8S8C8TCCCATBCCTCC h TCTA8AASA6AT7ATBAT6 m TAT
I I I  I l  I I I  I I  i I I I I I I ■ i I I I 1 i I ! . • I i I i ; ' I I '  ■' I i I I I ■ ; > ! • ; I : .. I 1 I I I I 'i i i i i i i 11 i i i i i i i i i i i i i i i i i i • • f ; i m i 1.1 i i ii i ; ■ i i •- i i 1 i i i ; i 1 r i • ■ 1
374678 . AATBCCTCBTGSTCGGBGTIjBSaijCCCATPCCTC-CATCTASWfiArTATBATBATAT
900 910 920- 930 940 950
280 290 300 310 320 330
9*73,Seq 6AGCCCTCBTCGAN6ACCACCTCCCCCTCCTCCC66ACNAAGC6Et[6GG6T6GTAHCAA
• M  • I * M  M  ! J I I ! M  I M  5 I ». II I ! » M  ! : 1 ! * I 1 t I M  1 I M  I : ! I ! J f ‘ I
I It I I M  M  I I I I I I I I I I 1 I I I I I I I ! I I I I ! ' I » I I »l I I > I ! M  ! « M  I ? ft
5746.78 • GA6CCCTCBTCBABGACCACCTCCCCCTCC7CCCBBACSAGGCEGCCBG5GTBGTA6CAG
960 970 980 . 999 1000 1010
: 340 350 360 370 380 390
!SN73.Seq AGCTCGGAATCTTCCTCTTCCTCCAACAACAACACCTAIIAHGBBGASACCTCATGBCCT h
I I | II I I I I II M  I I I I U  I I II I I ' f I I 1 t f M  f I I i I I | I II I I I I I M  H  1 I
I 1 i i I t I f i I I 1 I / r » I : I M  I1 II : • |» f i l l * !  iJ I 1 I » I » I l / I I t i « t I » r
574678 ASCTCSGAATCTTCCTCTTCCTCCACCACCACCACCT^A638GSABACCTCAT66CCTft
1020 1030 1040 1050 1060 1070
400. 410 420 430 M O  450
5«73,Seq TGACA6AAGAABGABACCT5BAA3ACCeTTACGACeGCATC-GTTG6TTTCAAT6CT6AT5
i ! » t * ’ I * ! ? M  : i : ' • : : • • i • 1 t m  l I • * m  1 ! 1 • i !’ 1 M  I ‘ i ’ m  • » i .» • • ! f
> f I I M  I I I I ) I I I } 1 I I I 1 ! M  M  f I 1 J I • I f I ! I I 1 » 5 I J 1 \ ! I I I I » I M  I » 1 »•
S'4678 T6ACABAAGABBGABACCTBG-AGACC6TTACtACGGCATGGTTBBTTTCA6T6C75ATG
1030 1090 1100 1110 1120 1130
--j 460 470 480 470 500
js«73.5?q AAACtrGBSACTCTBCAATAAGATACPTGGASCCCATCAHAA
j M  1 (I M. * I II II ! I M  ( I II I H I  I '• 1 I I I | | II III I I
! I I r M  > M  I f > I M  I f ’ T I M  I * I I I I t I I I | T f I f t f If
1574673 AAACTTGSSACTCTGCAAT-ASATACATGBAGCCCATCAGAATGGCAGATBGCTrA.T6AA
j \  • 1140 \  1150 1160 ' 1170 1180 1190
Transcriptional Coactivator ALY
Swl16.Seq 
Em H'j*il:Af047002
IP AF047002 standard; RNA; HUH; 993 BP.
<C AF047002;
HI g2896145
DT 20-FEB-1998 (Rel. 54, Created)
DT 20-FEB-1998 (Rel. 54, Last updated. V e r s i o n '1)
DE Homo sapiens transcriptional coacti v a t o r  ALY itRNA, partial cds. . . .
SCORES . Initl: 640 Initn: 1407 Opt:. 1764 z-score: 1569.1 E():
92.57. identity in.429 bp overlap
50 '60 70 . 90. 90 100
5*118.Seq GACCAGATCCTAGAACTAGTGGATCCCCC&GCTGCAG5--AATTCBGCACGAGCGGCfiC
t • ? II 'II . ! I I M  1 * I M  5 I
* i • r i t  j .» t » s  '• i * i i \
A f 047002 GG6GC6CA66CC6CCGC5CGA8TGAATCBAG5CGGC666CCCATCC&GAAC— CB6C-C
50 60 70 80 90 100
110 ' 120 170' ■ 140 130 / It-)
3wll9.Seq GABCCATCGCCCSCGGCBCGSCCGGCaBABBCGBCABGAACCGACCBGCSCCCTACAGCA
! «. I I I I I I I t I I I I I II 1 I M  ' I 1 : 1 M  1 I I M  I1 x 1 ! i11 I ■» I I M  1 • * I i : { : •
1 • f I I i r I I i M  : r i i |  |  j | |  » t  i i I i » » • J « • i s ? •, , | |  i » » i : , , . j ; , , , i • , . ,
Af04?002 B-GECATCeCCCGCGBCGCSBCCBGCGGARBCSGCAGSAACCSACCGSCSCCCTACAGCA
110 120 130 140 150 let1
170 180 ' 190 -200 210 220
3*11B.SEq GGCCAAAACAACnC C C 5 A C A A G T B 6 C A G C A C 5 6TCTTTTCBACABT60CTTC6SCGST8
f f'l I II IS M  • ! t » f * I S ' II 1 • ' I '. I ! ! !: 1f ? r 1 ! ! » I! I ! ! 1 I : L M  M  ? ?
t I f I I I 1 > I > 1 *. I 1 I i t M  I • 1 : > I M  | 1 l 1 > t |  I 1 : i I * | 1 .  |  ) |  f I , I t 1 I ; t • f ,
Af047002 ' GGCCAAAACAACTTCCCGACAAGTBBCAGCACGATCTTTTCGACAGTBGCTTCcGiSSIG 
170 ' 100 . 1=0 200 210 220
230- 240 250 260 270 260
S w l 18.Seq ' GTGCCBSCGTTGBAGACABGrGRGAMCTOCTGBrGTCCAATCTSBAT TTTSGAGTCTCA
I * M  1 t II I I I M  M  M  it 1 1 I » M  I M  I ! f ! M  I M  I • II I M  I I M  I I I! I M  « I M  
! ' M  ! I I I 1 I I M I M I I I I M ’ !!! l l l ' M ! | | ' i | | | ]  i i i i t . M M I  ! M I I ! l
Af047002 GTGCCSSCe-TSSAGACABGTGSGAAACTGCTGBTGTCCAArCtGGATTTTGGAGTCTCA
230 240 250 260 -270 280
290 300 310 320 330 340
5*118.Seq ■GACGCCGATATTCAASGAACTCTTlGCT6AATTTeGAACGCTGAAGAAHGC6eCTGTGCA
. M  M  I * t 11 *. 1 M  ! ! I t I 1 I » I ! I : M  f I I 1 M  I M  1 t ! I t I * M  ! ! I 1 ! ! ! ! I I I t l
I I l l  I I I I I I I I I I I I I I I ! I I I  I I I  I I I M  I '  I ! I I I I I  I ' . ! !  I I ! I I  I * I I I I I I I
Af047002 6ACGCCBATATTC-A6GAACTCTTTGCTGAATTTBGAACGCTBAA6AAG6CBGCTBTGCA
290 300 310 320 330 340
350 760 37u 380 390 400
Swl 13.Seq CTAT6ATC0C TC TGG TCCCAAC T TAA8AACAACANAC3 T6CAC T TT6AACCSSAAA0SCA
I ' ' ! I I I I I  I I I I I I ■ I I ! ! 1 I I I I I I ' I  I I t I I I ■ I I 1 I I ! i I I I ■ I I
i i i I i ; i ■ i i  i i ;  i t • > i i  i ' > i i i i i i i i I ' '  i i i i I • ) , i i i i i i i t  I i
af047002 CTATGArCGCTCTGGTCGCAGCTTAGBAACHSCAAACSTGCACTTTGABC— GSAASGCA
350 360 . 370 380 390
410 ■ 420 430 440 450 460
Swl18.Seq AATGCCCTGAANGCCATBAANCAANTACAfiCCGECGTLCCTCTGGATGGCCGCCCCATGA
! 1 I t I 11 ! I I I 1 It 1 t I ' I It ! M  11 • ! ‘• I \ I ! ! M  • I M  M  I ». I ! I 1 \ I • !
’ • ' » i i i « * i i ' r  i  i • ' t i i i i \  » t » » i i i • i « i j ,* i i i ,* i t i : i f  i i  i x ' n  i
Af047002 GATSCCCTGAA6GCCATGAAGC-ABTACfiA-CBECTTCCCTCTGGATGGCCGCCCCATGA
400 410 ' 420 430 440 450
‘ 470 480 490 500
Swl13,Seq ACATTCASETTBTCACGTCACAGATTGACGCflCAACQGA
i I I II I I I i iVj I I I I I II ! I I I M  I M  I I I II I I I lilt
1 '  ' I I I I I I ? , M  I I I  I • I I  M  I I  I I I ! I I I I i I I I I J I
■sfniTnn? aranrflRfTTCTnirfiTrflr.fiRflTTRAnRrArHfir.fiAAfiPrrJBCACASAGCGTAAACA
BIBLIOGRAPHY
Ackerman, M., Braun, D., Pereira, K. & Roizman, B. (1984). Characterisation of
Herpes Simplex 1 a  proteins 0, 4 and 27 with monoclonal antibodies. Journal 
o f Virology 52, 108-118.
Allende, J. E. & Allende, C. C. (1995). Protein kinase CK2: An enzyme with multiple 
substrates and a puzzling regulation. FASEBJ9 , 313-323.
Atwater, J. A., Wilson, R. & Verma, I. M. (1990). Regulated mRNA stability. Annual 
Review Genetics 24, 519-541.
Bachvarova, R. F. (1992). A maternal tail of poly(A). The long and short of it. Cell 
69, 895-897.
Bagga, P. S., Arhin, G. K. & Wilusz, J. (1998). DSEF-1 is a member of the hnRNP H 
family of RNA-binding proteins and stimulates pre-mRNA cleavage and 
polyadenylation in vitro. Nucleic Acids Research 26, 5343-50.
Bartel, P. L., Chien, C.-T., Stemglanz, R. & Fields, S. (1993). Using the two-hybrid 
system to detect protein-protein interactions. In Cellular Interactions in 
Development: A Practical Approach, pp. 153-179. Edited by D. A. Hartley. 
Oxford: Oxford University Press.
Beier, D. R. & Young, E. T. (1982). Characterization of a regulatory region upstream 
of the ADR2 locus of S. cerevisiae. Nature 300, 724-728.
Bello, L. J., Davison, A. J., Glenn, M. A., Whitehouse, A., Rethmeier, N., Schulz, T. 
F. & Clements, J. B. (1999). The human herpesvirus-8 ORF 57 gene and its 
properties. Journal o f General Virology 80, 3207-3215.
136
Blaho, J., Mitchell, C. & Roizman, B. (1993). Guanylylation and adenylation of the a  
regulatory proteins of herpes simplex virus require a viral P or y function. 
Journal o f Virology 67, 3891-3900.
Block, T. M., Deshmane, S., Masonis, J., Maggioncaldo, J., Valyi-Nagi, T. & Fraser, 
N. (1993). A herpes simplex virus type-1 latency-associated transcript mutant 
reactivates with normal kinetics from latent infection. Journal o f  Virology 64, 
3714-3426.
Block, T. M. & Hill, J. M. (1997). The latency associated transcripts (LAT) of herpes 
simplex virus: still no end in sight. Journal o f Neurovirology 3, 313-321.
Bogerd, H. P., Fridell, R. A., Madore, S. & Cullen, B. R. (1995). Identification of a 
novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. 
Cell 82,485-494.
Bomsztyk, K., Seuningen, I. V., Suzuki, H., Denisenko, O. & Ostrowski, J. (1997). 
Diverse molecular interactions of the hnRNP K protein. FEBS Letters 403, 
113-115.
Boyle, S. M., Ruvolo, V., Gupta, A. K. & Swaminathan, S. (1999). Association with 
the cellular export receptor CRM1 mediates function and intracellular 
localisation of Epstein-Barr virus SM protein, a regulator of gene expression. 
Journal o f Virology 73, 6872-6881.
Brent, R. & Ptashne, M. (1985). A eukaryotic transcriptional activator bearing the 
DNA specificity of a prokaryotic repressor. Cell 43, 729-736.
Bridge, E., Carmo-Fonseca, M., Lamond, A. I. & Petersson, U. (1993). Nuclear 
organisation of splicing snRNPs in adenovirus-infected cells. Journal o f  
Virology 67, 5792-5802.
137
Brosi, R., Groning, K., Behrens, S.-E., Luhrmann, R. & Kramer, A. (1993a). 
Interaction of mammalian splicing factor SF3a with U2 snRNP and 
relationship of its 60-kD subunit to yeast PRP9. Science 262, 102-105.
Brosi, R., Hauri, H. P. & Kramer, A. (1993b). Separation of splicing factor SF3 into 
two compartments and purification of SF3a activity. Journal o f Biological 
Chemistry 1993,17640-17646.
Brown, C. R., Nakamura, M. S., Mosca, J., Hayward, G. S., Straus, S. E. & Perera, L. 
P. (1995). Herpes simplex virus trans-regulatory protein ICP27 stabilizes and 
binds to 3' ends of labile mRNA. Journal o f Virology 69, 7187-7195.
Bruhn, L., Munnerlyn, A. & Grosschedl, R. (1997). ALY, a context-dependent
coactivator of LEF-1 and AML-1 is required for TCR alpha enhancer function. 
Genes and Development 11, 640-653.
Bruni, R. & Roizman, B. (1996). Open reading frame P - a herpes simplex virus gene 
repressed during productive infection encodes a protein that binds a splicing 
factor and reduces synthesis of viral proteins made from spliced mRNA. 
Proceedings o f  National Academy o f Sciences. USA 93, 10423-10427.
Buchenau, P., Saumweber, H. & Amdt-Jovin, D. J. (1997). The dynamic nuclear
redistribution of an hnRNP K-homologous protein during Drosphila embryo 
development and heat shock. Flexibility of transcription sites in vivo. Journal 
o f Cell Biology 137, 291-303.
Buisson, M., Hans, F., Kusters, I., Duran, N. & Sergeant, A. (1999). The C-terminal 
region but not the arg-x-pro repeat of Epstein Barr virus is required for its 
effect on RNA splicing and transport. Journal o f Virology 73, 4090-4100.
138
Bustello, X. R., Suen, K., Michael, W. M., Dreyfuss, G. & Barbacid, M. (1995).
Association of the vav proto-oncogene product with poly(rC)- specific RNA- 
binding proteins. Molecular Cell Biology 15, 1324-1332.
Byrappa, S., Pan, Y. B. & Gupta, K. C. (1996). Sendai virus P protein is constitutively 
phosphorylated at serine 249: High phosphorylation potential of the P protein. 
Virology 216, 228-234.
Caceres, J. F., Screaton, G. R. & Krainer, A. R. (1998). A specific subset of SR
proteins shuttles continuously between the nucleus and the cytoplasm. Genes 
and Development 12, 55-66.
Cai, W., Astor, T. L., Liptak, M., Cho, C., Coen, D. M. & Schaffer, P. A. (1993). The 
herpes simplex virus type 1 ICPO enhances virus replication during acute 
infection and reactivation from latency. Journal o f Virology 67, 7501-7512.
Campbell, M. E. M., Palfreyman, J. W. & Preston, C. M. (1984). Identification of 
herpes simplex virus sequences which encode a trans-acting polypeptide 
responsible for stimulation of immediate-early gene transcription. Journal o f  
Molecular Biology 180, 1-19.
Cao, W., Jamison, S. F. & Garcia-Bianco, M. A. (1997). Both phosphorylation and 
dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro. 
RNA 3, 1456-1467.
Challberg, M. D. (1991). Herpes simplex virus DNA replication. Seminars in 
Virology 2, 247-256.
Champion-Amaud, P. & Reed, R. (1996). The prespliceosome components SAP49 
and SAP 145 interact in a complex implicated in tethering U2 snRNP to the 
branch site. Genes and Development 8, 1974-1983.
139
Chang, D. D. & Sharp, P. A. (1990). Regulation of HIV depends upon recognition of 
splice sites. Cell 59, 789-795.
Chen, F., MacDonald, C. & Wilusz, J. (1995). Cleavage site determinants in a
mammalian polyadenylation signal. Nucleic Acids Research 23, 2614-2620.
Chen, J., Zhu, X. & Silverstein, S. (1991). Mutational analysis of the sequence 
encoding ICPO from herpes simplex virus type 1. Virology 180, 207-220.
Choo, Y. & Klug, A. (1997). Physical basis of a protein-DNA recognition code. 
Current Opinion in Structural Biology 7, 117-125.
Ciufo, D. M., Mullen, M.-A. & Hayward, G. S. (1994). Identification of a
dimizeration domain in the C-terminal segment of the IE110 trans-activator 
protein from herpes simplex virus. Journal o f Virology 68, 3267-3282.
Clements, J., Watson, R. & Wilkie, N. (1977). Temporal regulation of herpes simplex 
virus type 1 transcription : location of transcripts on the viral genome. Cell 12, 
275-285.
Colas, P., Cohen, B., Jessen, T., Grishina, I., McCoy, J. & Brent, R. (1996). Genetic 
selection of peptide aptamers that recognize and inhibit cyclin-dependent 
kinase 2. Nature 380, 548-550.
Collier, B., Goobar-Larsson, L., Sokolowski, M. & Schwartz, S. (1998). Translational 
inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated 
through interaction with herogenous ribonucleoprotein K and poly(rC)-binding 
proteins 1 and 2. Journal o f Biological Chemistry 273, 22648-22656.
Constanzo, F., Campadelli-Fiume, G., Foa-Thomas, L. & Cassai, E. (1977). Evidence 
that herpes simplex virus DNA is transcribed by cellular RNA polymerase II. 
Journal o f Virology 21, 996-1001.
140
Cooper, M., Goodwin, D., Hall, K., Stevenson, A., Meredith, D., Markham, A. & 
Whitehouse, A. (1999). The gene product encoded by ORF57 of herpesvirus 
saimiri regulates the redistribution of the splicing factor SC-35. Journal o f  
General Virology 80, 1311-1316.
Curtin, K. D. & Knipe, D. M. (1993). Altered properties of the herpes simplex virus 
ICP8 binding protein in cells infected with ICP27 mutant viruses. Virology 
196, 1-14.
Dargan, D. J., Patel, A. H. & Subak-Sharpe, J. H. (1995). PREPS - Herpes simplex 
virus type 1 specific particles produced by infected cells when viral-DNA 
replication is blocked. Journal o f Virology 69,4924-4932.
Davies, R. C., Calvio, C., Bratt, E., Larsonn, S. H., Lamond, A. I. & Hastie, N. D. 
(1999). WT1 interacts with the splicing factor U2AF65 in an isoform- 
dependent manner and can be incorporated into spliceosomes. Genes and 
Development 20, 3217-3225.
Davis, L. I. (1995). The nuclear pore complex. Annual Review Biochemistry 64, 865- 
896.
Davison, A. J. & Wilkie, N. M. (1983). Nucleotide sequences of the join between the 
L and S segments of herpes simplex virus type 1 and 2. Journal o f  General 
Virology 55, 315-331.
Defechereux, P., Debrus, S., Baudoux, L., Rentier, B. & Piette, J. (1997). Varicella- 
zoster virus open reading frame 4 encodes an immediate early protein with 
posttranscriptional regulatory properties. Journal o f  Virology 71, 7073-7079.
Dejgaard, K., Leffers, H., Rasmussen, H. H., Madsen, P., Kruse, T. A., Gesser, B.,
Nilesen, H. & Celis, J. E. (1994). Identification, molecular cloning, expression 
and chromosome mapping of a family of tranformation upregulated hnRNP-K
141
proteins derived by altnerative splicing. Journal o f Molecular Biology 236, 33- 
48.
Delius, H. & Clements, J. B. (1976). A partial denaturation map of herpes simplex 
virus type 1 DNA: evidence for inversions of the unique DNA regions.
Journal o f General Virology 33, 125-133.
Denisenko, O. N., O'Neill, B., Ostrowski, J., Seuningen, I. V. & Bomsztyk, K. (1996). 
Zikl, a transcriptional repressor that interacts with the heterogenous nuclear 
ribonucleoprotein particle K protein. Journal o f  Biological Chemistry 271, 
27701-27706.
Deshmane, S. L., Nicosia, M., Valyi-Nagy, T., Feldman, L. T., Dillner, A. & Fraser,
N. W. (1993). An HSV-1 mutant lacking the LAT TATA element reactivates 
normally in explant cocultivation. Virology 196, 868-872.
Dixon, R. & Schaffer, P. (1980). Fine structure mapping and functional analysis of 
temperature sensitive mutants in the gene encoding the herpes simplex virus 
type 1 immediate early protein VP 175. Journal o f Virology 36, 189-203.
Dobbelstein, M., Roth, J., Kimberly, W. T., Levine, A. J. & Shenk, T. (1997). Nuclear 
export of the ElB-kDa and E4 34-kDa adenoviral oncoproteins mediated by a 
Rev-like signal sequence. EM B O J16, 4276-4284.
Dobson, A. T., Sederati, F., Devi-Rao, G., Flanagan, J., Farrell, M. J., Stevens, J. G., 
Wagner, E. K. & Feldman, L. T. (1989). Identification of the latency- 
associated transcript promoter by expression of rabbit beta-globin mRNA in 
mouse sensory nerve ganglia latently infected with a recombinant herpes 
simplex virus. Journal o f Virology 63, 3844-3851.
Eggleton, P., Ghebrehiwet, B., Sastry, K. N., Cobum, J. P., Zaner, K. S., Reid, K. B.
& Tauber, A. I. (1995). Identification of a gClq-binding protein (gclq-R) on
142
the surface of human neutrophils. Subcellular localization and binding 
properties in comparison with the cClq-R. Journal o f  Clinical Investigation 
95, 1569-1578.
Estojak, J., Brent, R. & Golemis, E. (1995). Correlation of two-hybrid affinity data 
with in vitro measurements. Mollecular and Cellular Biology 15, 5820-5829.
Everett, R. D. (1984). Trans activation of transcription by herpes virus products: 
requirement for two HSV-1 immediate-early polypeptides for maximum 
activity. E M B O J13, 3135-3141.
Fearon, E. R., Finkel, T., Gillison, M. L., Kennedy, S. P., Casella, I., Tomaselli, G. F., 
Morrow, J. S. & Van, D. C. (1992). Karyoplasmic interaction selection 
strategy: A general strategy to detect protein-protein interactions in animal 
cells. Proceedings o f  the National Academy o f  Science. USA. 89, 7958-7962.
Fields, S. & Song, O. (1989). A novel genetic system to detect protein-protein 
interactions. Nature 340, 245-246.
Fischer, U., Darzynkiewicz, E., Tahara, S. M., Dathan, N. A., Luhrmann, R. & Mattaj, 
I. W. (1991). Diversity in the signals required for nuclear accumulation of U 
snRNPs and vareity in the pathways of nuclear transport. Journal o f  Cell 
Biology 113, 705-714.
Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W. & Luhrmann, R. (1995). The
HIV-1 Rev activation domain is a nuclear export signal that accesses an export 
pathway used by specific cellular RNAs. Cell 82, 475-483.
Flint, J. & Shenk, T. (1997). Viral transactivating proteins. Annual Review o f Genetics 
31, 177-212.
143
Fortes, P., Lamond, A. I. & Ortin, J. (1995). Influenza virus NS1 protein alters the 
subnuclear localisation of cellular splicing components. Journal o f  General 
Virology 76, 1001-1007.
Fridell, R. A., Fischer, U., Luhrmann, R., Meyer, B. E., Meinkoth, J. L., Malim, M. H. 
& Cullen, B. R. (1996). Amphibian transcription factor IIIA proteins contain a 
sequence element functionally equivalent to the nuclear export signal of 
human immunodeficiency virus type 1 Rev. Proceedings o f the National 
Academy o f Science USA 93,2936-2940.
Frink, R. J., Eisenberg, R., Cohen, G. & Wagner, E. K. (1983). Detailed analysis of 
the portion of the herpes simplex virus type 1 genome encoding glycoprotein
C. Journal o f  Virology 45, 634-647.
Fritz, C. C., Zapp, M. L. & Green, M. R. (1995). A human nucleoporin-like protein 
that specifically interacs with HIV Rev. Nature 376, 530-533.
Fu, X. D. (1995). The superfamily of arginine/serine-rich splicing factors. RNA 1, 
663-680.
Fuller, A. O. & Lee, W. C. (1992). Herpes simplex virus type-1 entry through a 
cascade of virus-cell interactions requires different roles of gD and gH in 
penetration. Journal o f Virology 66, 5002-5012.
Gaffney, D. F., McLauchlan, J., Whitton, J. L. & Clements, J. B. (1985). A modular 
system for the assay of transcription regulatory signals: the sequence 
TAATGARAT is required for herpes simplex virus immediate-early gene 
activation. Nucleic Acids Research 13, 7874-7882.
Gaillard, C., Weber, M. & Strauss, F. (1988). A sequence specific single-strand
binding protein for the late coding strand of the simian virus-40 control region. 
Molecular Cell Biology 62, 2380-2385.
Gallinari, P., Wiebauer, K., Nardi, M. C. & Jiricny, J. (1994). Localization of a 34- 
amino-acid segment implicated in dimerization of the herpes simplex virus 
type 1 ICP4 polypeptide by a dimerization trap. Journal o f  Virology 68, 3809- 
3820.
Ghebrehiwet, B., Lu, P. D., Zhang, W., Keilbaugh, S. A., Leigh, L. E., Eggleton, P., 
Reid, K. B. & Peerschke, E. I. (1997). Evidence that the two C lq binding 
membrane proteins, gClq-R and cClq-R, associate to form a complex.
Journal o f  Immunology 159, 1429-1436.
Gozani, O., Feld, R. & Reed, R. (1996). Evidence that sequence-independent binding 
of highly conserved U2 snRNP proteins upstream of the branch site is required 
for assembly of splicesomal complex A. Genes and Development 8, 1974- 
1983.
Guerra, B. & Issinger, O. (1999). Protein Kinase CK2 and its role in cellular
proliferation, development and pathology. Electrophoresis 20, 391-408.
Guo, N. (1997). Assignment of C1QBP encoding the Clq globular domain binding 
protein (gClq-R) to human chrosome 17 band p i3.3 by in situ hybridization. 
Cytogenetics and Cell Genetics 77, 283-284.
Gupta, A. K., Ruvolo, V., Patterson, C. & Swaminathan, S. (2000). The human 
herpesvirus 8 homologue of Epstein-Barr virus SM protein is a 
posttranscriptional activator of gene expression. Journal o f  Virology 74, 1038- 
1044.
Hamm, J. & Mattaj, I. W. (1990). Monomethylated cap structures facilitate RNA 
export from the nucleus. Cell 63, 109-118.
145
Hardwicke, M. A. & Sandri-Goldin, R. M. (1994). The herpes simpex virus regulatory 
protein ICP27 contributes to the decrease in cellular mRNA levels during 
infection. Journal o f  Virology 68,4797-4810.
Hardy, W. R. & Sandri-Goldin, R. M. (1994). Herpes simplex virus inhibits host cell 
splicing, and regulatory protein ICP27 is required for this effect. Journal o f  
Virology 68, 7790-7799.
Harris, R. A., Everett, R. D., Zhu, X., Silverstein, S. & Preston, C. M. (1989). Herpes 
simplex virus type 1 immediate-early protein Vmwl 10 reactivates latent 
herpes simplex virus type 2 in an in vitro latency system. Journal o f Virology 
63,3513-3515.
Hayward, S. D., Jacob, R. J., Wadsworth, S. C. & Roizman, B. (1975). Anatomy of 
herpes simplex virus DNA: evidence for four populations of molecules that 
differ in the relative orientations of their long and short components. 
Proceedings o f  the National Academy o f Science, USA 72,4243-4247.
Hermann, H., Frabrizio, P., Raker, V. A., Foulaki, K., Homig, H., Brahms, H. &
Luhrmann, R. (1995). snRNP Sm proteins share two evolutionary conserved 
sequence motifs which are involved in Sm protein-protein interactions. EMBO 
J 14, 2076-2088.
Hibbard, M. & Sandri-Goldin, R. M. (1995). Arginine-rich regions succeeding the 
nuclear localization region of herpes simplex virus type 1 regulator protein 
ICP27 are required for efficient nuclear localization and late gene expression. 
Journal o f Virology 69,4656-4667.
Hill, J. M., Sedarati, F., Javier, R. T., Wagner, E. K. & Stevens, J. G. (1990). Herpes 
simplex virus latent phase transcription facilitates in vivo reactivation.
Virology 174, 117-125.
Hirose, Y. & Manley, J. L. (1998). RNA polymerase II is an essential mRNA 
polyadenylation factor. Nature 395, 93-96.
Hodges, P. E. & Beggs, J. D. (1994). U2 fills a committment. Current Biology 4, 264- 
267.
Honess, R. W. & Roizman, B. (1974). Regulation of herpesvirus macromolecular
synthesis. Cascade regulation of the synthesis of three groups of viral proteins. 
Journal o f Virology 14, 8-19.
Hope, I. A. & Struhl, K. (1986). Functional dissection of a eukaryotic transcriptional 
activator protein, GCN4 of yeast. Cell 46, 885-894.
Hope, T. J., Klein, N. P., Elder, M. E. & Parslow, T. G. (1992). Trans-dominant 
inhibition of human immunodeficiency virus type 1 Rev occurs through 
formation of inactive protein complexes. Journal o f  Virology 66, 1849-1855.
Hsieh, T., Matsumoto, M., Chou, H., Schneider, R., Hwang, S., Lee, A. & Lai, M. 
(1998). Hepatitis C virus core protein interacts with heterogenous 
ribonucleoprotein K. Journal o f Biological Chemistry 273, 17651-17659.
Huang, Y., Wimler, K. M. & Carmichael, G. G. (1999). Intronless mRNA transport 
elements may affect multiple sites of pre-mRNA processing. EMBO J 18, 
1642-1652.
Ingram, A., Phelan, A., Dunlop, J. & Clements, J. B. (1996). Immediate early protein 
IE63 of herpes simplex virus type 1 binds RNA directly. Journal o f General 
Virology 77.
Jackson, R. J. & Standart, N. (1990). Do the poly(A) tail and 3' untranslated region 
control mRNA translation. Cell 62, 15-24.
Jang, K. & Latchman, D. (1992). The herpes simplex virus immediate early protein 
ICP27 stimulates the transcription of cellular Alu repeated sequences by
147
increasing the activity of transcription factor TFIIIC. Biochemical Journal 284, 
667-673.
Javier, R. T., Stevens, J. G., Dissette, V. B. & Wagner, E. K. (1988). A herpes
simplex virus transcript abundant in latently infected neurons is dispensable 
for establishment of the latent state. Virology 166, 254-257.
Kalderon, D., Richardson, W. D., Markham, A. F. & Smith, A. E. (1984). Sequence 
requirements for nuclear localisation of SV40 large T antigen. Nature 311, 33- 
38.
Kalland, K. H., Szilvay, M., Brokstad, K. A., Saetrevik, W. & Haukenes, G. (1994). 
The human immunodeficiency virus type 1 Rev protein shuttles between the 
cytoplasm and nuclear compartments. Molecular Cell Biology 14, 7436-7444.
Kanopka, A., Muhlemann, O., Petersen-Mahrt, S., Estmer, C., Ohrmalm, C. &
Akusjarvi, G. (1998). Regulation of adenovirus alternative RNA splicing by 
dephosphorylation of SR proteins. Nature 393,185-187.
Kim, F. J., Beeche, A. A., Hunter, J. J., Chin, D. J. & Hope, T. J. (1996).
Characterization of the nuclear export signal of human T-cell lymphotrophic 
virus type 1 Rex reveals that nuclear export is mediated by position-variable 
hydrophobic interactions. Molecular Cell Biology 1996, 5147-5155.
Kinchington, P. R., Bookey, D. & Turse, S. E. (1995). The transcriptional regulatory 
proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 
63 but not ORF61 are associated with purified virus particles. Journal o f  
Virology 69,4274-4282.
Krainer, A. R., Conway, G. & Kozak, D. (1990). Purification and characterisation of 
SF2, a human pre-mRNA splicing factor. Genes and Development 4, 1158- 
1171.
148
Krainer, A. R., Mayeda, A., Kozak, D. & Binns, G. (1991). Functional expression of 
cloned human splicing factor SF2 influences 5' splice site selection by 
activating proximal sites. Cell 62, 35-42.
Kramer, A. (1996). The structure and function of proteins involved in mammalian 
pre-mRNA splicing. Annual Review o f Biochemistry 65, 367-409.
Kristensson, K., Lycke, E., Ryotta, M., Svennerholm, B. & Vahlne, A. (1986).
Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. 
Effects of substances interacting with microtubular function and axonal flow. 
Journal o f General Virology 67, 2023-2028.
Ladomery, M. (1997). Multifunctional proteins suggest connections between
transcriptional and post-transcriptional processes. Bioessays 19, 903-909.
Leib, D. A., Bogard, C. L., Kosz-Vnenchak, M., Hicks, K. A., Coen, D. M., Knipe, D. 
M. & Schaffer, P. A. (1989). A deletion mutant of the latency associated 
transcript of herpes simplex virus type-1 reactivates from the latent infection. 
Journal o f Virology 63, 2893-2900.
Lieb, D. A., Coen, D. M., Bogard, C. L., Hicks, K. A., Yager, D. R., Knipe, D. M., 
Tyler, K. L. & Schaffer, P. A. (1989). Immediate-early regulatory gene 
mutants define different stages in the establishment and reactivation of herpes 
simplex virus latency. Journal o f Virology 63, 759-768.
Lin, A., Frost, J., Deng, T., Smeal, T., al-Alawi, N., Kikkawa, U., Hunter, T., Brenner, 
D. & Karin, M. (1992). Casein kinase-II is a negative regulator of C-Jun DNA- 
binding and AP-1 activity. Cell 70, 777-789.
Liu, Q. & Dreyfuss, G. (1995). In vivo and in vitro arginine methylation of RNA- 
binding proteins. Molecular Cell Biology 15, 2800-2808.
149
Luhrman, R., Kastner, B. & Bach, M. (1990). Structure of spliceosomal snRNPs and 
their role in pre-mRNA splicing. Biochim Biophys Acta 1087, 265-292.
Luo, Y., Yu, H. & Peterlin, B. M. (1994). Cellular protein modulates effects of human 
immunodeficiency virus type 1 Rev Journal o f  Virology 68, 3850-3856.
Ma, J. & Ptashne, M. (1988). Converting a eukaryotic transcriptional inhibitor into an 
activator. Cell 55, 443-446.
MacDonald, C., Wilusz, J. & Shenk, T. (1994). The 64 kilodalton subunit of the CstF 
polyadenylation factor binds to pre-mRNA downstream of the cleavage site 
and influences cleavage site location. Molecular and Cellular Biology 14, 
6647-6654.
Mackay, J. P. & Crossley, M. (1998). Zinc fingers are sticking together. Trends in 
Biochemical Science 23, 1-4.
Manley, J. & Tacke, R. (1996). SR proteins and splicing control. Genes and 
Development 10, 1569-1579.
Marais, R. M., Hsuan, J., McGuigan, C., Wynne, J. & Treisman, R. (1992). Casein 
Kinase-II phosphorylation increases the rate of serum response factor-binding 
site exchange. E M B O J11, 97-105.
Martin, T. E., Barghusen, S. C., Leser, G. P. & Spear, P. G. (1987). Redistribution of 
the nuclear ribonucleoprotein antigens during herpes simplex virus infection. 
Journal o f Cell Biology 105.
Massimi, P., Pirn, D., Storey, A. & Banks, I. (1996). HPV-16 E7 and adenovirus E la 
complex formation with a TATA box binding protein is enhanced by casein 
kinase II phosphorylation. Oncogene 12, 2325-2330.
150
Matthews, D. A. & Russell, W. C. (1998). Adenovirus core protein V interacts with 
p32 - a protein which is associated with both the mitochondria and the 
nucleus. Journal o f General Virology 79, 1677-1685.
Matunis, M. J., Michael, W. M. & Dreyfuss, G. (1992). Characterization and primary 
structure of the poly(c)-binding heterogenous nuclear ribonucleoprotein 
complex K-protein. Molecular Cell Biology 12,164-171.
McCarthy, A. M., McMahan, L. & Schaffer, P. A. (1989). Herpes simplex virus type 1 
ICP27 deletion mutants exhibit altered patterns of transcription and are DNA 
defficient. Journal o f  Virology 63, 18-27.
McGeoch, D. J., Cook, S., Dolan, A., Jamieson, F. E. & Telford, E. A. R. (1995).
Molecular phylogeny and evolutionary timescale for the family of mammalian 
herpesviruses. Journal o f Molecular Biology 257,443-458.
McGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C., McNab,
D., Perry, L. J., Scott, J. E. & Taylor, P. (1988). The complete DNA sequence 
of the long unique region in the genome of HSV-1. Journal o f  General 
Virology 69, 1531-1574.
McGregor, F., Phelan, A., Dunlop, J. & Clements, J. B. (1996). Regulation of herpes 
simplex virus type 1 poly(A) site usage and the action of the immediate-early 
protein IE63 in the early-late switch. Journal o f  Virology 70, 1931-1940.
McLauchlan, J., Simpson, S. & Clements, J. B. (1989). Herpes simplex virus induces 
a processing factor that stimulates poly(A) site usage. Cell 59, 1093-1105.
Mears, W. E., Lam, V. & Rice, S. A. (1995). identification of nuclear and nucleolar 
localization signals in the herpes simplex virus regulatory protein ICP27. 
Journal o f Virology 69, 935-947.
151
Mears, W. E. & Rice, S. A. (1996). The RGG motif of the herpes simplex virus ICP27 
protein mediates an RNA-binding activity and determines in vivo methylation. 
Journal o f Virology 70, 7445-7453.
Mears, W. E. & Rice, S. A. (1998). The herpes simplex virus immediate-early protein 
ICP27 shuttles between nucleus and cytoplasm. Virology 242, 128-137.
Meggio, F., Dagostino, D. M., Ciminale, V., Bianchi, L. C. & Pinna, L. A. (1996).
Phosphorylation of HIV-1 Rev protein: Implication of protein kinase CK2 and 
pro-directed kinases. Biochemical and Biophysical Research Communications 
226, 547-554.
Mellerick, D. M. & Fraser, N. W. (1987). Physical state of the latent herpes simplex 
virus genome in a mouse model system : evidence suggesting an episomal 
state. Virology 158, 265-275.
Mendelsohn, A. & Brent, R. (1994). Applications of interaction traps/two-hybrid
systems to biotechnology research. Current Opinion in Biotechnology 5,482- 
486.
Mendelsohn, A. & Brent, R. (1999). Protein interaction methods - towards an 
endgame. Science 284, 1948-1950.
Mermoud, J. E., Cohen, P. T. W. & Lamond, A. I. (1994). Regulation of mammalian 
spliceosome assembly by protein phoshporylation mechanism. EMBO J 13, 
5679-5688.
Meyer, B. E. & Halim, M. H. (1994). The HIV-1 Rev /ra«s-activator shuttles between 
the nucleus and the cytoplasm. Genes and Development 8, 1538-1547.
Meyer, B. E., Meinkoth, J. L. & Malim, M. H. (1996). Nuclear transport of human 
immunodeficieny virus type 1, visna virus, and equine infectious agent virus
Rev proteins: Identification of a family of nuclear export signals. Journal o f  
Virology 70, 2350-2359.
Miau, L., Chang, C., Shen, B., Tsai, W. & Lee, S. (1998). Identification of
heterogenous nuclear ribonucleoprotein K (hnRNP K) as a repressor of
C/EBPP -mediated gene activation. Journal o f Biological Chemistry 273, 
10784-10791.
Michael, N., Spector, D., Mavromara-Nazos, P., Kristie, T. M. & Roizman, B. (1988). 
The DNA-binding properties of the major regulatory protein a4 of herpes 
simplex virus. Science 239,1531-1534.
Michael, W. M., Eder, P. S. & Dreyfuss, G. (1997). The K nuclear shuttling domain:
A novel signal for nuclear import and nuclear export in the hnRNP K protein. 
EM B O J16, 3587-3598.
Michelotti, E. F., Michelotti, G. A., Aronsohn, A. I. & Levens, D. (1996). Multiple 
single-stranded cis elements are associated with activated chromatin of the 
human c-myc gene in vivo. Moelcular Cell Biology 16, 2350-2360.
Misteli, T. & Spector, D. L. (1997). Protein phosphorylation and the nuclear 
organisation of pre-mRNA splicing. Trends in Cell Biology 7, 135-138. 
Mitchell, C., Blaho, J., McCormick, L. & Roizman, B. (1997). The nucleotidylation of 
herpes simplex virus I regulatory protein a22 by human casein kinase II. 
Journal o f  Biological Chemistry 272, 25394-25398.
Muller, M. T. (1987). Binding of the herpes simplex virus immediate-early gene
product ICP4 to its own transcriptional start site. Journal o f  Virology 61, 858- 
865.
153
Murphy, R. & Wente, S. R. (1996). An RNA-export mediator with an essential 
nuclear export signal. Nature 383, 357-360.
Muta, T., Kang, D., Kitajima, S., Fujiwara, T. & Hamaski, N. (1997). p32 protein, a 
splicing factor 2-associated protein, is localized in mitochondrial matrix and is 
functionally important in maintaining oxidative phosphorylation. Journal o f  
Biological Chemistry 272, 24363-24370.
Neubauer, G., King, A., Rappsilber, J., Calvio, C., Watson, M., Ajuh, P., Sleeman, J., 
Lamond, A. & Mann, M. (1998). Mass spectrometry and EST-database 
searching allows characterization of the multi-protein spliceosome complex. 
Nature Genetics 20, 46-50.
Neville, M., Stutz, F., Lee, L., Davis, 1. & Rosbash, M. (1997). The importin-beta 
family member Crm lp bridges the interaction between Rev and the nuclear 
pore complex during nuclear export. Current Biology 7, 767-775.
Nicholades, N., Kinzer, K., Vogelstein, B. (1995). Analysis of the 5' region of PMS2 
reveals heterogenous transcripts and a novel overlapping gene. Genomics 29, 
329-334.
O'Hare, P. (1993). The virion transcription activator of herpes simplex virus. Seminars 
in Virology 4, 145-155.
O'Hare, P. & Hayward, G. S. (1985). Evidence for a direct role for both the 175,000- 
and 110,000-molecular-weight immediate-early proteins of herpes simplex 
virus in the transactivation of delayed-early promoters. Journal o f  Virology 53, 
751-760.
Ohtsuki, K., Maekawa, T., Harada, S., Karino, A., Morikawa, Y. & Ito, M. (1998). 
Biochemical characterization of HIV-1 Rev as a potent activator of casein 
kinase II in vitro. FEBS Letters 428, 235-240.
O'Neill, R. E., Talon, J. & Palese, P. (1998). The influenza virus NEP (NS2 protein) 
mediates the nuclear export of viral nucleoproteins. EMBO J 17, 288-296.
Ostareck, D. H., Ostareck-Lederer, A., Wilm, M., Thiele, B. J., Mann, M. & Hentze, 
M. W. (1997). mRNA silencing in erythroid differentiation: hnRNP K and 
hnRNP El regulate 15-Lipoxygenase Translation from the 3' end. Cell 89, 
597-606.
Ostrowski, J., Seuningen, I. V., Seger, R., Rouch, C. T., Sleath, P. R., McMullen, B.
A. & Bomsztyk, K. (1994). Purification, cloning, and expression of a murine 
phosphoprotein that binds the kappa-B motif in vitro identifies it as the 
homolog of the human heterogenous nuclear ribonucleoprotein K-protein - 
description of a novel DNA-dependent phosphorylation process. Journal o f  
Biological Chemistry 269, 17626-17634.
Ostrowski, J., Sims, J. E., Sibley, C. H., Valentine, M. A., Dower, S. K., Meier, K. E. 
& Bomsztyk, K. (1991). A serine threonine kinase acitvity is closely 
associated with a 65 kDa phosphoprotein specifically recognized by the kappa- 
B enhancer element. Journal o f Biological Chemistry 266, 12722-12733.
Palmer, D. & Malim, M. H. (1996). The human T-cell leukemia virus type 1
pottranscriptional trans-activator Rex contains a nuclear export signal. Journal 
o f Virology 70, 6442-6445.
Pangiotidis, C. A., Lium, E. K. & Silverstein, S. J. (1997). Physical and functional
interactions between herpes simplex virus immediate-early proteins ICP4 and 
ICP27. Journal o f Virology 71, 1547-1557.
Pereira, L., Wolff, M. H., Fenwick, M. & Roizman, B. (1977). Regulation of
herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides 
made in HSV-1 and HSV-2 infected cells. Virology 77, 733-749.
Petersen-Mahrt, S. K., Estmer, C., Ohrmalm, C., Matthews, D. A., Russell, W. C. & 
Akusjarvi, G. (1999). The splicing factor-associated protein, p32, regulates 
RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. 
E M B O J18, 1014-1024.
Peterson, K. L., Zhang, W., Lu, P. D., Keilbaugh, S. A., Peerschke, E. I. &
Ghebrehiwet, B. (1997). The Clq-binding cell membrane proteins cClq-R and 
gClq-R are released from activated cells: subcellular distribution and 
immunochemical characterisation. Clinical Immunology and 
Immunopathology 84, 17-26.
Phelan, A., Carmo-Fonseca, M., McLauchlan, J., Lamond, A. I. & Clements, J. B. 
(1993). A herpes simplex virus type 1 immediate-early gene product, IE63, 
regulates small nuclear ribonucleoprotein distribution. Proceedings o f  
National Academy o f Science. USA 90, 9056-9060.
Phelan, A. & Clements, J. B. (1997). Herpes simplex virus type 1 immediate early 
protein IE63 shuttles between nuclear compartments and the cytoplasm. 
Journal o f  General Virology.
Phelan, A., Dunlop, J. & Clements, J. B. (1996). Herpes simplex virus type 1 protein 
IE63 affects the nuclear export of virus intron-containing transcripts. Journal 
o f Virology 70, 5255-5265.
Phillips, A. C. & Vousden, K. H. (1997). Analysis of the interaction between human 
papillomavirus type 16 E7 and the TATA binding protein TBP. Journal o f 
General Virology 78, 905-909.
Picard, D., Khursheed, B., Garabedian, M. J., Fortin, M. G., Lindquist, S. &
Yamamoto, K. R. (1990). Reduced levels of HSP90 compromise steroid- 
receptor action in vivo. Nature 313, 166-168.
156
Post, L. E. & Roizman, B. (1981). A generalized technique for deletion of specific 
genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not 
essential for growth. Cell 1981, 227-32.
Preston, C. M., Frame, M. C. & Campbell, M. E. M. (1988). A complex formed
between cell components and an HSV structural polypeptide binds to a viral 
immediate early gene regulatory DNA-sequence. Cell 425-434.
Pugh, B. F. & Tijian, B. (1990). Mechanism of transcriptional activation by SP1 - 
evidence for coactivators. Cell 61, 777-789.
Purves, F. C., Ogle, W. O. & Roizman, B. (1993). Processing of the herpes virus
regulatory protein alpha 22 mediated by the UL13 protein kinase determines 
the accumulation of a subset of alpha and gamma mRNAs and proteins in 
infected cells. Proceedings o f the National Academy o f  Sciences USA. 90, 
6701-6705.
Quinlan, M. P. & Knipe, D. M. (1985). Stimulation of expression of a herpes simplex 
virus DNA-binding protein by two viral functions. Molecular Cell Biology 5, 
957-963.
Quinn, J. P., McGregor, R. A., Fiskerstand, C. E., Davey, C., Allan, J. & Dalzel, R. G. 
(1998). Identification of a novel multifunctional structural domain in herpes 
simplex virus 1 genome: implications for viral latency. Journal o f General 
Virology 79, 2529-2532.
Rice, S. A. & Knipe, D. M. (1988). Gene-specific transactivation by herpes simplex 
virus type 1 alpha protein ICP27. Journal o f Virology 62, 3814-3823.
Rice, S. A. & Knipe, D. M. (1990). Genetic evidence for two distinct transactivation 
functions of the herpes simplex virus a  protein ICP27. Journal o f Virology 64, 
1704-1715.
157
Rice, S. A. & Lam, V. (1994). Amino acid substitution mutations in the herpes 
simplex virus ICP27 protein define an essential gene regulation function. 
Journal o f Virology 68, 823-833.
Rice, S. A., Lam, V. & Knipe, D. M. (1993). The acidic amino-terminal region of 
herpes simplex virus type 1 alpha protein ICP27 is required for an essential 
lytic function. Journal o f  Virology 67, 1778-1787.
Rice, S. A., Long, M. C., Lam, V., Schaffer, P. A. & Spencer, C. A. (1995). HSV 
ICP22 protein is required for viral modification of RNA polymerase II and 
establishment of the normal viral transcription program. Journal o f  Virology 
69, 5550-5559.
Richard, N., Iacampo, S. & Cochrane, A. (1994). HIV-1 Rev is capable of shuttling 
between the nucleus and the cytoplasm. Virology 204, 123-131.
Rock, D. (1993). The molecular basis of latent infections by alphaherpes viruses. 
Seminars in Virology 4, 157-165.
Roizman, B. (1979). The structure and isomerization of herpes simplex virus 
genomes. Cell 16, 481-494.
Roizman, B. & Sears, A. (1996). Herpes simplex viruses and their replication. In
Virology, 3 edn, pp. 2231-2296. Edited by B. Fields, D. Knipe & P. Howley. 
Philadelphia: Raven Press.
Rout, M. P. & Wente, S. R. (1994). Pores for thought: nuclear pore complex proteins. 
Trends in Cell Biology 89, 715-725.
Saavedra, C. A., Hammell, C. M., Heath, C. V. & Cole, C. N. (1997). Export of heat 
shock mRNAs following stress in S. cerevisiae employs a distinct pathway 
defined by Riplp and also requires a subset of factors essential for export of 
poly(A)+ RNA. Genes and Development 11, 2845-2856.
Sacks, W. R., Greene, C. C., Aschman, D. P. & Schaffer, P. A. (1985). Herpes 
simplex virus type 1 ICP27 is an essential regulatory protein. Journal o f  
Virology 55, 796-805.
Sacks, W. R. & Schaffer, P. A. (1987). Deletion mutants in the gene encoding the 
herpes simplex virus type 1 immediate-early protein ICPO exhibit impaired 
growth in cell culture. Journal o f Virology 61, 829-839.
Sandri-Goldin, R. M. (1998). ICP27 mediates HSV RNA export by shuttling through 
a leucine-rich nuclear export signal and bindng viral intronless RNAs through 
an RGG motif. Genes and Development 12, 868-879.
Sandri-Goldin, R. M. & Hibbard, M. K. (1996). The herpes simplex virus type 1
regulatory protein ICP27 coimmunoprecipitates with anti-Sm antiserum, and 
the C terminus appears to be required for this interaction. Jornal o f  Virology 
70, 108-118.
Sandri-Goldin, R. M., Hibbard, M. K. & Hardwicke, M. A. (1995). The C-terminal 
repressor region of herpes simplex virus type 1 ICP27 is requred for the 
redistribution of small nuclear ribonucleoprotein particles and splicing factor 
SC35; however, these alterations are not sufficient to inhibit host cell splicing. 
Journal o f Virology 69, 6063-6076.
Sanz-Ezquerro, J., Santaren, J. F., Sierra, T., Aragon, T., Ortega, J., Ortin, J., Smith,
G. L. & Nieto, A. (1998). The PA influenza virus polymerase subunit is a 
phosphorylated protein. Journal o f General Virology 79, 471-478.
Schullery, D., Ostrowski, J., Denisenko, O., Stempka, L., Shnyreva, M., Suzuki, H., 
Gschwendt, M. & Bomsztyk, K. (1999). Regulation interaction of protein 
kinase C5 with the heterogenous nuclear ribonucleoprotein K protein. Journal 
o f Biological Chemistry 274, 15101 -15109.
Schuly, T. F. (1998). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). 
Journal o f General Virology. 79, 1573-1591.
Semmes, O., Chen, L., Sarisky, R., Gao, Z., Zhong, L. & Hayward, S. (1998). Mta has 
properties of an RNA export protein and increases cytoplasmic accumulation 
of Epstein-Barr virus replication gene mRNA. Journal o f  Virology 72, 9526- 
9534.
Seuningen, I. V., Ostrowski, J. & Bomsztyk, K. (1995). Description of an interleukin- 
1 responsive kinase that phosphorylates the K protein. Enhancement of 
phosphorylation by selective DNA and RNA motifs. Biochemistry 34, 5644- 
5650.
Seuningen, I. V., Ostrowski, J., Bustelo, X., Sleath, P. & Bomxztyk, K. (1996). The K 
protein domain that recruits the interleukin 1-responsive K-protein-kinase lies 
adjacent to a cluster of c-src and Vav SH3-binding sites - implications that K- 
protein acts as a docking platform. Journal o f Biological Chemistry 270, 
26976-26985.
Sheldrick, P. & Berthelot, N. (1974). Inverted reptitions in the chromsome of herpes 
simplex virus. Cold Spring Harbour Symposium on Quantitative Biology 9, 
471-480.
Simos, G. & Georgatos, S. D. (1994). The lamin B receptor-associated protein p34
shares sequence homology and antigenic determinants with the splicing factor 
2-associated protein p32. FEBS Letters 346, 225-228.
Singh, M., Fraefel, C., Bello, L. J., Lawrence, W. C. & Schwyzer, M. (1996).
Identification and characterization of BICP27, an early protein of bovine 
herpesvirus 1 which may stimulate mRNA 3' processing. Journal o f  General 
Virology 77, 615-625.
160
Siomi, H., Choi, M., Siomi, M. C., Nussbaum, R. L. & Dreyfuss, G. (1994). Essential 
role for KH domains in RNA binding: impaired RNA binding by a mutation 
in the KH domain of FMR1 that causes Fragile X syndrome. Cell 77, 33-39.
Siomi, H. & Dreyfuss, G. (1995). A nuclear localization domain in the hnRNP A1 
protein. Journal o f Cell Biology 129, 551-560.
Soliman, T. M., Sandri-Goldin, R. M. & Silverstein, S. J. (1997). Shuttling of the
herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and 
the cytoplasm mediates the expression of late proteins. Journal o f  Virology 71, 
9188-9197.
Steveley, W. S., Katan, M., Stirling, V., Smith, G. & Leader, D. P. (1985). Protein- 
kinase activities associated with the virions of pseudorabies and herpes- 
simplex virus. Journal o f General Virology 66, 661-673.
Stow, N. D. & Stow, E. C. (1986). Isolation and characterization of a herpes simplex 
virus type 1 mutant containing a deletion within the gene encoding the 
immediate-early polypeptide Vmwl 10. Journal o f General Virology 67,2571- 
1585.
Struhl, K. (1991). Acid connections. Current Biology 1, 188-191.
Stutz, F., Kantor, J., Zhang, D., McCarthy, T., Neville, M. & Rosbash, M. (1997). The 
yeast nucleoporin Riplp contributes to multiple export pathways with no 
essential role for its FG repeat. Genes and Development 11, 2587-2868.
Stutz, F. & Robash, M. (1998). Nuclear RNA export. Genes and Development 12, 
3303-3319.
Su, L. & Knipe, D. M. (1989). Herpes simplex virus alpha protein ICP27 can inhibit 
or augment viral gene transactivation. Virology 170, 496-504.
161
Szilagyi, J. F. & Cunningham, C. (1991). Identification and characterisation of a novel 
non-infectious herpes simplex virus related particle. Journal o f General 
Virology 62.
Takagaki, Y., Ryner, L. C. & Manley, J. L. (1989). Four factors are required for 3' end 
cleavage of pre-mRNAs. Genes and Development 3,1711-1724.
Takimoto, M., Tomonaga, T., Matunis, M., Avigan, M., Krutzsch, H., Dreyfuss, G. & 
Levens, D. (1993). Specific binding of heterogeneous ribonucleoprotein 
particle protein-K to the human c-myc promoter, in vitro. Journal o f  
Biological Chemistry 268, 18249-18258.
Tange, T. O., Jensen, T. H. & Kjems, J. (1996). In vitro interaction between human 
immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2- 
associated protein, p32. Journal o f  Biological Chemistry 271, 10066-10072.
Taylor, S. J. & Shalloway, D. (1994). An RNA-binding protein associated with Src 
through its SH2 and SH3 binding domains in mitosis. Nature 368, 867-870.
Tomonaga, T. & Levens, D. (1995). Heterogeneous nuclear ribonucleoprotein-K is a 
DNA-binding transactivator. Journal o f Biological Chemistry 270, 4875-4881.
Tomonaga, T., Michelotti, G., Libutti, D., Uy, A., Sauer, B. & Levens, D. (1998).
Unrestraining genetic processes with a protein-DNA hinge. Molecular Cell 1, 
759-764.
Tomow, J. & Santangelo, G. G. (1990). Efficient expression of Saccharomyces 
cerevisiae glycolytic gene ADH1 is dependent upon a cis-acting regulator 
element (UASPRG) found initially in genes encoding ribosomal proteins. Gene 
90, 79-85.
Truant, R., Kang, Y. & Cullen, B. R. (1999). The human Tap nuclear RNA export 
factor contains a novel transportin-dependent nuclear localization signal that
162
lacks nuclear export signal function. Journal o f Biological Chemistry 274, 
32167-32171.
Tsieh, T. Y., Matsumoto, M., Chou, H. C., Schneider, R., Hwang, S., Lee, A. & Lai, 
M. (1998). Hepatitis C Virus core protein interacts with heterogenous nuclear 
ribonucleoprotein K. Journal o f Biological Chemistry 273,17651-17659.
Ullman, K. S., Powers, M. A. & Forbes, D. J. (1997). Nuclear export receptors from 
importin to exportin. Cell, 967-970.
Uprichard, S. L. & Knipe, D. M. (1996). Herpes simplex ICP27 mutant viruses exhibit 
reduced expression of specific DNA replication genes. Journal o f  Virology 70, 
1969-1980.
Vancurova, I., JochovaRupes, J., Lou, W. & Paine, P. L. (1995). Distinct
phosphorylation sites differentially influence facilitated transport of an NLS- 
protein and its subsequent intranuclear binding. Biochemical and Biophysical 
Research Communications 217,419-427.
Vasavada, H. A., Ganguly, S., Germino, F. J., Wang, Z. X. & Weissman, S. M.
(1991). A contingent replication assay for the detection of protein-protein 
interactions in animal cells. Proceedings o f the National Academy o f  Science. 
USA 88, 10686-10690.
Vaughan, P. J., Thibault, K. J., Hardwicke, M. A. & Sandri-Goldin, R. M. (1992). The 
herpes simplex virus immediate early protein ICP27 encodes a potential metal 
binding domain and binds zinc in vitro. Virology 189, 377-384.
Voit, R., Schnapp, A., Kuhn, A., Rosenbauer, H., Hirschmann, P., Stunnenberg, H. G. 
& Grummt, I. (1992). The nucleolar transcription factor MUBF is 
phosphorylated by casein kinase-II in the C-terminal hyperacidic tail which is 
essential for transactivation. EMBO Journal 11, 2211-2218.
Wadd, S., Bryant, H., Fihol, O., Scott, J. E., Hsieh, T.-Y., Everett, R. D. & Clements,
J. B. (1999). The multifunctional herpes simplex virus IE63 protein interacts 
with heterogenous ribonucleoprotein K and with casein kinase 2. Journal o f  
Biological Chemistry 274, 28991-28998.
Wagner, E. K., Guzowski, J. F. & Singh, J. (1995). Transcription of the herpes
simplex virus genome during productive and latent infection. In Progress in 
Nucleic Acid Research and Molecular Biology, pp. 123-165. Edited by W. H. 
Cohn & K. Moldave. Moldave: Academic Press.
Wang, Y. L., Finan, J. E., Middeldorp, J. M. & Hayward, S. D. (1997). p32/Tap, a 
cellular protein that interacts with EBNA-1 of Epstein-Barr virus. Virology 
236, 18-29.
Watson, R. J. & Clements, J. B. (1980). A herpes simplex virus type 1 function
continuously required for early and late virus RNA synthesis. Nature 285, 329- 
330.
Wen, W., Meinkoth, J. L., Tsien, R. Y. & Taylor, S. S. (1995). Identification of a 
signal for rapid export of proteins from the nucleus. Cell 82, 463-473.
Weng, Z., Thomas, S. M., Rickies, R., Taylor, J., Brauer, A., Seidel-Dugan, C.,
Michael, W. M., Dreyfuss, G. & Brugge, J. (1994). Identification of Src, Fyn 
and Lyn SH3-binding proteins: implications for a function of SH3 domains. 
Molecular Cell Biology 14, 4509-4521.
Whitehouse, A., Cooper, M. & Meredith, D. (1998). The immediate-early gene
product encoded by open reading frame 57 of Herpesvirus saimiri modulates 
gene expression at the posttranscriptional level. Journal o f  Virology 72, 857- 
861.
164
Wichmann, I., Garcia-Lozano, L., Respaldiza, N., Gonzales-Escribano, M. F. & 
Nunez-Roldan, A. (1999). Autoantibodies to transcriptional regulation 
proteins DEK and ALY in a patient with systemic Lupus Erthematosus. 
Human Immunology 60, 57-62.
Wickens, M. (1990). In the beginning is the end: regulation of poly(A) addition and 
removal during early development. Trends in Biological Science 15, 320-324.
Wilcox, K. W., Kohn, A., Skylanskaya, E. & Roizman, B. (1980). Herpes simplex
virus phosphoproteins. I. Phopshate cycles on and off some viral polypeptides 
and can alter their affinity for DNA. Journal o f  Virology 33, 167-182.
Will, C. L. & Luhrmann, R. (1997). Protein functions in pre-mRNA splicing in 
metazoa. Current Opinions in Genetics Development 7, 205-211.
Winkler, M., Rice, S. & Stammeringer, T. (1994). UL69 of human cytomegalovirus, 
an open reading frame with homology to ICP27 of herpes simplex virus, 
encodes a transactivator of gene expression. Journal o f  Virology 68, 3943- 
3954.
Xiao, S. H. & Manley, J. L. (1997). Phosphorylation of the ASE/SF2 RS domain
affects both protein-protein and protein-RNA interactions and is necessary for 
splicing. Genes and Development 11, 334-344.
York, I., Roop, C., Andrews, D., Riddell, S., Graham, F. & Johnson, D. (1994). A 
cytosolic herpes simplex protein inhibits antigen presentation to CD8+ T 
lymphocytes. Cell 77, 525-535.
Yu, L., Loewenstein, P. M., Zhang, Z. & Green, M. (1995). In vitro interaction of the 
TFIIB with the cellular protein TAP. Journal o f Virology 69, 3017-3023.
165
Zhang, B. L., Kraemer, B., Sengupta, D. & Wickens, M. (1999). Yeast three-hybrid 
systems to detect and analyse interactions between RNA and protein. Methods 
in Enzymology 306, 93-113.
Zhi, Y. & Sandri-Goldin, R. (1999). Analysis of the phosphorylation sites of herpes 
simplex virus type 1 regulatory protein ICP27. Journal o f  Virology 73, 3246-
Zhi, Y., Sciabica, K. S. & Sandri-Goldin, R. M. (1999). Self-interaction of the herpes 
simplex virus type 1 regulatory protein ICP27. Virology 257, 341-351.
Zhu, X., Chen, J., Young, C. S. H. & Silverstein, S. (1990). Reactivation of latent
herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene 
products. Journal o f Virology 64, 4489-4498.
3257.
166
